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      A family of water soluble and positively charged L-arginine based poly (ester 
amide)s (Arg-PEAs) was synthesized by solution polycondensation. These 
biodegradable Arg-PEAs consist of 3 nontoxic building blocks: L-arginine, diols and 
dicarboxylic acids.  The Arg-PEAs were prepared by the reaction of tetra-p-
toluenesulfonic acids salts of bis-(L-arginine) α, ω-alkylene diesters and di-p-
nitrophenyl esters of dicarboxylic acids.  Optimal conditions of the monomers and 
polymers synthesis were investigated, and the monomers and Arg-PEAs were 
chemically characterized.  Arg-PEAs were found to have good solubility in water and 
many other polar solvents. .  Arg-PEAs were evaluated by many biological assays for 
the gene delivery applications. Structure-function relationship of the Arg-PEAs 
revealed that changing the number of methylene groups in the diol or/and diacid 
segment could finely tune the hydrophobic and cationic properties of the Arg-PEAs, 
and then affect the gene delivery efficiency. MTT assay showed that all the prepared 
Arg-PEAs and Arg-PEA/DNA complexes were non-toxic to the cell lines even at very 
large doses. Some of Arg-PEAs showed comparable or higher transfection efficiency 
than the commercial transfection agents, Superfect® and Lipofectamine2000®.  
      Based on the above results, a new generation of Arg-PEAs, oligoethylene glycols 
and L-arginine based poly (ether ester amide)s (Arg-PEEAs) were developed. The 
 new Arg-PEEAs had more flexible chain due to the introduction of oligoethylene 
glycols. Structure-function relationship of the Arg-PEEAs was intensively studied. 
MTT assay showed that all the and Arg-PEEA/DNA complexes were non-toxic to the 
cell lines, primary cells and stem cells even at very large doses. The Arg-PEEAs 
expanded the gene transfection from cell lines to primary cells/stem cells, and showed 
comparable or higher transfection efficiency than the commercial transfection agents, 
Superfect® and Lipofectamine2000®.   
      Arg-PEAs with double bond functionality (Arg-UPEAs) could be photo-
crosslinked with Pluronic- diacrylate (Pluronic-DA) to form cationic hybrid hydrogels. 
The physicochemical and mechanical properties of the hybrid hydrogels were studied. 
The fibroblast and endothelial cells were cultured on the hybrid hydrogel surface and 
inside the hydrogel, respectively. The results indicated that the introduction of Arg-
UPEAs could significantly increase the cell attachment performance on hydrogel 
surface and viability inside the hydrogel.  
      Some new L-phenylalanine based poly (ester amide)s (Phe-PEA) or derivatives 
were developed as the coating materials causing low inflammatory response. One 
example is the block copolymer of Phe-PEA and poly (ε –caprolactone) (PCL) [PEA-
b-PCL], another example is the L-Arginine and L-phenylalanine based hybrid poly 
(ester amide)s (Arg-Phe-PEAs). The new biomaterials were characterized and studied 
the cellular responses, such as cell attachment and macrophage inflammatory 
response. The results indicated that they could promote the cell attachment and cause 
very low inflammatory response.   
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1.A Abstract 
 
      In order to improve the gene therapy efficiency, new gene delivery systems have 
recently been fast developed1-9. Among them, the synthetic delivery systems, 
especially cationic polymer based systems, have aroused great interests from scientist 
and clinicians due to their versatile property choices and clinical safety1-9. Many 
reports indicated that the cationic properties and chemical structure of the polymers 
have very important effects on DNA/vector complex size and stability, DNA uptake, 
stability of DNA in the endosome and cytoplasm and the targeting of DNA to the cell 
nucleus1-9. The deep understanding of cationic polymers’ structure-function 
relationship would help to elucidate the details and mechanisms for DNA delivery and 
stability within cells. However, few review articles systematically addressed this 
structure-function issue. This review chapter would go over and discuss the current 
status of polycations as non-viral gene delivery vectors, especially focus on how the 
modification of polycations’ structure affect the polymer property, then affect the gene 
delivery efficiency. The knowledge would help to design new polycations with high 
transfection efficiency and low cytotoxicity simultaneously. 
 
1.B Gene Therapy 
 
      In the early 1970s, gene therapy was first defined as the treatment of human 
disease by transferring the genetic material into specific cells of the patients1-11. 
During the past several decades, gene therapy has obtained significant attention as a 
potential method for treating genetic diseases and cancers 1-11. With the fast growing 
of biotechnology, gene therapy has been developed rapidly and led to the first genetic 
treatment of patients under approved FDA protocols in 19901-11. From that, thousands 
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of gene therapy clinical trials have been approved and operated worldwide1-11. 
However, the successful rate of gene therapy was not very encouraging1-13. A 
successful delivery system must be able to effectively transport DNA across the 
plasma membrane, through the intracellular environment, and finally into the nucleus 
without damage1-11. Based on the reported gene trial results, one of the key limitations 
was that there had not been safe, efficient and controllable methods for gene delivery1-
13. 
 
1.C Gene Delivery Vectors 
 
      Currently the research efforts for gene delivery are focused on the following 
areas1-13: 1, obtaining effective delivery vectors that compact and protect 
oligonucleotides from the nucleases degradation in the blood or cytosol; 2, the 
delivery vectors should be biocompatible, causing low cytotoxicity and inflammation 
response. Normally, gene delivery vectors could be divided into viral vector and non-
viral vector. 
 
      For the viral vectors, the advantages and disadvantages have been well 
documented1-13. Because of the specialized structures evolved after million years, viral 
delivery systems, including retroviruses and adenoviruses, have exhibited pretty high 
delivery efficiency of DNA and RNA to numerous cells5. However, the limitations 
brought by viral vector systems, including payload capacity, toxicity and 
immunogenicity, targeting of specific cell types, production and packaging, 
recombination, and production cost, restricted their clinical applications and 
encouraged the investigations of non-viral gene delivery vectors5. 
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      Therefore, non-viral gene delivery systems, especially synthetic DNA delivery 
systems, have greatly aroused the interests from both researchers and clinicians1-13. 
For the non-viral synthetic gene delivery vectors, the majority of them, furthermore, 
could be divided into three sub categories: 1, cationic lipids/liposomes; 2, cationic 
dendrimers; 3, cationic polymers. All of them have shown the strong gene delivery 
capability. Among them, the cationic polymers aroused highest interests because of 
their versatile choices of polymer structure, charge property, functional groups, 
molecular weight and other physicochemical properties1-13.  
 
1.D In Vitro Gene Delivery Pathway for Cationic Polymers 
 
      Good biocompatibility, high payload capacity and easiness for large-scale 
production make the non-viral vectors, especially cationic polymers, increasingly 
attractive for gene therapy1-11. However, unlike viral systems that have been evolved 
to overcome cellular barriers and immune defense, most of the reported non-viral gene 
delivery vectors showed relative inefficient transfection and cytotoxicity due to the 
numerous cellular obstacles1-11.  Therefore, identifying the details for each barrier of 
the delivery pathway would help to overcome the barriers and improve gene delivery 
efficiency.  For the in vitro gene delivery pathway of cationic polymers, though some 
steps have been explained clearly, the majority steps and details of the pathway and 
barriers are still unclear and need further investigations1-11. The commonly agreed 
gene delivery pathway for cationic polymers could be divided into the following 
steps5: (A) DNA/polycation complex formation; (B) uptake and endocytosis; (C) 
escape from endosome or degradation (endosome and lysosome); (D) intracellular 
release or degradation (cytosol); (E) nuclear targeting, entry and expression.  
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        The first step of the pathway is polymer/DNA complex formation5.  By 
electrostatic interaction, the positively charged polycations condense negatively 
charged DNA and form polyelectrolyte complex. The key factors for this step are the 
stability and size of the complex particle in the solutions5. Normally, there would be 
excessive positive charge on the complex particle surface to keep the particle stable 
and facilitate the interaction with the cellular membrane. For a successful DNA 
delivery, the reports suggested that it would be in the range of 50-250 nm. And the 
aggregation of complexes would significantly reduce the gene delivery efficiency5. 
 
        In the second step, the complexes are taken up by cells through endocytosis5. 
Before the endocytosis, the DNA/polymer complex need attach to the cell membrane 
by electrostatic interaction or receptor/ligand (R/L) interaction5. Endocytosis is the 
process by which cells absorb molecules from outside the cell by engulfing them with 
their cell membrane and it is a multistep process involving binding, internalization, 
formation of endosomes, fusion with lysosomes, and lysis. The enzymes and low pH 
within endosomes and lysosomes usually cause degradation of entrapped DNA and 
associated complexes.  
 
      So the efficiency of gene delivery is related with destabilization and escaping from 
endosomes, which is the 3rd step of the gene delivery pathway5. Methods/mechanisms 
to enhance polycation/DNA complex early release from endosome have been actively 
explored. One of the escaping mechanisms is called “proton sponge effect”, which 
was caused by cationic polymers with buffering capability that promote endosome 
osmotic swelling, disruption of the endosome membrane and intracellular release of 
DNA. 
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      After escaping from the endosome, the DNA need move through the cytosol 
toward the nucleus and the movement is probably controlled by diffusion, which is 
slow5. During this process, DNA must be protected from the cytoplasm nucleases. 
Before or after entering the nucleus, the DNA must be released from the complexes. 
For this step, only complexes with intermediate stability will gain the maximal gene 
expression because stable complexes may restrict DNA release and unstable 
complexes would cause rapid DNA degradation. The liberation rate and percentage of 
DNA from polycations is directly related with the polymer structural property. The 
final nucleus entry is to occur through nuclear pores (~10 nm in diameter) or during 
cell division5. For this nuclear targeting step, the knowledge about nuclear targeting is 
still relatively unclear and the understanding/exploiting nuclear targeting should 
greatly help to improve the DNA delivery efficiency. 
 
      Based on the above discussions, there following are major barriers for the non-
viral gene delivery pathway through polycations5: low uptake across the cell 
membrane, inadequate release and stability of DNA, and lack of nuclear targeting. In 
addition to these major barriers, several other issues also need to be overcome, 
including optimization of DNA condensation, size of DNA complexes, cell targeting 
and cytotoxicity5. 
 
      Overall, the process and mechanism for polycations gene delivery are very 
complicated and many steps/barriers affect the success of gene delivery5. Since most 
of the key steps/barriers have direct or indirect relationships with the polycations’ 
properties, which is determined by polycations’ functional groups and structure, the 
investigation and elucidation of the polymer structure-function relationship is very 
important for polycation based gene delivery.  
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      Almost all of the polycations’ functional groups for gene delivery are the amine 
based groups, which are functional groups that contain basic nitrogen atoms. 
Depending on how many of the hydrogen atoms are replaced, amines could be divided 
into three different basic classes: primary amine, secondary amine and tertiary amine. 
Most of the amine based cationic groups, including the amine derivatives with 
complicated structure, such as azole family, could be looked as the different 
combinations of the three basic types of amines. For the amines in the amides part, the 
amines are attached to carbonyl group and could not show the cationic property, so 
they would not be considered as the functional group for DNA condensing.  
 
 
 
 
 
 
Figure 1.1 Examples of Amine Groups for Gene Delivery 
 
      This introduction chapter reviews the polycation non-viral DNA delivery systems, 
highlighting the typical systems and focusing on how the polymer structure and 
functional amine groups affect the DNA transfection efficiency, cytotoxicity and 
delivery mechanism. The examples and discussions would focus on applying different 
methods to enhance DNA penetration of the plasma membrane, approaches for 
optimizing protection and intracellular release of DNA, and ways of improving DNA 
targeting to the nucleus. In the aspects of tuning the polymer structure and other 
properties, the following are some general principles for the chemical modifications of 
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polycations: 1, by introducing hydrophilic or hydrophobic segments, such as PEG 
(hydrophilic) and polyester (hydrophobic), amphiphilic polymer structure could be 
obtained. The polymer solubility and polymer/DNA complex stability would be 
significantly affected; 2, by introducing functional groups with buffering capability, 
such as imidazole group and PEI, the proton sponge effect would be obtained; 3, by 
introducing peptide sequences or antibody/antigen, the complex would be able to have 
specific interaction with cell membrane. These modification methods could be 
separately applied to the specific systems or be applied with different combinations. 
 
1.E Natural Polymers as Non-Viral Gene Delivery Vectors 
1.E.1 Chitosan 
 
      Chitosan is prepared from deacetylation of chitin to have the polymer composed of 
D-glucosamine and N-acetyl- D-glucosamine subunits linked by (1, 4) glycosidic 
bonds14, 15. The primary amine group in chitosan has a pKa value around 6.5, which 
made chitosan positively charged and soluble in acidic or neutral solution14, 15. As the 
only basic polysaccharide existing in nature, the biodegradability, biocompatibility, 
and cationic property of chitosan has helped it become one of the most attractive non-
viral gene delivery vectors14-17.  
 
 
 
 
 
 
 Figure 1.2   Chemical Structure of Chitosan 
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      Since the middle of 1990s, chitosan had been widely tested for gene delivery 
applications14-18. The results indicated that molecular weight of chitosan, in a certain 
range, could affect the chitosan/DNA complex particle size and stability, and then 
influence the gene transfer efficiency19. It was found that the size of chitosan/DNA 
complex increases with the increasing of chitosan molecular weight and higher 
molecular weight chitosan forms more stable chitosan/DNA complexes 19, 20.  In the 
molecular weight range of 15 kDa to 220 kDa, the transfection efficiency increases 
with the increasing of molecular weight of chitosan21. However, this molecular weight 
effect has not been evaluated or discussed for the chitosan with molecular weight 
larger than 250 kDa. To improve transfection efficiency of chitosan, numerous 
modifications to the polymer structure have been made16, 18, 20, 22-30. For example, by 
conjugating chitosan with hydrophilic PEG or dextran14, 25, 31, 32, the stability of 
chitosan/DNA complex would be improved and complex cytotoxicity would be 
decreased. And hydrophobic moieties, such as deoxycholic acid, stearic acid, and 
other alkyl chains have been conjugated to chitosan to reduce the aggregation of 
chitosan/DNA complex and improve the interactions between the complexes and cell 
surfaces26, 33, 34. The transfection results showed that the alkylated chitosan derivatives 
perform much higher transfection efficiency than unmodified chitosan26, 33, 34. 
 
      To improve the cationic properties (charge density and buffering capability) of 
chitosan, several methods were utilized, such as grafting chitosan with polylysine, 
polyethyleneimine, urocanic acid, guanidine group and quaternization of chitosan 
amine groups27, 35, 36.   These modifications resulted in improved transfection 
efficiency, but cause higher cytotoxicity compared to unmodified chitosan27, 35, 36. 
Various cell-targeting ligands have been conjugated to chitosan so that chitosan/DNA 
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complexes could be delivered to specific cell types. Galactose, lactose, folate, and 
trisaccharide have also been used to improve the hepatic cell-targeting and improve 
the gene transfection efficiency24, 29, 37-39. 
 
 
      
 
 
 
 
 
     Figure 1.3   Chemical Structure of Chitosan-g-PEG 
 
 
1.E.2 Dextran and Cyclodextrin 
 
      Dextran is a branched polysaccharide composed of glucose units with varying 
lengths and the molecular weight is ranging from 10 to 150 kDa. Because of its good 
biocompatibility and wide availability, dextran has aroused interest from scientists for 
the gene delivery applications40-42. Since dextran itself has no amine based groups, the 
chemical modification is needed to introduce the positively charged amine groups to 
dextran40-42. One example is diethylaminoethyl-dextran (DEAE-dextran), which has 
been widely used for gene transfer applications for decades40.  
 
      Recently, dextran-g-spermine polycations have been synthesized by oxidizing 
dextran with potassium periodate followed by reductive amination with spermine and 
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the polymers showed good transfection efficiency41, 42. However, the further 
modification, quaternization of dextran-g-spermine showed reduced transfection 
efficiency43. The reason could be due to the hindered release of DNA from complex or 
the significant change of the polymer structure43. Further modification of dextran-g-
spermine with PEG showed improved gene transfer efficiency44.  
 
 
 
 
 
 
 
 
 
Figure 1.4   Chemical Structure of Dextran 
 
 
 
 
 
 
 
 
 
 
 
OH
OH
H
O
H
OHH
OH
CH2
OH
OH
H
O
H
OHH
OH
H2C
OH
OH
H
O
H
OHH
CH2OH
OH
H
O
H
OHH
OH
12 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5   Chemical Structure of β-cyclodextrin 
 
      Another type of glucose based polysaccharide system, cyclodextrin, was also 
widely evaluated for gene delivery applications because of the excellent 
biocompatibility and plenty of applications for the drug delivery45-55. Davis et al. 
reported that incorporating β-cyclodextrin into cationic polymers by polymerization of 
a bifunctional β-cyclodextrin monomer to prepare linear β-cyclodextrin based 
polymers49, 53, 56. Transfection results showed good gene transfer efficiency and 
limited toxicity49. Further investigation showed that the length of methylene units (n) 
between β-cyclodextrin monomer units affects the cyclodextrin/DNA complex’s 
transfection efficiency and cytotoxicity: longer chain lengths cause decreased charge 
density, and then decrease the complex cytotoxicity50. The results indicated that for 
the methylene units (n) ranging from 4 to 10, lowest cytotoxicity and highest 
transfection efficiency were obtained for polymers with 6, 7, or 8 methylene units50. 
And for n equals 10, the polymer showed highest toxicity and lowest transfection 
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efficiency, which could be due to the reduced polymer solubility50. And the reduced 
polymer solubility means the increased hydrophobicity. Similar study of β-
cyclodextrin based complex showed that increasing the hydrophilicity of the β-
cyclodextrin spacer unit can reduce cytotoxicity because of the improved chain 
flexibility57. However, quantitative evaluation of the hydrophobicity/hydrophilicity is 
still needed for this system57. 
 
      Other chemical modifications were also applied to cyclodextrin system. The 
PEGylation of cationic β-cyclodextrin could help to reduce the complex aggregation48. 
Peptide conjugated β-cyclodextrin polymers, such as adamantane-PEG-galactose or 
adamantane-PEG-transferrin conjugated polymer, have shown successful cell 
targeting gene transfer ability58. Imidazole or PEI modified β-cyclodextrin complex 
could own buffering capacity and facilitate the endosomal escape. However the 
cytotoxicity of the modified cyclodextrin may be increased. 59, 60 
 
      Overall, for the polysaccharides based polymers as gene delivery carriers, the 
limitations are mainly focused on the following areas: 1, most of them have very broad 
molecular weight distribution. Currently there was no very effective method for this 
issue; 2, the sugar ring unit of the polysaccharides caused the less flexibility of 
polymer chain, which may affect the stability of the polymer/DNA complex. The 
introduction of PEG may help to improve the flexibility; 3, missing or inadequate 
nitrogen based functional groups for DNA condensing. Conjugating with PLL, PEI or 
other amine based groups/polymers would help to solve this issue, but the cytotoxicity 
may be increased.        
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1.F Synthetic Polymers as Non-viral Gene Delivery Vectors 
1.F.1 Non-biodegradable Synthetic Polymers     
1.F.1.a Polyethylenimine (PEI) 
 
      Polyethylenimine (PEI) is one of the most widely investigated non biodegradable 
cationic polymers for gene transfection36, 61-75. In 1995, Behr et al reported the first test 
of PEI as gene carrier64. After that, PEI and its derivatives have been widely used for 
gene delivery applications36, 61-75. Due to the mixed primary/ secondary/tertiary amines 
in the polymer chain, PEI has been shown the buffering capability, which was called 
the “proton sponge effect”75. Because of the high density of amines, PEI showed 
strong self protonation ability. At the physiological pH, there are about 80% of the 
amines remaining unprotonated and less than 50% nitrogens were unprotonated at a 
pH of 567. This buffering capacity allows PEI/DNA complex to avoid lysosomal 
trafficking and the following degradation.   
 
 
 
 
Figure 1.6   Chemical Structure of Linear PEI 
 
       For the molecular weight effect, Godbey et al. showed that transfection efficiency 
of PEI increases with the increasing of molecular weight in the range of 600 and 
70,000 Da76-78. However, it has been proved that higher molecular weight PEI caused 
higher cytotoxicity76-78. The degree of branching of PEI also affects DNA complex 
formation and stability79.        Chemical modifications to PEI polymer structure have 
been applied to improve transfection efficiency61, 72, 80-89.  PEGylation creates a 
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hydrophilic exterior environment that reduces interactions of the PEI/DNA with 
plasma proteins80, 82, 84, 90.  It was found that the length and density of PEG chains 
conjugated to PEI have an effect on transfection efficiency. DNA could be effectively 
transfected when a high density of short PEG chains (550 Da) are grafted onto PEI81, 
86. Besides PEGylation, quaternization of amines, RGD peptides, transferrin, folate, 
mannose and galactose have been introduced to PEI to improve transfection efficiency 
and the transfection results were very positive69, 84, 85, 87, 90-94.  
 
      The hydrophobic effect was investigated by reacting PEI with the hydrophobic 
amino acids (such as alanine and leucine) or dodecyl and hexadecyl halides69. After 
reaction, the PEI hydrophobicity was significantly enhanced and transfection 
efficiency was improved69.  Many other functional groups were used to modify PEI to 
improve transfection efficiency, such as linking cholesterol to the amines71. For low 
molecular weight branched PEI (1.8 kDa), transfection efficiency increases and 
toxicity is reduced with the addition of cholesterol71. Lee et al. synthesized 
biodegradable PEI derivatives by treatment of low molecular weight PEI (800 Da) 
with linkers95. These compounds showed reduced transfection efficiency and 
cytotoxicity compared to 25 kDa PEI95. In addition to disulfide linkages, PEI 
derivatives with ester linkages have been prepared to create biodegradable gene 
carriers61, 63, 72, 89. Kim et al. synthesized biodegradable PEI-PEG conjugates by 
reacting low molecular weight PEI (600, 1200, 1800 Da) with PEG succinimidyl 
succinate (2000 Da)61. These PEI-PEG conjugates showed reduced cytotoxicity and 
improved gene transfer ability61. However, it should be pointed out that the 
degradation products of PEI-PEG are non biodegradable PEI and PEG.  Kissel et al. 
incorporated PEG-polycaprolactone (PEG-PCL) grafts onto the PEI structures89, 96. 
These polymers showed reduced cytotoxicity and some of them exhibited improved 
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transfection efficiency 89, 96. Cho et al. investigated PCL-PEI conjugates synthesized 
via Michael addition of PEI (600, 1200, 1800 Da) and polycaprolactone diacrylate63. 
Results showed that these PEI derivatives exhibit significantly higher transfection 
efficiency compare to 25 kDa PEI63. Pack et al. synthesized PEI derivatives with ester 
linkages by similar reactions and the new compounds showed significantly lower 
cytotoxicity and higher transfection efficiency than 25 kDa PEI97. Cho et al. 
synthesized linear PEI-b-PEG using a Michael-type addition with low molecular 
weight PEI (423 Da) and PEG diacrylates74. These compounds exhibited reduced 
cytotoxicity and improved gene transfer efficiency compared to 25 kDa PEI74.  In 
addition to the disulfide and ester linkages, hydrolyzable amide and imine linkages 
have also been investigated72, 98. Kissel et al. synthesized low molecular weight L-
lactic acid-co-succinic acid and reacted this compound with low molecular weight 
branched PEI (1200 Da). These amide-linked compounds exhibited reduced 
cytotoxicity compared to 25 kDa PEI and improved transfection efficiency compared 
to 1.2 kDa PEI72. Kim et al. synthesized imine linked PEI by treating low molecular 
weight branched PEI (1.8 kDa) with glutadialdehyde98. While these structures showed 
reduced cytotoxicity, transfection efficiency was lower than that of 25 kDa PEI98. 
 
1.F.1.b Polymethacrylate 
 
      Because of the cationic charge, poly [2-(dimethylamino) ethyl methacrylate] 
(PDMAEMA) and its derivatives were tested as gene transfer agents99. Evaluations of 
these compounds showed that the highest transfection efficiency with acceptable 
cytotoxicity could be obtained from the polymers when the polymer molecular weight 
is greater than 300 kDa100. The successful in vitro transfection of PDMAEMA/DNA 
complex was thought to be due to the polymer’s endosome destabilizing ability101.  
17 
 
 
      Various chemical modifications have been applied to PDMAEMA to improve the 
transfection efficiency. Hennink et al. attempted to improve the endosome escaping 
capability of PDMAEMA by incorporating an additional tertiary amino group in each 
unit to promote the “proton sponge” effect102. However, the modified polymer showed 
reduced cytotoxicity and transfection efficiency103, which could be due to the 
significant change of the polymer structure. Schacht et al. converted various 
percentages of the amine groups of PDMEMA into pyridine, imidazole, and 
carboxylic acid groups to improve endosomal escape. The transfection efficiency for 
all the modified systems were decreased, which continued to indicate that proton 
sponge effect may not be the only dominating effect for gene delivery and the polymer 
structure effect is also very important103. Guanidinium side groups were introduced to 
PDMAEMA because of the strong cell membrane penetrating capability and the 
modified polymer showed improved transfection efficiency104. 
 
 
 
 
 
               Figure 1.7   Chemical Structure of Poly (methacrylate) 
 
      Hydrophobic and hydrophilic segments were incorporated to reduce the 
cytotoxicity of PDMAEMA105, 106. For examples, the 2-(dimethylamino)ethyl 
methacrylate could be copolymerized with other monomers, such as  methyl 
methacrylate (MMA), a hydrophobic monomer; N-vinyl-pyrrolidone (NVP), a 
hydrophilic monomer; and ethoxytriethylene glycol methacrylate (triEGMA), a 
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hydrophilic monomer105. The PDMAEMA-MMA copolymer showed reduced 
transfection efficiency and increased cytotoxicity106. The PDMAEMA-triEGMA and 
the PDMAEMA-NVP copolymers both showed reduced cytotoxicity and improved 
transfection efficiency106. Polymer structure-function study showed that increased 
ratios of comonomer to PDMAEMA decreased cytotoxicity, but also reduced the 
polymer DNA condensing capability106. However, these copolymers showed 
significant transfection efficiency improvements106.  
 
      To promote cellular uptake of PDMAEMA-based polymers, many targeting 
agents, such as folate, hepatocyte-targeting agents (including galactose and lactose), or 
tumor targeting protein, have been incorporated onto the PDMAEMA and the 
modified PDMAEMA showed improved transfection efficiency 107-111. In recent years, 
incorporation of hydrolyzable side chains to PDMAEMA polymers to obtain 
biodegradable PDMAEMA gene carriers has been tried112, 113. For example, Hennink 
et al. synthesized a methacrylate-based polymer with carbonate component (pHPMA-
DMAE) and the polymer showed improved gene transfer efficiency114. 
 
1.F.2 Biodegradable Synthetic Polymers   
1.F.2.a Poly (L-lysine) (PLL)     
 
      Poly (L-lysine) (PLL) is prepared by the ring-opening polymerization of N-
carboxy-(N-benzyloxycarbonyl)-L-lysine anhydride (Lysine-NCA) using a primary 
amine initiator115.  The Lysine-NCA was synthesized from the ε-amine protected L-
lysine115. Since the primary ε-amino groups of PLL have a pKa value of 9.7, all NH2 
groups of PLL are protonated at physiological pH.  In 1975, Laemmli et al reported 
the using of poly (L-lysine) (PLL) for DNA condensation116. After that, this polymer 
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was quickly evaluated for gene transfer tests35, 90, 117-130. According to the sponge 
effect theory, PLL could not offer buffering capacity to help the PLL/DNA complex 
escape from endosome. The endosomal release of PLL/DNA complex could be 
improved by adding chloroquine, which raises endosomal pH to decrease DNA 
degradation by inhibiting lysis125. Another modification for buffering effect is to graft 
the PLL with imidazole groups to, which have a pKa around 6.0, providing PLL with 
buffering capacity129. 
 
 
 
 
 
 
 
Figure 1.8 Chemical Structure of Poly (L-lysine)  
 
      For the molecular weight effect, PLL need a molecular weight higher than 3000 
Da to effectively condense DNA to form stable complexes122. However, the high 
molecular weight PLL showed relatively high cytotoxicity119. The incorporation of 
imidazole groups into PLL or prepare multi-arm PLL derivatives could reduce the 
cytotoxicity129, 131. PLL/DNA complexes were found to tend to aggregate and 
precipitate in the solution132. In order to avoid the formation of insoluble precipitates 
and enhance the stability of PLL/DNA complex, poly (ethylene glycol) (PEG) was 
introduced to PLL117, 119, 121, 133-135. The complexes of PLL-b-PEG/DNA showed the 
ability to reduce the complex particle size, stabilize the particles and resistant to 
deoxyribonuclease I (DNase I) digestion121, 133. On the other side, the polyester 
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segments were grafted to the PLL chain so that the hydrophobicity and hydrolysis 
property were introduced. Poly (lactic-co-glycolic acid) (PLGA) and poly (lactide-b-
ethylene glycol) (PLA-b-PEG) have been successfully grafted into the PLL chain and 
the new polymers showed reduced cytotoxicity and significant transfection efficiency 
compared to PLL135-137. And histidine residues could further introduced to promote 
buffering capacity129.  
 
      To overcome nonspecific cell targeting, various targeting moieties were introduced 
to PLL,   such as apoprotein E derived peptide138, galactose139, lactose119, folate90 and 
transferrin140, 141. Antigen-antibody interactions could also be used to improve cell 
targeting.  Besides PLL, poly (L-arginine) and poly (L-histidine) have also been 
evaluated for gene delivery applications and they showed very good cell membrane 
penetration capability.  
 
1.F.2.b Poly(glycoamidoamine) 
 
      Poly (glycoamidoamine) is a polymer family with carbohydrate component along 
a linear amino backbone142. For example, the poly (glycoamidoamines) with D-
glucaric acid as the carbohydrate moiety showed almost no cytotoxicity and 
significant gene transfection efficiency143. And the transfection efficiency could be 
improved when increase chain length of the amine-containing monomer unit143. 
Further study showed that the stereochemistry of the hydroxyl groups of the poly 
(glycoamidoamine) also affects the transfection efficiency by altering the stability of 
the complex 144, 145. Recent studies continued to investigate the structure-function 
relationships of poly (glycoamidoamines)59, 146 and the results showed that the higher 
density of amino groups promoted greater cellular uptake and the gene delivery 
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efficiency was related to the complex stability147. Recent study also indicated that the 
branched poly (glycoamidoamines) were less toxic due to the decreased secondary 
amine density, but the gene delivery performance was decreased, too148. 
 
 
 
 
 
   
Figure 1.9 Chemical Structure of Poly (glycoamidoamine) 
 
1.F.2.c Poly (amido amine) (PAA) 
 
     The cationic linear poly (amido amines) have been  prepared by hydrogen-transfer 
polymerization of aliphatic primary monoamines or bis(secondary amines) and 
bisacrylamides to form polymer structures with amido and tertiary amino functional 
groups149. Barbucci et al. confirmed that the protonation of PAA limit the 
conformational freedom of the polymer and lead to a more rigid structure150, 151. The in 
vitro MTT assay confirmed that the PAA had lower cytotoxicity compared with high 
molecular weight PLL and PEI 152 and the gene transfection studies of PAA showed 
high transfection efficiency 153-155. PAA with disulfide linkages in the bisacryamide 
monomer unit to create a reducible polymeric structure have been synthesized by 
Engbersen et al156 and these PAAs showed reduced cytotoxicity and improved gene 
transfer results as compared to branched 25 kDa PEI156. Modifications to the side 
chain of these biodegradable PAA polymers showed that both hydroxyl and histidine 
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functional groups could further reduce the cytotoxicity and improve transfection 
efficiency of PAA/DNA complex157, 158. 
 
 
 
 
 
 
Figure 1.10 Chemical Structure of Poly (amido amine) 
 
1.F.2.d Poly(4-hydroxy-L-proline) 
 
      Poly (4-hydroxy-L-proline) (PHP) was the first reported hydrolytically degradable 
cationic polymer130, 159. PHP was prepared by polymerization of N-cbz-4-hydroxy- L-
proline followed by deprotection160.  The polymer could be degraded within controlled 
period ranging from a few hours to 3 months159. Results from the transfection studies 
showed that PHP could condense DNA effectively and PHP have showed good 
transfection efficiency and significantly reduced cytotoxicity when compared to PEI 
or PLL130, 159, 161. 
 
 1.F.2.e Poly[R-(4-aminobutyl)-L-glycolic acid] (PAGA) 
 
      Poly[R-(4-aminobutyl)-L-glycolic acid] is a type of biodegradable polyester with 
similar structure of PLL. It was prepared by conversion of the R-amino group of N-
cbz-L-lysine to a hydroxyl group followed by polymerization then deprotection162. 
This biodegradable polymer could be degraded within controlled period ranging from 
N
H
N
O
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a few hours to 6 months163.  In vitro gene transfer studies showed that PAGA/DNA 
complexes had no cytotoxicity and better transfection efficiency compared to 
PLL/DNA complexes162, 164-166.  
 
1.F.2.f Poly(amino ester) 
 
      Langer et al. reported the gene delivery tests using poly (β-amino esters), which 
could be completely degraded within a few hours without killing cells167, 168.  Some of 
the poly (β-amino esters) showed good gene transfer efficiencies compared to PEI, 
PLL, and Lipofectamine 2000167-169. A study of over 2300 poly (β-amino esters) 
prepared from hydrophobic diacrylate monomer units showed improved transfection 
efficiency170. The structure-function relationships of these polymers revealed that 
molecular weight, end groups, and polymer/DNA ratio effect transfection efficiency. 
170 Poly (β -amino esters) capped with diamine chains exhibit high transfection 
efficiency. However, the cytotoxicity increased a lot, which could be due to more 
effective DNA binding171. The hyperbranched poly (β-amino esters) also showed 
significant gene transfer capacity172-174.  
 
1.F.2.g Phosphorus Based Polymers 
 
      Degradable phosphorus based polymers, such as poly (phosphazenes) (PPZ) 175-177, 
poly (phosphoesters) (PPE) 178, 179, and poly (phosphoramidates) (PPA) 178, 179, have 
been widely tested for gene delivery. These polymers showed low cytotoxicity and 
good gene transfer capability in vitro compared to PDMAEMA175-179. Transfection 
efficiency of polyphosphoesters with amine terminated side chains is between PLL 
and PEI179. Further studies showed that the DNA releasing rate was affected by the 
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side chain180. For complexes containing alkyl side chains with terminal amines, the 
rate of DNA release increases with the increasing of chain length180. In addition, it was 
shown that polymers with secondary amine-terminated alkyl side chains release DNA 
more quickly than the primary amine polymers180. Polyphosphoramidates with 
spermidine side chains showed transfection efficiency better than that of PEI181. 
 
1.G Conclusion  
       
      In the past decades, tremendous progresses have been made in the design and 
synthesis of non-viral polycation vectors for gene delivery.  Some common design 
principles have also been widely accepted. The 1st important principle is that nearly all 
synthetic vectors have the positive charge necessary for electrostatic interaction with 
DNA. It has been widely accepted that the structure and density of the amine groups 
significantly affect transfection efficiency. Normally increasing the charge density of 
the amine groups would improve the polymer’s transfection efficiency, but may cause 
higher cytotoxicity. The cytotoxicity could be reduced by incorporating histidine or 
guanidine functional groups and normally higher transfection efficiency could be 
achieved simultaneously. The quaternization of amine groups is another commonly 
used method to increase the cationic charge density. However, the effect of 
quaternization was not always encouraging in terms of transfection efficiency and 
cytotoxicity. Buffering capability is very important for obtaining high transfection 
efficiency, however, introducing buffering functional groups sometimes may not 
effectively increase the transfection ability, and the reasons for the phenomena were 
unclear. However, the significant changing of polymer structure may affect 
polycations’ transfection efficiency a lot.   
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      Introduction of hydrophilic groups, such as PEG, would improve the stability of 
polycation/DNA complexes, then increase the transfection efficiency and decrease the 
transfection cytotoxicity.  Inclusion of hydrophobic groups, such as steroidal moieties, 
alkyl chains, and hydrophobic amino acids, would help to improve the nonspecific 
cellular uptake and generally result in higher transfection efficiency. Conjugating the 
polycation vector with a number of cell targeting agents would promote the specific 
cellular uptake of polycation/DNA complexes. 
 
      Overall, many efforts have been applied for the investigation of polycations 
structure-function relationship for gene delivery applications. However, there have not 
been any reported systematical and quantitative works for the polycations structure-
function relationship. In order to help to develop new generation of polycation gene 
delivery vectors, the following chapters discussed a new polymer family, arginine 
based poly (ester amide), as gene delivery vectors and the structure-function 
relationship was intensively, systematically and quantitatively studied.    
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2.A Abstract 
 
      A family of water soluble and positively charged L-arginine based poly (ester 
amide)s (Arg-PEAs) was synthesized and characterized. These biodegradable 
polymers consist of 3 nontoxic building blocks: L-arginine, diols, and dicarboxylic 
acids.  The Arg-PEAs were prepared by solution polycondensation reaction of tetra-p-
toluenesulfonic acids salts of bis-(L-arginine) α, ω-alkylene diesters and di-p-
nitrophenyl esters of dicarboxylic acids.  Optimal conditions of the monomers and 
polymers synthesis were investigated, and the monomers and Arg-PEAs were 
chemically characterized.  Arg-PEAs were found to have good solubility in water and 
many other polar solvents. Structure-function relationship of the Arg-PEAs revealed 
that changing the number of methylene groups in the diol or/and diacid segment could 
finely tune the hydrophobic and cationic properties of the Arg-PEAs. MTT assay 
showed that all the prepared Arg-PEAs were non-toxic to the cell lines even at very 
large doses. Arg-PEAs with double bond functionality could be photo-crosslinked 
with polyethylene glycol diacrylate (PEGDA) to form cationic hybrid hydrogels.   
 
2.B Introduction 
 
      In recent years, due to the fast growing of biotechnology and pharmaceutical 
science, many new biodegradable and biocompatible synthetic polymers have been 
developed 1-9. For examples, absorbable aliphatic polyesters, such as polylactide 
(PLA), polyglycolide (PGA), poly-ε-caprolactone (PCL) and their copolymers are the 
most well-known and widely used polymeric biomaterials because of their good 
biocompatibility, biodegradability, mechanical and processing property 1, 2, 5, 6, 9-12.   
These FDA-approved absorbable aliphatic polyesters have been widely used in wound 
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closure, tissue engineering, drug delivery and medical implants 1, 2, 5, 6, 9-12. However, 
all of these aliphatic polyester-based synthetic absorbable biomaterials are soluble in 
organic solvents only. Their poor water solubility greatly limits their applications in an 
aqueous-based biological system.  
 
       The rapid development of biotechnology demands new generations of water 
soluble, biocompatible and biodegradable synthetic polymers with various 
physicochemical, functional and biological properties. For this purpose, recently, 
many kinds of chemical modifications have been applied to the current available 
synthetic biodegradable and biocompatible polymers to meet the demands in 
biomedical applications. One approach is to introduce the polyether into the 
absorbable polymers’ main or side chain, such as the PLA-b-PEG 13 and PLL-b-PEG 
14, 15, which have been widely investigated in the areas of antibiofouling, self-
assembly, drug/gene delivery and nanotechnology. The incorporation of polyether 
segment will improve the solubility, hydrophilicity of absorbable aliphatic polyesters 
and increase the circulation time in vivo.   Another interesting approach is to introduce 
the poly (amino acid)s or polypeptide into the polymer backbone. The introduction of 
natural amino acids would bring the polymer many new properties, such as 
functionality, biodegradability and charge property in addition to the improvement of 
hydrophilicity. One example for this approach is polyester-b-poly (amino acid)s, such 
as PLA-co-PLL and PCL-co-PLL,  which have been widely used in the drug delivery 
and tissue engineering scaffold area 4, 16, 17. However, these modifications could hardly 
make the water insoluble absorbable aliphatic polyesters into water soluble polymers.  
   
       In this study, we report the design of a water soluble, biocompatible and 
biodegradable polymer family for biotechnology applications. This polymer family 
52 
 
belongs to the amino acid-based poly (ester amide) (PEA, Figure 2.1) category.  
Amino acid based-PEAs are biodegradable and biocompatible synthetic polymers 
having both ester and amide linkages on their backbones, which bring good 
mechanical and biological properties with enzyme-catalyzed biodegradability 5, 8, 18-22.   
Combining the favorable properties of polyesters, polyamides, and poly (amino acid)s, 
amino acid-based PEAs have shown very promising applications in the biomedical 
and biotechnology area 5, 8, 18-22. The PEA backbone consists of nontoxic building 
blocks like α-amino acids, fatty diols and aliphatic dicarboxylic acids. The varieties of 
combinations of the 3 types of building blocks offer a variety of PEAs for different 
purposes. And functional groups, such as double bonds, amine or hydroxyl groups, 
could be incorporated into the polymer chains 8, 20.  Due to the hydrophobic amino 
acids used (e.g., Phe, Leu), all these amino acid-based PEAs reported so far have one 
common characteristic: they dissolve in organic solvents only and are not water 
soluble 19.   
 
      L-arginine (Arg) is a natural amino acid present in the proteins of all life forms. It 
carries a positive charge at a physiological pH due to its strong basic guanidine group 
with an isoelectric point of 10.96 and pKa above 12.5, which is expected to have a 
strong capability to neutralize negatively charged polymers (proteins/nucleic acids). 
So L-arginine based poly (ester amide)s (Arg-PEAs) family (Figure 2.2) could achieve 
two major goals: water solubility and cationic characteristic. The diacid and diol parts 
of Arg-PEAs can be utilized to not only adjust the physicochemical properties of the 
Arg-PEA polymers (e.g., hydrophilicity and charge density) but also to convert the 
resulting Arg-PEA polymers into different physical forms like hydrogels. Some 
preliminary cell membrane penetrating and DNA transfection tests of 4 types Arg-
PEAs have showed that the Arg-PEA/DNA complex could pass through the cell 
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membrane and transfect SMC A10 cell lines very easily with very low toxicity 
compared with commercial transfection agents23, which indicated that the Arg-PEAs 
could have great potential as gene delivery vector and molecular target agent. 
However, the details of Arg-PEA monomer and polymer synthesis and 
physicochemical characterizations have never been reported and discussed, which is 
very important for developing new types or generations of Arg-PEAs, derivatives and 
other related polymers. In this paper, we report the details of synthesis of an Arg-PEA 
family. The synthesis protocols were intensively studied and optimized. The resulting 
cationic L-Arginine based poly (ester amide)s were characterized by standard 
physicochemical methods. The cytotoxicity of all the Arg-PEAs was assessed by MTT 
assay. These data would provide solid physicochemical support for the biological 
applications of Arg-PEA, such as for small molecules/nucleic acid/protein delivery, 
molecular targeting agents and tissue engineering scaffolds. 
 
 
 
 
 
 
Figure 2.1 Chemical structure of poly (ester amide) 
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Figure 2.2 Chemical structure of Arg-PEAs: x-Arg-y-S (S stands for toluenesulfonic 
acid salt), where x is the number of methylene groups between two closest amide 
groups and y is the number of methylene groups between two closest ester groups. 
 
2.C Experimental 
2.C.1 Materials 
 
      L-Arginine (L-Arg), p-toluenesulfonic acid monohydrate, fumaryl chloride, 
succinyl chloride, adipoyl chloride, sebacoyl chloride, ethylene glycol, 1, 4-
butanediol, 1,6-hexaniol and p-nitrophenol were all purchased from Alfa Aesar (Ward 
Hill, MA) and used without further purification. Triethylamine from Fisher Scientific 
(Fairlawn, NJ) was dried by refluxing with calcium hydride, and then distilled before 
use. Superfect® was purchased from Qiagen. Polyethylenimine (PEI) with a reported 
weight average molecular weight of 25,000, poly(L-lysine) (PLL)-hydrobromide, 
ethidium bromide, MTT, Phosphate-buffered saline (PBS, pH 7.4), HEPES were 
purchased from Sigma (St. Louis, MO).  Organic solvents like methanol, toluene, 
ethyl acetate, acetone, 2-propanol and dimethyl sulfoxide (DMSO) were purchased 
from VWR Scientific (West Chester, PA) and were purified by standard methods 
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before use. Other chemicals and reagents if not otherwise specified were purchased 
from Sigma (St. Louis, MO). 
 
2.C.2 Measurement Methods 
 
      The physicochemical properties of the prepared monomer and polymers were 
characterized by various standard methods. For Fourier transform infrared (FTIR) 
characterization, the samples were ground into powders and mixed with KBr at a 
sample/KBr ratio of 1:10 (w/w). FTIR spectra were then obtained with a PerkinElmer 
(Madison, WI) Nicolet Magana 560 FTIR spectrometer with Omnic software for data 
acquisition and analysis. 1H NMR spectra were recorded with a Varian Unity Inova 
400-MHz spectrometer (Palo Alto, CA). Deuterated water (D2O-d2; Cambridge 
Isotope Laboratories, Andover, MA) with tetramethylsilane as an internal standard or 
deuterated dimethyl sulfoxide (DMSO-d6; Cambridge Isotope Laboratories) was used 
as the solvent. MestReNova software was used for the data analysis. Elemental 
analyses of the synthesized polymers were performed with a PE 2400 CHN elemental 
analyzer by Atlantic Microlab (Norcross, GA). The thermal properties of the 
synthesized Arg-PEAs were characterized with a DSC 2920 (TA Instruments, New 
Castle, DE). The measurements were carried out from -10 to 200 °C at a scanning rate 
of 10 °C/min and at a nitrogen gas flow rate of 25 mL/min. TA Universal Analysis 
software was used for thermal data analysis. X-ray diffraction data were obtained from 
powdered samples with a θ–θ diffractometer (Scintag, Inc., Cupertino, CA) with Cu 
Kα radiation (wavelength 1.5405 Å). The solubility of Arg-PEAs in common organic 
solvents at room temperature was assessed by using 2.0 mg/mL as a solubility 
standard to determine whether a Arg-PEA polymer is soluble or not in a solvent. The 
quantitative solubility of Arg-PEAs in distilled water at room temperature was 
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measured by adding distilled water step by step until the clear solution was obtained. 
For the molecular weight measurement, Arg-PEAs were prepared at a concentration of 
1 mg/mL in a 0.1% (w/v) LiCl in DMAc solution. The sample molecular weights were 
determined from a standard curve generated from polystyrene standards with 
molecular weights ranging from 841.7 kDa to 2.93 kDa that were chromatographed 
under the same conditions as the samples. The standard curve was generated from a 
3rd order polynomial fit of the polystyrene standard molecular weights. 
 
2.C.3 Synthesis of  Monomers and Polymers 
 
      The general scheme of the synthesis of Arg-PEAs was divided into the following 
three major steps : the preparation of di-p-nitrophenyl ester of dicarboxylic acids (I) 
(Figure 2.3), the preparation of tetra-p-toluenesulfonic acid salts of bis (L-arginine), 
α, ω　 -alkylene diesters (II) (Figure 2.4), and the synthesis of Arg-PEAs (III) via 
solution polycondensation of (I) and (II) (Figure 2.5). Monomer I has been 
synthesized in our prior studies 19.  Monomer II is new, and modified procedures were 
used to accommodate the ionic nature of the L-arginine.  
 
2.C.3.a  Synthesis of Di-p-nitrophenyl Ester of Dicarboxylic Acids (I) 
 
      Di-p-nitrophenyl esters of dicarboxylic acids were prepared by reacting 
dicarboxylic acyl chloride varying in methylene length with p-nitrophenol as 
previously reported 19,20.  Three saturated and one unsaturated monomers were made; 
the three saturated diacid monomers were: di-p-Nitrophenyl Succate (NSu) with x=2; 
di-p-Nitrophenyl Adipate (NA) with x=4; di-p- Nitrophenyl Sebacate (NS) with x=8; 
and one unsaturated monomer was di-p-Nitrophenyl Fumarate (NF) with x=2. x is the 
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numbers of methylene group in the diacid.  An example of the diacid monomer 
synthesis is given below. Di-p-nitrophenyl succinate (NSu) was prepared in 65 % 
yield by the reaction of the succinyl chloride (0.15 mol, 16 mL) with p-nitrophenol 
(0.31 mol) in acetone in the presence of triethylamine (0.32 mol). An ice/water 
mixture bath was used to keep the p-nitrophenol and triethylamine mixed acetone 
solution (400 mL) at 0 °C. Succinyl chloride was diluted in 100 mL of cold acetone 
before dropped into the above chilled solution with stirring for 2 h at 0 °C and 
overnight at room temperature. The resulting di-p-nitrophenyl ester of succinic acid 
was precipitated in distilled water, washed completely, and then dried in vacuo at 
room temperature before final recrystallization in ethyl acetate/DMF(4:1, v:v) for 
three times. The final product is needle-like, colorless crystal.  
 
 
 
  
 
 
Figure 2.3 Synthesis of monomer I: di-p-nitrophenyl ester of dicarboxylic acids 
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Figure 2.4 Synthesis of monomer II:  
Tetra-p-toluenesulfonic acid salt of bis (L-arginine) alkylene diesters 
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Figure 2.5 Synthesis of Arg-PEAs 
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2.C.3.b  Synthesis of Tetra-p-toluenesulfonic Acid Salt of Bis(L-arginine) Alkylene 
Diesters (II) 
 
      Because of the strong positive charge characteristic of L-arginine, the prior PEA 
non-charged monomer synthesis protocol (e.g., Phe, Leu) was modified. In brief, the 
amount of p-toluenesulfonic acid used for the synthesis of p-toluenesulfonic acid salt 
of L-arginine diester was doubled when compared with the prior synthesis of p-
toluenesulfonic acid salt of non-ionic hydrophobic amino acids diesters19,20.  The need 
to double the amount of p-toluenesulfonic acid in the current case is because of the 
preferential consumption of the p-toluenesulfonic acid by the strong basic guanidine 
group on L-arginine side chain. For example, L-arginine (0.04 mol) and 1, 4-
butanediol (0.02 mol) were directly mixed in a three neck round bottom flask with 
toluene (400 mL, b.p. 110 ºC) with the presence of p-toluenesulfonic acid 
monohydrate (0.082 mol). The solid-liquid reaction mixture was heated to 130 ºC and 
reflux with stirring for 24 hr with 2.16 mL (0.12 mol) of water was generated. The 
reaction mixture (viscous solid) was then cooled to room temperature. Toluene was 
decanted. The resulting product was finally purified by dissolving the product in 2-
propanol at 75 ºC with stirring and then precipitating at 4 ºC for three times. The ideal 
precipitation time is around 12h. 2-propanol was changed every time after 
precipitating and decanted afterwards, and the white sticky mass was dried in vacuo. 
The final product was white powder, and obtained in high yields (70~90%). Three 
types of monomer II were made in this study: tetra-p-toluenesulfonic acid salt of bis 
(L-arginine) ethane diesters, Arg-2-S, y=2; tetra-p-toluenesulfonic acid salt of bis (L-
arginine) butane diesters, Arg-4-S, y=4; tetra-p-toluenesulfonic acid salt of bis (L-
arginine) hexane diesters, Arg-6-S, y=6. S indicated that the arg diester monomer was 
in the p-toluenesulfonic acid salt form. 
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2.C.3.c  Synthesis of Arg-PEAs (III) by Solution Polycondensation of I and II 
Monomers 
 
      Arg-PEAs were prepared by solution polycondensation of the monomer I (Arg-2-
S, Arg-4-S, and Arg-6-S) and monomer II (NSu, NA, NS and NF) at a variety of 
combinations. Such combinations and the resulting Arg-PEAs are summarized in 
Table 2.1. The saturated Arg-PEAs are labeled as x-Arg-y-S, where x and y are the 
number of methylene group in diacid and diol, respectively. The unsaturated Arg-
PEAs are labeled as x-UArg-y-S, where x and y are the number of CH and CH2 groups 
in diacid and diol, respectively. U means the Arg-PEA is unsaturated. An example of 
the synthesis of 8-Arg-6-S via solution polycondensation is given here. Monomers NS 
(1.0 mmol) and Arg-6-S (1.0 mmol) in 1.5 mL of dry DMSO were mixed well by 
vortexing. The mixture solution was heated up to 75°C with stirring to obtain a 
uniformed mixture. Triethylamine (0.31 mL, 2.2 mmol) was added drop by drop to the 
mixture at 75°C with vigorous stirring until the complete dissolution of the monomers. 
The solution color turned into yellow after several minutes. The reaction vial was then 
kept for 48 hrs at 75°C in a thermostat oven without stirring. The resulting solution 
was precipitated in cold ethyl acetate, decanted, dried, re-dissolved in methanol and 
re-precipitate in cold ethyl acetate for further purification. Repeat the purification for 2 
times before drying in vacuo at room temperature. The final Arg-PEAs are yellow or 
pale yellow solid powder.  
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Table 2.1 Arg- PEAs prepared by different combination of monomers 
 
 
 
 
 
 
2.C.4 Cell Culture and Cytotoxicity 
 
      Rat aortic A10 vascular smooth muscle cells (SMC)s obtained from American 
Tissue Culture Collection (ATCC) were provided by Dr. Bo Liu’s lab at Cornell Weill 
Medical College. The SMCs were grown as recommended at 37°C in 5% CO2 in 
Dulbecco’s minimal essential medium (DMEM) supplemented with 10% FBS 
(Germini, Woodland, CA) and antibiotics. 
 
      The cytotoxicity of Arg-PEAs was performed by MTT assay. Cultured SMC were 
seeded at an appropriate cell density concentration (3,000 cells/well) in 96-well plates 
and incubated overnight in a 5 % CO2 incubator at 37 oC. The cells were then treated 
with various Arg-PEA solutions for 4 h or 48 h. Cells were treated only with normal 
cell culture media were used as negative control (NC). PEI, PLL-HBr and Superfect® 
treated cells were used as positive control. After 48 h incubation, 15 μL of MTT 
solution (5 mg/mL) was added to each well, the cell culture plate was incubated for 4 
h at 37 °C, 5 % CO2. After that, the cell culture medium including polymer solution 
was carefully removed and 150 μL of acidic isopropyl alcohol (with 0.1 M HCl) was 
added to dissolve the formed formazan crystal. OD was measured at 570 nm (subtract 
background reading at 690 nm) using a microplate reader. The cell viability (%) was 
 Arg-2-S Arg-4-S Arg-6-S 
NSu 2-Arg-2-S 2-Arg-4-S 2-Arg-6-S 
NA 4-Arg-2-S 4-Arg-4-S 4-Arg-6-S 
NS 8-Arg-2-S 8-Arg-4-S 8-Arg-6-S 
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calculated according to the following equation: Viability (%) = (OD570 (sample)-OD690 
(sample))/ (OD570 (control)-OD690 (control)) × 100%, where the OD570 (control) represents the 
measurement from the wells treated with medium only, and the OD570 (sample) from the 
wells treated with various polymers. Triplicates were used in each experiment. 
 
2.C.5  Gel Retardation Assay  
 
      The N3014 DNA used here was purchased from New England Lab, and the DNA 
was visualized by UV illumination (FOTO/UV 300 Transilluminator). The Arg-
PEA/DNA complexes were prepared by adding the cationic Arg-PEA polymer 
aqueous solutions into the solution of the DNA in 20 mM HEPES buffer at pH 7.4. 
After mixing the two solutions together, it was immediately but slightly vortexed for 
2-3 seconds, and then equilibrated at an ambient condition for 30 minutes. The ratio of 
Arg-PEA to DNA used to prepare the complexes is represented as the weight ratio, 
and a wide range of weight ratios of Arg-PEA to DNA weight ratio was tested. The 
Arg-PEA/DNA complexes were analyzed by electrophoresis in a 1% agarose gel 
stained with ethidium bromide (10 ug/mL) in TAE buffer at 100 V for 60 min. N3014 
DNA solution without Arg-PEA was used as blank control. The migration of DNA 
from the Arg-PEA/DNA complex was recorded by a digital camera (Panasonic WV-
BP330) installed on the Polaroid MP-4 land camera copy stand. 
 
2.C.6  Fabrication of Arg-PEA/ Polyethylene Glycol Diacrylate (PEGDA) Hybrid 
Hydrogel 
 
      To assess the functionality of the unsaturated Arg-PEAs, hybrid hydrogels from 
the unsaturated Arg-PEAs were fabricated in an aqueous medium by a photo means. 
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PEGDA as a co-precursor (molecular weight: 4,000) was synthesized according to a 
modified procedure of a previously   reported method 24,25.  Several types of Arg-
PEA/PEGDA hybrid hydrogel were fabricated. An example for such a fabrication is 
given here. An unsaturated Arg-PEA (2-UArg-2-S) solution of a concentration of 10.0 
% (w/v) was prepared by dissolving 0.5 gram 2-UArg-2-S in 5.0 mL distilled water in 
a glass bottle. PEGDA (Mn=4,000) solution (25 wt %) was then added into the 
prepared 2-U-Arg-2-S solution at a weight feed ratio of PEGDA to 2-UArg-2-S (i.e., 
4.0/1.0). The photoinitiator, 4-(2-hydroxyethoxy) phenyl-(2-hydroxy-2-propyl) ketone 
(Irgacure 2959) was added to the precursor solution at a concentration of 0.1 %( m/v). 
The mixed solution was then stirred for 10 minutes at 50°C to ensure a complete 
dissolution of the photoinitiator. The homogenous, transparent solution was first 
transferred to a custom-made 20 well Teflon mold (with 500 μm volume per well) 
using a micropipette, and then irradiated by a long-wavelength UV lamp (365 nm and 
100 W) at room temperature for 10 mins. After photo-gelation, the hydrogel samples 
were immersed in distilled water at room temperature for 48 h to leach out any 
unreacted residual chemicals. During this period, distilled water was replaced every 12 
hours.    
 
2.D Results and Discussion 
 
      As discussed in the introduction part, the main purpose of this paper is to report 
the synthesis and characterization protocols of Arg-PEAs, so that the new similar 
systems could be prepared and characterized easily based on the above knowledge. 
More study about the relationship between polymer structure and biological functions 
will be reported in the following chapters.   
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2.D.1 Synthesis of Monomers 
 
      Four types of di-p-nitrophenyl esters of dicarboxylic acids (NSu, NA, NS and NF) 
were synthesized here as the monomers to react with the tetra-p-toluenesulfonic acid 
salt of bis (L-arginine) alkylene diester monomer (II) to provide amide linkage in Arg-
PEA backbone. Except the synthesis of the tetra-p-toluenesulfonic acid salts of bis(L-
arginine) alkylene diesters monomer, the synthesis and characterization of other 
monomers have been reported previously19,20. The tetra-p-toluenesulfonic acid salts of 
bis (L-arginine) alkylene diesters are newly developed for the first time. The amounts 
of p-toluenesulfonic acid used were the main difference of monomer synthesis 
between the current Arg-based monomers and other hydrophobic amino acid based 
monomers. According to our data, the excessive p-toluenesulfonic acid was needed 
because of the strong alkalinity of the guanidine group of Arginine. p-toluenesulfonic 
acid preferred to react with guanidine group first to form a stable salt, then reacted 
with the amine group of arginine, if there were excessive amounts of p-toluenesulfonic 
acid. Three types of new monomer II were prepared: Tetra-p-toluenesulfonic acid salt 
of L-Arginine ethane-1,2-diester (Arg-2-S), Tetra-p-toluenesulfonic acid salt of L-
Arginine butane-1,4-diester (Arg-4-S), and Tetra-p-toluenesulfonic acid salt of L-
Arginine hexane-1,6-diester (Arg-6-S). The only difference among these three types 
of monomer II is the methylene chain length (y) in the diol part between the two 
adjacent ester groups: number of CH2 varies from 2 to 6 from Arg-2-S to Arg-6-S.  
 
      The chemical structures of these 3 types of Arg-based monomer II were all 
confirmed by FTIR and 1HNMR.  As shown in Figure 2.6, the absorption bands of the 
ester group were observed in the regions ~ 1180 cm-1 (⎯O⎯) and ~ 1758 cm-1 
(⎯CO⎯), and NH vibrations at 3290 cm-1All the synthesized tetra-p-toluenesulfonic 
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acid salts of bis(L-arginine) alkylene diesters are very moisture sensitive and should 
be stored under vacuum at room temperature.  
 
      The following are some physical and chemical details of the tetra-p-
toluenesulfonic acid salts of bis(L-arginine) alkylene diesters monomers: Arg-2-S: 
Yield of purified product: 75%. Appearance: amorphous white powder. IR: 1753 cm-1 
[-CO-], 1178 cm-1 [-O-]; 1HNMR (DMSO-d6, ppm, δ): 1.63[4H,-CH2-CH2-CH2-NH-
], 1.82[4H,-OC (O)-CH (NH3+) CH2-(CH2)2-], 2.29[6H, H3C-Ph-SO3-], 3.10[4H,-
(CH2)2-CH2-NH-], 4.06 [2H,+H3N-CH(R)-C(O)-O-], 4.39[4H, -(O)C-O-CH2-], 7.18, 
7.53[16H, Ph], 7.69 [10H, -CH2-NH(NH2+)-NH2], 8.42[6H, +H3N-CH(R)-C(O)-O-]; 
Arg-4-S: Yield of purified product: 78%. Appearance: amorphous white powder. IR: 
1743 cm-1 [-CO-], 1170 cm-1 [-O-]; 1HNMR (DMSO-d6, ppm, δ): 1.52[4H,-OC(O)-
CH(NH3+)-CH2-CH2-CH2-NH-], 1.65[4H,-(O)C-O-CH2-CH2-], 1.80[4H,-OC (O)-CH 
(NH3+) CH2-(CH2)2-], 2.29[6H, H3C-Ph-SO3-], 3.10[4H,-(CH2)2-CH2-NH-], 4.04 
[2H,+H3N-CH(R)-C(O)-O-], 4.14[4H,-(O)C-O-CH2-CH2-] , 7.18, 7.53[16H, Ph], 7.71 
[10H, -CH2-NH(NH2+)-NH2], 8.40[6H, +H3N-CH(R)-C(O)-O-] ; Arg-6-S: Yield of 
purified product: 84%. Appearance: amorphous white powder. IR: 1749 cm-1 [-CO-], 
1171 cm-1 [-O-]; 1HNMR (DMSO-d6, ppm, δ): 1.34, [4H,-(O)C-O-CH2-CH2-CH2], 
1.61, [4H,-(O)C-O-CH2-CH2-CH2],  1.81, [4H,-OC (O)-CH (NH3+) CH2-(CH2)2-], 
2.29, [6H, H3C-Ph-SO3-],  3.11, [4H,-(CH2)2-CH2-NH-],  4.03, [2H,+H3N-CH(R)-
C(O)-O-], 4.15, [4H,-(O)C-O-CH2-CH2-CH2], 7.15, 7.50[16H, Ph], 7.73[10H, -CH2-
NH(NH2+)-NH2], 8.43[6H, +H3N-CH(R)-C(O)-O-] 
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2.D.2  Synthesis of Arg-PEA Polymers and Their Properties 
 
      Arg-PEAs were prepared according to the reaction scheme in Figure 2.5. The 
yields, glass transition temperature (Tg), molecular weight of repeating unit are given 
in Table 2.2. The reaction conditions were optimized in terms of reaction temperature 
and time, catalyst and its concentration, the molar ratio between 2 monomers, 
monomer concentration. After testing, we found that the optimal polycondensation 
reaction conditions for the Arg-PEAs are: reaction temperature: 75°C; duration: 48 h, 
concentration of each monomer: 1.0-1.5 mol/L; the reaction medium: DMSO; catalyst 
(acid acceptor): NEt3.  The molar ratio of the two monomers (I and II) should be 
exactly equal to 1.0: 1.0, and the molar ratio between the monomer and acid receptor 
is suggested to be 1.0: 1.1. The final product yields are high (> 80%) under the 
optimized reaction conditions.  
 
      For the chemical structure identification of all the synthesized Arg-PEAs, their 
structures were confirmed by both 1HNMR and FTIR spectra. Figure 2.7 shows the 
FTIR spectra of 3 Arg-PEAs. The carbonyl bands at 1648–1650 cm-1 (amide I), 1538–
1542 cm-1 (amide II), and 1738–1742 cm-1 (ester), and NH vibrations at 3290 cm-1 are 
typical for all PEAs obtained. Figure 2.8 shows an example of the 1HNMR spectrum 
of 2-Arg-2-S.  
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Table 2.2 Physical and Thermal Characteristics of Arg-PEAs 
 
 
 
 
 
 
 
 
 
 
 
 
Polymer Unit Formula Unit 
MW 
(g/mol) 
Charge 
Density 
(mol/kg)
Tg (Ԩ) Polymer 
Yield 
2-Arg-2-S C32H48N8O12S2 800.9 2.497 50±2 80% 
2-Arg-4-S C34H52N8O12S2 828.9 2.413 46±2 83% 
2-Arg-6-S C36H56N8O12S2 857.0 2.333 39±2 89% 
4-Arg-2-S C34H52N8O12S2 828.9 2.413 48±2 90% 
4-Arg-4-S C36H56N8O12S2 857.0 2.333 42±2 88% 
4-Arg-6-S C38H60N8O12S2 885.0 2.260 38±2 83% 
8-Arg-2-S C38H60N8O12S2 885.0 2.260 42±2 91% 
8-Arg-4-S C40H64N8O12S2 913.1 2.190 36±2 87% 
8-Arg-6-S C42H68N8O12S2 941.1 2.125 34±2 92% 
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Figure 2.6 FTIR spectra of the tetra-p-toluenesulfonic acid salts of bis (L-arginine) 
diesters 
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Figure 2.7 FTIR spectra of Arg-PEAs 
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Figure 2.8 HNMR spectra of 2-Arg-2-
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      For the thermal property of the Arg-PEAs, they do not have melting points (Tm) 
because all the Arg-PEAs are in the amorphous state which is confirmed by the X-ray 
diffraction data (see Figure 2.10).  The glass transition temperature (Tg) of saturated 
Arg-PEAs (Table 2.2) ranged between 30-55 oC. An examination for the effect of the 
number of methylene groups in the diol (y) and diacid (x) parts of the Arg-PEAs 
revealed that an increase in either x or y led to a lower Tg. For example, if x value was 
fixed at 2, the Tg decreased from 50 oC to 39 oC when the y value was increased from 
2 to 6, The same trend was observed when y value was fixed.  This relationship is 
consistent with non-ionic hydrophobic amino acid-based and many other PEA 
systems19, such as the Phe-PEA system, for example,  if x value was fixed at 4, the Tg 
decreased from 59 oC  to 49 oC  when the y value was increased from 4 to 6. Based on 
the previous reports, the Phe-based PEAs showed higher Tg than Val or Leu-based 
PEAs because of the stereo-hindrance effect of the aromatic groups of L-Phe, and it 
was observed that the Tg value of ionic Arg-PEAs is close to the corresponding non-
ionic Phe-PEAs, which could be due to the stereo-hindrance effect of guanidine 
groups of L-arginine and the cationic property of the guanidine groups. Currently it is 
not clear which is the main factor affecting the Tg of Arg-PEAs, and further studies 
would be focused on this area. For the water soluble unsaturated Arg-PEAs, due to the 
existing of double bonds in the Arg-PEA backbone,  much higher Tg values were 
observed when compared with the saturated Arg-PEAs; this relationship between Tg 
and instauration in PEA is also consistent with the thermal data of the water insoluble 
unsaturated Phe-based PEA system20.   
 
      The solubility of some Arg-PEAs in water and common organic solvents at room 
temperature is shown in Table 2.3. Solubility was assessed at 2.0 mg/mL at a room 
temperature. Due to their strong polar nature, Arg-PEAs tended to dissolve in polar 
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solvents. All of the Arg-PEAs synthesized were soluble in polar organic solvents like 
DMSO, methanol or water, but did not dissolve in non-polar or weak polar organic 
solvents like ethyl acetate or chloroform. And the unsaturated Arg-PEAs showed no 
solubility difference from the saturated Arg-PEAs.  The effect of x and y material 
parameters on Arg-PEA water solubility (Figure 2.9) revealed that both x and y had a 
major impact on the water solubility of Arg-PEAs; and an increase in the methylene 
chain length in either the dicarboxylic acid part (x) or in the diols (y) part reduced the 
water solubility significantly due to the increasing hydrophobicity. So the water 
solubility of Arg-PEAs could be used as an index of polymer 
hydrophilicity/hydrophobicity. By adjusting the x or y, the Arg-PEA polymers’ 
hydrophilicity/hydrophobicity could be fine tuned to meet specific needs. 
 
1.D.3  Molecular Weight and Charge Density of Arg-PEAs 
 
      The molecular weight (MW) of 2-Arg-2-S, 4-Arg-2-S and 8-Arg-2-S (Table 2.4) 
were obtained with the help of MediVas, LLC.  The MW data in Table 2.4 indicate 
that all the three Arg-PEAs had Mn between 12.5 kg/mol and 14.5 kg/mol with narrow 
polydispersity (PDI) of 1.07 – 1.10. The x or y values did not have any significant 
impact on MW and PDI of Arg-PEAs. Compared with other amino acid-based PEAs 
from Phe or Leu, the MW of the Arg-PEA was lower, which may be due to the more 
complicated and ionic chemical structure of Arg-PEAs.   
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Table 2.3 Solubility of Arg-PEAs in various solventsa 
 
 2-
Arg-
2-S 
2-
Arg-
4-S 
4-
Arg-
6-S 
4-
Arg-
2-S 
4-
Arg-
4-S 
4-
Arg-
6-S 
8-
Arg-
2-S 
8-
Arg-
4-S 
8-
Arg-
6-S 
Water + + + + + + + + + 
Ethanol + + + + + + + + + 
Methanol + + + + + + + + + 
1-Propanol + + + + + + + + + 
2-Propanol + + + + + + + + + 
DMA + + + + + + + + + 
DMF + + + + + + + + + 
DMSO + + + + + + + + + 
THF - - - - - - - - - 
Acetone - - - - - - - - - 
Chloroform - - - - - - - - - 
Ethyl 
Acetate 
- - - - - - - - - 
Hexane - - - - - - - - - 
a 2mg/mL was chosen as the solubility standard; + means soluble, - means insoluble 
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Figure 2.9 Solubility of Arg-PEAs in distilled water 
 
Table 2.4 MW of some Arg-PEAs 
 
 
 
 
 
 
       The charge density of Arg-PEAs can be calculated by using guanidine group 
density (mol/kg) and is shown in Table 2.2.  The guanidine group density was found 
to be controlled by both x and y; and a low x or y led to a higher charge density, and a 
high x or y resulted in a reduction in charge density. However, the difference in charge 
density of the current Arg-PEA system was not large; for example, the difference 
between 2-Arg-2-S (highest charge density) and 8-Arg-6-S (lowest charge density) 
was around 18%, so we can say all the Arg-PEAs in the present study have a similar 
cationic strength.  
Polymer Mn (kg/mol) Mw (kg/mol) PDI 
2-Arg-2-S 12.8 13.7 1.07 
4-Arg-2-S 14.4 15.9 1.10 
8-Arg-2-S 13.2 14.1 1.07 
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 2.D.4  X-Ray Diffraction 
 
      Figure 2.10 presents a wide-angle X-ray diffraction diagram of the 3 synthesized 
Arg-PEAs (2-Arg-2-S, 2-Arg-4-S, and 2-Arg-6-S). Unlike some saturated 
hydrophobic PEAs, such as the Phe-based PEAs which are semi-crystalline polymers 
with melting temperatures, all the Arg-PEAs in this study are amorphous, which could 
be attributed to the salt form in the Arg-PEAs.  The large p-toluenesulfonic acid 
counter ion adjacent to the guanidine group could prevent the tight and orderly 
packing of the Arg-PEA chains required for crystallization.   
 
2.D.5  Cytotoxicity of Arg-PEAs by MTT Assay 
 
      Cytotoxicity of Arg-PEAs was evaluated by MTT assay. The MTT system is a 
simple, accurate, reproducible method of detecting living cells via mitochondrial 
dehydrogenase activity. An increase in cell number (cell proliferation) results in an 
increase in the amount of MTT formazan formed and an increase in UV absorbance. 
Poly (L-lysine) hydrobromide (PLL-HBr), Poly (ethylenimine) (PEI) and Superfect® 
were used as the controls. Figure 2.11 showed an example of the MTT results. The 
data in Figure 2.11 showed that all the four Arg-PEAs exhibited far better rat A10 
SMC cell line viability over a wide concentration range than the three controls, PLL-
HBr, PEI and Superfect® which showed significant cytotoxicity. Compared to 
Superfect®, PLL-HBr and PEI, Arg-PEAs are nontoxic and very safe to the cells even 
at a high dosage. In addition to the amino acid nature of Arg-PEAs, the relatively 
lower positive charge density (Table 2.2, guardinine density, ranging from 2.13 to 2.50 
mol/kg) of Arg-PEA than the widely studied PEI and PLL-HBr which have a much 
higher charge density (nitrogen atoms density of 23.3 mol/kg and 4.78mol/kg, 
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respectively) may be responsible for the much better cell biocompatibility in Arg-
PEAs.   
 
2.D.6  Analysis of Polymer/Nucleic Acid Complexes by Gel Retardation Assay 
 
      The aim of the gel retardation assay is to preliminarily and visually determine the 
feasibility of the polyplex formation between cationic Arg-PEAs and anionic nucleic 
acids; such polyplex formation is the first major step toward the transfection 
application. The complexes of DNA and cationic Arg-PEAs were prepared at various 
weight ratios and analyzed by 1% agarose gel electrophoresis. Normally the N/P ratio 
is used for the characteristic composition of the Polymer/DNA complex under 
different circumstances. N/P ratio is the ratio of concentrations of total nitrogen atoms 
(N) of the polycation to the phosphate groups (P) of DNA. In the current study of Arg-
PEA system, the only working nitrogen atoms for plasmid DNA are in the guanidine 
group and three nitrogen atoms only offer one positive charge(due to resonance); 
therefore, the weight ratio of polymer to DNA was used for examine the effect of Arg-
PEAs on their DNA condensation capability. A typical example of an electrophoresis 
experiments for all Arg-PEA tested is shown in Figure 2.12. In this example, the 
migration of the DNA fragments in the gel was retarded as the weight ratio of 4-Arg-
2-S to DNA increased, demonstrating that the 4-Arg-2-S was able to bind to DNA and 
completely neutralize its charge when the Arg-PEA to DNA weight ratios were above 
a critical level. As the ratio of the Arg-PEA to DNA increased further, more gel 
retardation occurred (Figure 2.12, from lane 5 to lane 2). This method allows an 
estimation of the appropriate weight ratios of Arg-PEA polymer to DNA required for a 
complete neutralization of DNA. The detailed effect of the hydrophobic and cationic 
properties of a variety of Arg-PEAs on their DNA condensing and gene transfection 
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capability will be presented in a future study. Other polyelectrolyte complex studies in 
our labs also confirmed that Arg-PEAs could interact with other negatively charged 
polymers to form stable complex. For example, when Arg-PEAs and hyaluronic acid 
aqueous solutions were mixed together, they will form stable complex and precipitate 
from the solutions.   
 
2.D.7  Fabrication of Arg-PEA/PEGDA Hybrid Hydrogel 
 
      In order to obtain cationic hydrogels, hybrid hydrogels from both Arg-PEA and 
PEGDA precursors were fabricated in an aqueous medium by a photo means. Figure 
2.13 showed the hydrogel image of 2-UArg-2-S/PEGDA (at 1.0:4.0, w/w). The left 
image is a completely swollen hydrogel, while the right one is a completely dried 
hydrogel. The presence and amounts of 2-UArg-2-S in the hybrid hydrogel has been 
confirmed by elemental analysis. According to the unpublished data, the measured 
amounts of 2-U-Arg-2-S is very close to the theoretical value, which confirmed that 
the 2-U-Arg-2-S was almost completely involved the photocrosslinking reaction. This 
type of cationic Arg-PEA/PEGDA hybrid hydrogel could have many potential 
applications in the tissue engineering scaffold and drug delivery area.      
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Figure 2.10 X-ray diffraction diagram of Arg-PEAs 
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Figure 2.11 Cytotoxicity tests of Arg-PEAs by MTT assay. Negative control (NC) is 
A10 SMC cell line only without any materials treatment. Various concentrations were 
tested on Superfect® (SF), PLL-HBr, PEI and Arg-PEA polymers (from 2-Arg-2-S to 
2-Arg-6-S). The numbers after the material name indicate the corresponding polymer 
concentration (ug/mL) 
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2.E Conclusion 
 
      A new family of water soluble and cationic L-Arginine-based poly (ester amide)s 
(Arg-PEAs) have been successfully synthesized and characterized. Various 
characterization methods have been used to investigate the physicochemical properties 
of the Arg-PEAs. Arg-PEAs are in the amorphous salt form and proved to be water 
soluble. The relationship between polymer hydrophilicity and polymer structure was 
studied, and found that fewer CH2 units in the Arg-PEA was, the more hydrophilic the 
Arg-PEA polymer became. The data from the in vitro MTT assay demonstrated that 
the Arg-PEA polymers are non-toxic to rat A10 SMC cells even at large dosages. The 
successful hydrogel fabrication from the unsaturated Arg-PEAs in an aqueous medium 
offered a new type of cationic hydrogel. These Arg-PEAs may have the potential 
applications for drug delivery and tissue engineering applications.    
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3.A Abstract 
 
      The goals of this study are to evaluate in-depth of a family of water soluble and 
cationic L-arginine based poly (ester amide)s (Arg-PEAs) as non-viral gene delivery 
vectors and to thoroughly examine the relationship between Arg-PEAs chemical 
structure and their gene transfection efficiency and cytotoxicity. The results revealed 
that changing the number of methylene groups in the diol or diacid unit (x or y) of 
Arg-PEAs could finely tune the hydrophilic/hydrophobic property of Arg-PEAs, 
which would greatly affect the polymers’ DNA condensing ability and transfection 
efficiency. The gel retardation assay data show that Arg-PEA’s DNA condensing 
ability increased with increasing either x or y value (i.e., decreasing hydrophilicity). 
The transfection results obtained from luciferase and GFP assays in rat aortic smooth 
muscle A10 cell lines (SMC A10) showed that many Arg-PEAs had higher 
transfection efficiency than the commercial transfection reagent Superfect®, but at a 
much lower cytotoxicity.  The optimized Arg-PEA/DNA weight ratio (WR) for best 
transfection performance showed a relationship that the WR decreased with 
decreasing Arg-PEA hydrophilicity. The zeta potential data of the Arg-PEA/DNA 
complexes provided a detailed relationship between the DNA condensation and 
chemical structure of the Arg-PEA, and the data were consistent with the transfection 
outcomes of Arg-PEA. The in vitro MTT assay data indicated that all the Arg-
PEA/DNA complexes, over a wide range of dosages, had a minimum cytotoxicity as 
evident in the cell viability and morphology of SMC A10 and rat smooth muscle 
primary cells.  
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3.B Introduction 
 
      Gene therapy can be defined as the treatment of human disease by transferring the 
genetic material into specific cells of patients. During the past several decades, with 
the fast growing molecular biology techniques, gene therapy technology has been 
developed rapidly1-8. Since the first treatment of patients with gene transfer techniques 
under the approved FDA protocols in 1990, more than 1000 gene therapy clinical 
trials have been approved worldwide. However, the successful rate of gene therapy is 
not very encouraging1-7. Based on the reported gene trial results, one of the key 
limitations is that there have not been safe, efficient and controllable methods for gene 
delivery4-12.  
 
       Gene delivery can be mainly accomplished by either virus or non-viral transfer 
methods. The advantages and disadvantages of viral delivery have been well 
documented3. Based on the aspect of the clinical safety, the non-viral gene delivery 
method appears to be the most promising approach. For the reported non-viral gene 
delivery vectors, most of them can be divided into the following 4 broad categories: 
water soluble cationic polymers, lipids, dendrimers and nanoparticles. Among them, 
the water soluble synthetic and natural polycations have attracted the most attentions10-
15. A large number of cationic polymers have been tested for gene delivery. Among 
them, poly-L-lysine (PLL)15-17 and polyethylenimine (PEI)13, 18-20have been intensively 
studied because of their strong interaction with the plasmid DNA, resulting the 
formation of a compact polymer/DNA complex. Other synthetic and natural 
polycations developed as non-viral vectors includes polyamidoamine dendrimers21, 22 
and chitosan23-25, imidazole-containing polymers with proton-sponge effect26-28, 
membrane-disruptive peptides and polymers like polyethylacrylic acid (PEAA)29, 30, 
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poly[alpha-(4-aminobutyl)-L-glycolic acid] (PAGA)31, and poly(amino acid) based 
materials32. However, most of them could not achieve both high transfection 
efficiency and low toxicity simultaneously. 
  
      Recently, many important works were focused on how the polycation’s 
property/structure affect the transfection efficiency or decrease the cytotoxicity of 
polycations33-53. One well-known example is to introduce the PEG chain to the 
polycation’s backbone or side chain, such as poly (L-lysine)-b-PEG and chitosan-g-
PEG, 18, 25, 54-58 to form an amphiphilic structure of the polycations. But the results 
indicated that the introduction of PEG could not help to improve the transfection 
efficiency in most cases18, 25, 54-58. Putnam et al reported how to improve the 
transfection efficiency by balancing the side-chain termini of primary amine and 
imidazole groups 12. Anderson et al prepared around 500 polymers with 70 primary 
structures to study the structure/properties relationship for gene delivery34. Wong et al 
did interesting research to explore the relationship between gene delivery efficiency 
and polymer pendant groups’ hydrophilic/hydrophobic properties59. Three 
hydrophobic residues (C4 butyl, C6 hexyl, and C8 octyl) were intensively assessed in 
terms of their transfection efficiency. Wong et al. found that the introduction of 
hydrophobic residues would improve the polyplex stability, and hence improved the 
transfection efficiency. The authors suggested that the improvement of polyplex 
stability may be related with the conformation rearrangement of polymer during the 
formation of polyplex, suggested further investigations were needed for the 
understanding of mechanism of the hydrophobic residues.  So more quantities works 
and precise models/systems are needed for a better understanding of the relationship 
of polycation structure-function.  
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       Here we designed a precise model, L- arginine based poly (ester amide) (Arg-
PEAs, Figure 3.1 and 3.2), to quantitatively study how the hydrophilicity of the 
polymer backbone could affect their gene delivery; and we proposed the following 
hypothesis for this study: polycations’ hydrophilicity can regulate the interaction 
between polymer and DNA, and affect the polymer’s DNA delivery capability. The 
amino acid-based poly (ester amide)s have several unique properties for this non-viral 
gene delivery trial. First, functional poly (ester amide)s (PEAs, Figure 3.2) are newly 
developed biodegradable and biocompatible polymers having specific functional 
groups for a variety biomedical applications60-65. The diacid and diol parts of the PEA 
repeating unit could be precisely controlled and adjusted by selecting different 
monomers. For example, by changing the number of methylene groups in the diacid or 
diol segment (x and y), a variety of Arg-PEAs having different hydrophilicity or 
hydrophobicity could be designed for a systematic and quantitative study of structure 
– biological function relationship. These Arg-PEAs would have similar other 
important properties, such as molecular weight and density of functional groups 
(cationic density). The similarity eliminated many other possible factors that could 
affect the gene delivery efficiency. Second, L-arginine carries a positive charge at 
physiological pH due to the guanidino group, a very strong basic group with an 
isoelectric point of 10.96 and pKa above 12.5, which could have a strong potential to 
condense negatively charged nuclear acids like plasmid DNA. Thirdly, Arg-based 
polymers have been shown to enter cells efficiently.  Futaki et al. and Mitchell et al 
have reported in their in vitro studies that the poly (L-arginine) can enter the cells 
more efficiently than other polycationic homopolymers66, 67, however, high molecular 
weight poly (L-arginine) was found to be very toxic to cells66-69. Recently, preliminary 
cell membrane penetrating capability and DNA transfection feasibility of a few Arg-
PEAs were reported8 and showed that the Arg-PEA/DNA complex could pass through 
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the cell membrane easily and transfect rat aortic SMC A10 cell lines well with very 
low toxicity when compared with a commercial transfection agent (Superfect®). That 
preliminary study suggested that the Arg-PEAs could have a great potential as a non-
viral gene delivery vector and molecular target agent.  
 
 
 
 
 
 
 
Figure 3.1 General Chemical Structure of an Amino Acid-based Poly (ester amide) 
 
 
 
 
 
 
 
 
 
Figure 3.2 Chemical structure of Arg-PEAs: x-Arg-y-S, where x is the number of 
methylene groups between two adjacent amide linkages and y is the number of 
methylene groups between two adjacent ester linkages. S stands for toluenesulfonic 
acid salt. 
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      In this paper, we advanced that preliminary study further by systematically and 
comprehensively examining the detailed relationship between Arg-PEA polymer 
chemical structures and their properties and transfection efficiency for the purpose of 
achieving a better understanding of the relationship between the newly developed 
water soluble cationic Arg-PEA structure and their biological functions. Vascular 
smooth muscle cells were chosen to test the transfection efficiency of Arg-PEAs for 
two reasons. 1) Vascular smooth muscle cells are very important for the formation of 
vascular lesions, which are major causes of stroke or infarction. 2) Vascular smooth 
muscle cells (SMC) are very difficult to be transfected with current non-viral gene 
vectors70-72. Only few papers discussed the gene transfection of SMC via non viral 
vectors, such as the poly (β-amino ester), PLGA, and cationic phospholipid 
lipopolyplexes73, 74. Brito et al reported the poly (β-amino ester) and cationic 
phospholipid lipopolyplexes system for SMC transfection73. They found that the 
polymers showed low cytotoxicity and better transfection performance than the 
Lpofectin® control. And more new cationic polymers or dendrimers would be needed 
for SMCs to examine their suitability to achieve high transfection efficiency and low 
cytotoxicity simultaneously toward SMC. 
 
      In this work, a series of Arg-PEAs having different methylene chain length due to 
different x and y (x=2, 3, 4, 6; y=2, 4, 8) were prepared to test our hypothesis that the 
hydrophilicity of water soluble polycations like Arg-PEAs can regulate the interaction 
between polymer and DNA, and subsequently affect the polymer’s DNA delivery 
capability.. These Arg-PEAs would have a wide range of hydrophilicity and charge 
density for a systematic evaluation of the relationship between chemical structure of 
the polymers and their properties and transfection efficiency. The findings could help 
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achieve a better understanding of the structure-function relationship of this new family 
of water soluble cationic biodegradable Arg-PEAs. 
 
3.C Experimental 
3.C.1 Materials  
 
      L-Arginine, p-toluenesulfonic acid monohydrate, succinyl chloride, adipoyl 
chloride, sebacoyl chloride, ethylene glycol, 1,3-propanediol, 1, 4-butanediol, 1,6-
hexaniol, triethylamine and p-nitrophenol were all purchased from Alfa Aesar (Ward 
Hill, MA) and used without further purification. Polyethylenimine (PEI) with a 
reported weight average molecular weight (Mw) of 25,000, poly (L-lysine) (PLL)-
hydrobromide (Mw 300,000), ethidium bromide, MTT, Dulbecco’s phosphate-buffered 
saline (PBS, pH 7.4), TAE, HEPES and other buffers were purchased from Sigma (St. 
Louis, MO). Dulbecco’s modified eagle medium (DMEM), penicillin–streptomycin 
(PS, 100 U/mL), trypsin–EDTA (TE, 0.5 % trypsin, 5.3 mM EDTA tetra-sodium), 
fetal bovine serum (FBS) were obtained from Gibco BRL (Rockville, MD). 
 
   Embryonic rat smooth muscle cells A10 and rat aortic smooth muscle primary 
cells (RSMC primary cell) were obtained from American Type Culture Collection 
(ATCC, Manassas, VA). DNA size marker N3014 was purchased from New England 
Lab (Woburn, MA). Qiagen endotoxin-free plasmid Maxi kits and Superfect® was 
purchased from Qiagen (Valencia, CA). Promega Luciferase Assay Kit containing 
luciferase cell culture lyses reagent and luciferase substrates were obtained from 
Promega (Madison, WI). Organic solvents like methanol, toluene, ethyl acetate, 
acetone, 2-propanol and dimethyl sulfoxide (DMSO) were purchased from VWR 
Scientific (West Chester, PA) and were purified by standard methods before use. 
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Other chemicals and reagents if not otherwise specified were purchased from Sigma 
(St. Louis, MO). 
 
3.C.2 Synthesis of Monomers and Polymers  
 
      The general scheme of Arg-PEA synthesis was divided into the following three 
major steps: the preparation of di-p-nitrophenyl ester of dicarboxylic acids64 (I) 
(Figure 3.3), the preparation of tetra-p-toluenesulfonic acid salts of bis (L-arginine), α, 
ω-alkylene diesters (II) (Figure 3.4), and the synthesis of Arg-PEAs (III) via the 
solution polycondensation of monomers (I) and (II) (Figure 3.5).   
 
 
 
  
Figure 3.3 Synthesis of Monomer I: Di-p-nitrophenyl Ester of Dicarboxylic Acid 
 
 
 
 
 
 
 
 
Figure 3.4 Synthesis of Monomer II: Tetra-p-toluenesulfonic Acid salt of Bis(L-
arginine) Alkylene Diesters 
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Figure 3.5 Synthesis of Arg-PEAs from monomers I and II 
 
      Di-p-nitrophenyl esters of dicarboxylic acids (Monomer I) were prepared by 
reacting dicarboxylic acyl chloride varying in methylene length (x) with p-nitrophenol 
described in our previously reported studies64-65. Three monomers were prepared: di-p-
Nitrophenyl Succinate (NSu with x=2); di-p-Nitrophenyl Adipate (NA with x=4); di-
p-Nitrophenyl Sebacate (NS with x=8). x indicates the numbers of methylene group in 
the diacid. For the synthesis of p-toluenesulfonic acid salt of L-arginine diester (II), 
four types of monomer IIs were prepared in this study: tetra-p-toluenesulfonic acid 
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DMSO solvent and are listed in Table 3.1. The details of Arg-PEA synthesis were 
given elsewhere. All Arg-PEAs are labeled as x-Arg-y-S, where x and y are the 
number of methylene groups in diacid and diols, respectively. The molecular weights 
of some Arg-PEAs (x=2, 4, 6; y=2, 3) were obtained from the help of MediVas, LLC, 
San Diego, CA.   
 
Table 3.1, Arg-PEAs (x-Arg-y-S) prepared by different combination of diacids and 
diols building blocks 
 
 
 
 
 
 
3.C.3 Gel Retardation Assay 
 
      The Arg-PEA/DNA complexes for a gel retardation assay were prepared by adding 
the DNA marker (N3014 DNA maker) solution into the Arg-PEA aqueous solutions 
(in 1X PBS buffer). After mixing the two solutions together, it was immediately 
vortex for 2-3 seconds, and then equilibrated at an ambient condition for 30 minutes. 
Arg-PEA/DNA complexes were analyzed by electrophoresis in a 1% agarose gel 
stained with ethidium bromide (10 µg/mL) with TAE buffer at 100 V for 90 min.  
Total injection volume was 15 µL which consisted of 2 µL blue dye solution, 2 µL 
DNA marker solution (500 µg/mL), several µL of the Arg-PEA polymer PBS solution 
and several µL of pure PBS buffer solution. The Arg-PEA solutions must be made 
freshly or stored at 4 °C before use. The amount of DNA was fixed at 1µg per test. 
 Arg-2-S Arg-3-S Arg-4-S Arg-6-S 
NSu 2-Arg-2-S 2-Arg-3-S 2-Arg-4-S 2-Arg-6-S 
NA 4-Arg-2-S 4-Arg-3-S 4-Arg-4-S 4-Arg-6-S 
NS 8-Arg-2-S 8-Arg-3-S 8-Arg-4-S 8-Arg-6-S 
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After mixing all the solutions, the final system was shaken or centrifuged heavily for 
several seconds. The N3014 DNA maker solution without Arg-PEA was used as a 
blank control. The N3014 DNA marker was visualized by an UV illumination 
(FOTO/UV 300 Transilluminator). The migration of DNA from the Arg-PEA/DNA 
complex was recorded by a digital camera (Panasonic WV-BP330).  
 
3.C.4 Cell Culture 
 
      The rat SMC A10 cell lines and rat aortic smooth muscle primary cells (RSMC 
primary) were grown as recommended at 37 °C in 5% CO2 in Dulbecco’s minimal 
essential medium (DMEM) supplemented with 10% FBS and antibiotics. The A10 cell 
lines were used from passages 6 to 12 and RSMC primary cells were used from 
passages 3-5. Media was changed every 2 days. Cells were grown to 70% confluence 
before splitting, harvesting or transfection.  
 
3.C.5 Preparation of Plasmid DNA and Complexes of Arg-PEA/DNA for Zeta 
Potential Measurement and Transfection Study 
 
       The luciferase encoding reporter plasmids COL(-772)/LUC and green 
fluorescence protein encoding reporter plasmid DNA (GFP) were all provided by Dr. 
Bo Liu’s lab. All plasmids were prepared using Qiagen endotoxin-free plasmid Maxi 
kits according to the supplier’s protocol. The quantity and quality of the purified 
plasmid DNA was assessed by spectrophotometric analysis at 260 and 280 nm as well 
as by electrophoresis in 1% agarose gel. Purified plasmid DNA were resuspended in 
TAE (Tris-acetate-EDTA) buffer and frozen in -20 °C. The DNA solution obtained 
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had a concentration around 1.5-2.0 mg/mL and was diluted to around 0.5 mg/mL 
before use. 
 
      The Arg-PEA/DNA complexes were prepared by adding the plasmid DNA buffer 
solution into the freshly prepared Arg-PEA PBS buffer solutions at a room 
temperature to obtain a desirable Arg-PEA to DNA weight ratio (WR). In this paper, a 
wide range of WR (from 50 to 6,000) of Arg-PEA to DNA was tested. The mixed 
solution was immediately and slightly vortex for several seconds and then equilibrated 
at an ambient condition for 20-30 minutes.  All the Arg-PEA solutions and Arg-
PEA/DNA complexes were freshly prepared and used within 4 hours.  
 
3.C.6 Zeta Potential Measurements for Arg-PEA/DNA Complexes 
 
  The charge property and the relationship of charge-structure of the Arg-PEA/DNA 
complex were studied by zeta potential measurements. Arg-PEA solutions (2 mg/mL) 
were prepared by dissolving Arg-PEAs in 1X PBS buffer solution and the solution 
was filtered (0.45 µm pore size, Whatman®) before experiments. The Arg-PEA/DNA 
complexes were prepared by adding the plasmid DNA buffer solution of pre-
determined amounts to the freshly made Arg-PEA PBS buffer solutions (1mL volume 
total) to obtain desirable Arg-PEA to DNA weight ratio. The mixed solution was 
immediately and slightly vortex for several seconds, and then equilibrated at an 
ambient condition for 20 minutes. After that, the zeta potential of the Arg-PEA/DNA 
complexes was measured at 25 °C by using a Malvern Zetasizer Nano-ZS machine. 
Zeta potentials were calculated by using the Smoluchowsky model for aqueous 
suspensions according to manufacturer’s protocol. The following Arg-PEAs were 
selected for this study: 2-Arg-2-S, 8-Arg-2-S and 8-Arg-6-S. Each type of Arg-PEA 
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was measure with a series of WR of Arg-PEA to DNA. Each sample was measure in 
triplicate. 
 
3.C.7 Gene Transfection and Luciferase Assay 
 
       The complexes formed between plasmid DNA and the Arg-PEAs were assessed 
for their in vitro transfection activity utilizing a transient expression of luciferase 
reporter in SMC A10 cells. First, the transfection protocol for Arg-PEAs was studied 
and optimized in terms of cell density, type of buffer for polymer/DNA complex 
formation, transfection time and media, and temperature. After this optimization, all 
transfection experiments were carried out according to the optimized protocol.  
 
      The details for the optimized transfection protocol for Arg-PEAs are given below. 
SMC A10 cells were seeded in 0.5 mL complete DMEM (10% FBS, 1% Hepes, 1% 
penicillin-streptomycin) at 30 x 103 per well in a 24-well plate 24 hours before 
transfection (70% confluent at transfection). Before transfection, the cell culture media 
was removed and the cells were washed with PBS buffer twice. Then 1.0 mL warmed 
serum free DMEM media (without antibiotics) was added into each well. For 
Superfect® and Lipofectamine2000®, the media was used according to the 
manufacturer’s recommendation. The formulated Arg-PEA/DNA complex solution 
was then added into each well. The plasmid DNA amount was fixed at 1 μg per well. 
For the Superfect® formulation, 1 μg of plasmid DNA in 60 μL serum-free DMEM 
were supplemented with 5 µL (3 μg/ µL) of the Superfect® solution in all experiments 
according to the manufacturer’s recommendation. The transfection mixtures were 
immediately and slightly piped up and down for a few seconds, the cells were 
transfected for 4 h at 37 °C (5 % CO2) in an incubator, and then the media solution 
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was removed. After that, 0.5 mL of complete DMEM (10 % FBS, 1 % Hepes, 1 % 
penicillin-streptomycin) were added into each well and kept incubated at 37 °C (5 % 
CO2) in an incubator. After 48 hours, cells were harvested for luciferase reading.. 
Triplicate results were obtained in each data point.  
 
      Gene expression was then determined by the luciferase activity using a DT 20/20 
luminometer (Turner Biosystems, Sunnyvale, CA) with Dual Luciferase Assay System 
(Promega) according to the manufacturer’s instruction. Luciferase assay was 
performed according to Promega’s recommendation. Briefly, cells from each well of a 
24-well plate were lysed in 100 μL lysis buffer, transferred to a micro-tube, and then 
centrifuged at 10,000 g for 2 min. Supernatants were collected and analyzed for 
luciferase activity. In a typical experiment, 20 μL of supernatant was added to 
luminometric tubes containing 100 μL of luciferase substrate (Promega). Light 
emission was measured with a Dual-luciferase detection system for periods of 5 sec, 
and the relative light units (RLUs) were determined. Triplicate results were used in 
each experiment. RLUs were normalized to the protein contents of each sample 
measured by spectrophotometric analysis. 
 
3.C.8 Green Fluorescence Protein (GFP) Assay 
 
      To visually confirm the transfection efficiency obtained from the luciferase 
activity reading, we also transfected the SMC A10 cells with a plasmid DNA encodes 
for Green Fluorescent Protein (GFP). The transfection protocol was the same as the 
one used for luciferase assay, except GFP instead of plasmid DNA was used.  After 48 
h transfection, cells were examined under a fluorescence microscope (Nikon TE2000-
U DIC inverted microscope with UV, GFP/FITC and Tx Red filter sets) for any GFP 
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expression (cells showed green). The cell images were recorded from the random but 
typical fields of the cell culture wells.  
 
3.C.9 Evaluation of Cytotoxicity of the Arg-PEA/DNA complexes 
 
      The evaluation of the cytotoxicity of Arg-PEA/DNA complexes was performed by 
MTT assay. The cultured SMC A10 cells and RSMC primary cells were seeded at an 
appropriate cell density concentration (5,000 cells/well) in 96-well plates and 
incubated overnight in a 5% CO2 incubator at 37 oC. The cells were, then, treated with 
various Arg-PEA/DNA complex solutions for 4 h. The media was removed after 4h 
and complete DMEM was then added. Cells treated only with normal cell culture 
media were used as the negative control (NC). PEI, PLL-HBr and Superfect® treated 
cells were used as the positive control. After 48 h incubation at 37 °C and 5% CO2, 15 
μL of MTT solution (5 mg/mL) was added to each well, followed by 4h incubation at 
37 °C, 5% CO2. The cell culture medium including complex solution was carefully 
removed and 150 μL of acidic isopropyl alcohol (with 0.1 M HCl) was added to 
dissolve the formed formazan crystal. OD was measured at 570 nm (subtract 
background reading at 690 nm) using a VersaMax Tunable Microplate reader. The cell 
viability (%) was calculated according to the following equation: Viability (%) = 
(OD570(sample)-OD620(sample))/ (OD570(control)-OD620(control)) × 100%; where the OD570(control) 
represented the measurement from the wells treated with medium only, and the 
OD570(sample) from the wells treated with various Arg-PEA/plasmid DNA complexes. 
Thus, the cell viability was expressed as the percentage of the blank negative control. 
Triplicates were used in each experiment.  
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3.C.10 Statistics 
 
   Where appropriate, the data are presented as mean ± standard error of the mean 
calculated over at least three data points. JMP software (version 8.0, from SAS 
Company) was used for statistical analysis of data obtained. Significant differences 
compared to control groups were evaluated by unpaired Student’s t-test or Dunnet test 
at p 0.05, and between more than two groups by Tukey’s test with or without one-way 
ANOVA analysis of variance.  
 
3.D Results and Discussions  
3.D.1 Synthesis and Physicochemical Characterization of Arg-PEAs 
 
      The details of the synthesis and characterization of all the prepared monomers and 
polymers of Arg-PEAs have been given elsewhere.  In this study, the synthesis 
protocols of all the Arg-PEAs were optimized. The Arg-PEAs synthesized in this 
study were in the p-toluenesulfonic acid salt form, while all other PEAs from prior 
reported studies were not in any salt form61-64, 75, 76. This is because of the strong base 
nature of the guanidine group in L-Arginine.  Due to its strong base nature, the p-
toluenesulfonic acid counter ion, which is normally removed by triethylamine in the 
last step of polycondensation of amino acid based PEAs from hydrophobic amino 
acids like phenylalanine and leucine, was tightly bound to the guanidine group. The p-
toluenesulfonic acid counter ion, however, was found not to adversely affect the DNA 
binding capability of Arg-PEAs, and all the Arg-PEAs are nontoxic to the cells even at 
large dosages.  
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      The cationic property (charge density) and some other physicochemical properties 
of the Arg-PEA polymers synthesized with different x and y are listed in Table 3.2. 
The data suggested that Arg-PEA has a positive charge density (guardinine  groups 
density was used as an index) ranging from 2.13 to 2.50 mol/kg, while the widely 
studied PEI and PLL-HBr have a much higher charge density (nitrogen atoms density) 
of 23.3 mol/kg and 4.78 mol/kg, respectively. However, the guardinine group has a 
much higher pKa than the amine groups of PEI and PLL-HBr, suggesting a stronger 
interaction with anionic DNA chain. For the Arg-PEAs, it is rational to assume that 
the shorter the repeat unit (i.e., smaller x or/and y) was, the higher the charge density 
would be.  The calculated charge density data in Table 3.2, however, show little 
difference among all the Arg-PEAs studied. For example, the difference between 2-
Arg-2-S (highest charge density due to the smallest x and y) and 8-Arg-6-S (lowest 
charge density) was around 18%; thus, we can state that all the Arg-PEAs synthesized 
in this study had a similar cationic property and would not be the main factor affecting 
the observed different gene delivery efficiency of this Arg-PEA system.   
  
      Some studies have shown that MW of polycations could affect the gene delivery 
efficiency77, 78. The data in Table 3.3 show that all the MW of the six Arg-PEAs were 
within a narrow range (Mn between 12.8 kg/mol and 15.9 kg/mol) and the 
polydispersity was small (< 1.17 with most < 1.10). Therefore, different x or/and y 
material parameters did not show an apparent effect on the MW of the Arg-PEAs 
prepared in this study. Since the MW difference in Arg-PEAs was very small, it was 
not expected to be the dominant factor affecting the gene delivery data in this study.  
 
        In this study, the hydrophilicity of Arg-PEAs was quantitatively evaluated in 
terms of their solubility in distilled water at room temperature (Figure 3.6); and these 
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quantitative data were associated with the interaction of Arg-PEAs with DNA and 
transfection efficiency in the first time.  The solubility data in Figure 3.6 indicate that 
the solubility of Arg-PEAs decreased with an increase in either x or y.  For example, 
the solubility of Arg-PEAs decreased from 200 mg/mL to 10mg/mL as x increased 
from 2 (2-Arg-2-S) to 8 (8-Arg-2-S) at a constant y=2. A similar solubility – structure 
relationship was also found with an increase in y at a constant x.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Arg-PEA solubility in distilled water 
  
       To examine the effect of even vs. odd numbers of methylene chain length, y=3 
was chosen for such an illustration. At a constant y=3, the Arg-PEA solubility had the 
same relationship with an increasing x value, the solubility decreased with an increase 
in x. However, at a fixed x value, the solubility of Arg-PEA at y=3 was higher than the 
solubility of Arg-PEAs at y=2 and 4. This Even–Odd effect has not been addressed in 
published gene delivery studies. For the following discussions, we will separate Arg-
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PEAs having the odd y value (y=3) from all the rest Arg-PEAs, which have both even 
x and y values. 
 
       The goal of this study was to examine the hypothesis that Arg-PEA chemical 
structure affects hydrophilicity (water solubility was used as a quantitative index), 
which, in turn, affects the Arg-PEA/DNA interaction, and affect the transfection 
efficiency and cytotoxicity. As mentioned in the introduction part, many others’ 
published important studies of gene transfection have focused on the modification of 
the side chain of existing polymers or making amphiphilic block copolymers to 
increase the transfection efficiency or cell viability 12, 34, 54, 59. Many reports discussed 
the introduction of PEG chain to the polycation’s backbone or side chain to form 
block copolymer or grafted polymer to change the polycations properties, such as poly 
(L-lysine) -b-PEG and chitosan-g-PEG, 18, 25, 54-58. Wong et al did intensive study to 
explore the three types of pendant hydrophobic residues (C4 butyl, C6 hexyl, and C8 
octyl)59, and more hydrophobic residue would cause less DNA binding stability. 
However, they did not discuss with details about how the segments in polymer 
backbone could be adjusted to improve the transfection efficiency and decrease the 
cytotoxicity. Putnam et al reported the balancing the side-chain termini of primary 
amine and imidazole groups 12 to regulate the charge properties of the polymers to 
improve the transfection efficiency and decrease the cytotoxicity. Though the 
hydrophobic/hydrophilic properties were also modified meanwhile, it was not 
discussed in details in that report. Anderson et al reported around 500 polymers with 
70 primary structures to study the structure/properties relationship for gene delivery34, 
however, due to the complications and huge amount of the 70 systems, many factors, 
especially from polymer structure, could not be intensively discussed in details. In this 
report, we are more interested in how the hydrophobic/hydrophilic properties of 
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polycations’ backbone affect the DNA/polymer interaction and transfection efficiency. 
So, overall, more quantities works and precise but simple models/systems, especially 
focusing on the hydrophobic/hydrophilic properties of repeating unit,  are needed for a 
better understanding of the relationship of polycation structure-function.  
 
      In this paper, we focused on a few easily defined chemical structure parameters of 
Arg-PEAs (i.e., x and y) and how the variation in x and y could affect hydrophilicity 
of Arg-PEAs and their transfection performance and cytotoxicity. The data obtained in 
this study could advance the understanding of the relationship among chemical 
structure, hydrophilicity, zeta potential and transfection of the Arg-PEA based 
biomaterials8.  
 
3.D.2 Gel Retardation Assay      
 
      Gel Retardation Assay is a widely used method for measuring DNA condensing 
capability of polymeric transfection candidates. In this study, the main goal is to 
determine the proper WR of Arg-PEA to DNA required for a completely condensing 
of DNA during the polyplex formation, the first key step toward non-viral gene 
transfection.  Figure 3.7 exhibits all the electrophoresis data for the Arg-PEA/DNA 
complexes. These results demonstrated the DNA condensation capability of Arg-
PEAs, and provided the basic formulation information for subsequent transfection 
experiments. Most important of all, the electrophoresis data showed that different 
types of Arg-PEAs (in terms of x and y parameters) required different amounts of 
Arg-PEAs for a complete DNA condensation as indicated by the different WR.  
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Table 3.2 Arg-PEA Properties 
 
Polymer  Unit Formula Unit MW 
(g/mol) 
Charge Density 
(mol/kg) 
Polymer 
Yield 
2-Arg-2-S C32H48N8O12S2 800.9 2.497 80% 
2-Arg-3-S C33H50N8O12S2 814.9 2.454 83% 
2-Arg-4-S C34H52N8O12S2 828.9 2.413 83% 
2-Arg-6-S C36H56N8O12S2 857.0 2.333 89% 
4-Arg-2-S C34H52N8O12S2 828.9 2.413 90% 
4-Arg-3-S C35H54N8O12S2 842.9 2.372 87% 
4-Arg-4-S C36H56N8O12S2 857.0 2.333 88% 
4-Arg-6-S C38H60N8O12S2 885.0 2.260 83% 
8-Arg-2-S C38H60N8O12S2 885.0 2.260 91% 
8-Arg-3-S C39H62N8O12S2 899.0 2.225 83% 
8-Arg-4-S C40H64N8O12S2 913.1 2.190 87% 
8-Arg-6-S C42H68N8O12S2 941.1 2.125 92% 
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  Table 3.3 Molecular Weight of Arg-PEAs 
 
 
 
 
 
 
 
 
 
 
In order to have a better quantitative comparison of the DNA condensation 
capability of Arg-PEAs, the minimum WR of Arg-PEA to DNA that could completely 
condense DNA was selected and compared (Figure 3.8). For examples, 2-Arg-2-S 
needed a minimum WR of 50 to completely condense the DNA marker; while 8-Arg-
2-S needed a minimum WR of 5 for a complete condensation. This difference in 
minimally required WR is believed to be mainly attributed to different levels of 
hydrophilicity/hydrophobicity of Arg-PEAs since the calculated charge density 
difference between these 2 Arg-PEAs was relatively small, e.g., the largest difference 
in charge density was 18% between 2-Arg-2-S and 8-Arg-6-S. The data in Figure 3.8 
show that if x or y was fixed at 2, the minimally required WR was reduced with an 
increase in y or x, respectively. This relationship, however, did not hold at a larger 
fixed x or y value (such as x=8 and y=6). For example, at a fixed x=8, an increase in y 
value from 2 to 6 led to an increase in the minimally required WR. It is not clear what 
the reason behind this observation is.  It may be attributed to the shift of the balance of 
hydrophilicity and hydrophobicity or polymer conformation at this higher x and y 
Polymer Mn 
(kg/mol) 
Mw 
(kg/mol) 
PDI 
2-Arg-2-S 12.8 13.7 1.07 
2-Arg-3-S 13.5 14.5 1.08 
4-Arg-2-S 14.4 15.9 1.10 
4-Arg-3-S 14.5 16.0 1.11 
8-Arg-2-S 13.2 14.1 1.07 
8-Arg-3-S 15.9 18.5 1.17 
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values. Our trend at low fixed x or y is different from the trend reported by Wong et 
al, who explored three types of pendant hydrophobic residues (C4 butyl, C6 hexyl, and 
C8 octyl)59 and found more hydrophobic residue would cause less DNA binding 
stability. This trend difference could be caused from many aspects: 1, our system is 
changing the length of CH2 units in the backbone unit, while Wong et al’s system is 
for side chain; 2, two polycation systems are significantly different in the aspects of 
polymer structure and functional groups and Wong et al used poly 
(methacryloxysuccinimide) as backbone, which was not biodegradable.. However, we 
estimate that for Arg-PEA system with very large x and y (larger or equal to 8), the 
trend would be same as trend of Wong’s system.  
 
A comparison of the minimally required WR of Arg-PEA to DNA for a complete 
condensation (Figures 3.7 & 3.8) with the solubility data of Arg-PEAs (Figure 3.6), 
we can conclude that the Arg-PEAs’ hydrophilicity (in terms of solubility) can greatly 
affect the DNA condensing capability. 
 
      We also found that the Arg-PEA buffer solutions, if stored at 4 °C, could retain 
their DNA condensing capability for around 2 months, suggesting there was no 
obvious structure change or degradation of Arg-PEAs in the buffer solution at 4 °C. 
And it is very important to recognize that a complete Arg-PEAs dissolution, precise 
polymer concentration and volume are critical for reproducible data. In this study, the 
Arg-PEA polymers must be dissolved completely and the volume should be in the 
range of 2-5 µL to avoid any possible experimental errors. Some Arg-PEAs have a 
very low water solubility and would take a very long time for a complete dissolution. 
If the polymers solutions were not properly prepared, the results would be different.   
 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Gel retardation assay to show the effect of hydrophobic block length (x or 
y) of Arg-PEAs on the condensation ability to DNA: B means blank, (only 1 µg 
N3014S DNA, no Arg-PEA); the other column numbers are the WR of Arg-PEA to 
DNA. The Arg-PEAs are: 2-Arg-2-S, 2-Arg-3-S, 2-Arg-4-S, 2-Arg-6-S (first row, 
from left to right): 4-Arg-2-S, 4-Arg-3-S, 4-Arg-4-S, 4-Arg-6-S (second row, from left 
to right); 8-Arg-2-S, 8-Arg-3-S, 8-Arg-4-S, 8-Arg-6-S (third row line, from left to 
right) 
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Figure 3.8 The minimum weight ratio (WR) of Arg-PEA to DNA required to 
completely condensing DNA as a function of methylene chain length in diacid (x) and 
diol segments (y) of Arg-PEA polymers 
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3.D.3 Transfection Efficiency 
 
       In this paper, the plasmid DNA that encodes for a firefly luciferase driven by a 
collagen promoter was used. By measuring luciferase activities in cell lysates, which 
in this case is mainly determined by the amount of DNA transferred into the cells, we 
compared the transfection efficiency of Arg-PEAs with a commercial transfection 
agent, Superfect® for examining the transfection feasibility of Arg-PEAs.  
 
      In any transfection protocol development, cell density, transfection time, 
transfection temperature, transfection media and buffer types are important parameters 
for optimization to achieve the best transfection data.  In the Arg-PEA/DNA system, 
the optimized transfection protocol of a particular 2-Arg-3-S/DNA system was: 
transfection time: 3-4 h; transfection temperature: 37 °C; transfection media: serum 
free DMEM media without antibiotics; buffer for Arg-PEA/DNA: HEPES (20 mM) or 
PBS buffer (1X); cell density: 20,000-30,000 per well for 24-well cell culture plate. At 
this optimized condition, it was observed that the luciferase activity could reach the 
peak value over a range of WR of Arg-PEA to DNA.  
 
       Figure 3.9 showed an example of the transfection results from three types of Arg-
PEA/DNA at various WR: 2-Arg-3-S, 4-Arg-3-S and 8-Arg-3-S. PEI was used here as 
the polymer control and the transfection efficiency was very poor compared with 
Lipofectaimine2000 and Arg-PEAs. The data show that all the Arg-PEA/DNA could 
show some transfection capability over a very broad WR range, and each type of Arg-
PEA/DNA showed a peak transfection at a specific WR.  For example, the 8-Arg-3-
S/DNA showed transfection capability over WR from 100 to 1000, but its highest 
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transfection capability was around WR of 200. For the 2-Arg-3-S/DNA system, the 
peak transfection, however, occurred at WR 2,000. 
 
These transfection results also showed that the WR of Arg-PEAs/DNA to reach 
the optimum transfection efficiency (Figure 3.9) was much higher than the minimal 
WR required to completely condense DNA in the electrophoresis data (Figure 3.7). 
The transfection agent’s DNA condensation capability is known to have a profound 
effect on the subsequent gene delivery efficiency, but is not the only factor that is 
responsible for the outcome of gene delivery efficiency.  This may be attributed to the 
need of excess amounts of Arg-PEAs required to achieve not only a stable Arg-
PEA/DNA complex system in the transfection media but also provided additional 
cationic charge to the Arg-PEA/DNA complex for its proper penetration into the cells 
membranes.  The larger dosage of Arg-PEA required for the optimized transfection, 
however, didn’t impose any adverse cytotoxicity as described later. 
 
To compare the transfection efficiency of all the Arg-PEAs, the highest or peak 
RLU/mg (relative light unit/mg) of each polymer was selected and normalized against 
the RLU/mg value of the commercial control (Superfect®), i.e., setting the RLU/mg 
value of the control at 100 (Figure 3.10).  This normalization process removed the 
batch to batch variation.  The normalized transfection data in Figure 3.10 showed that 
most of these Arg-PEAs had comparable or better transfection efficiency (i.e., those 
Arg-PEAs having 100 or greater normalized values) than the commercial transfection 
reagent Superfect®. Those Arg-PEAs having lower x and y values (2 and 3) were the 
most favorable for higher transfection efficiency, while high y value, especially y=6, 
is not favorable for high transfection. Arg-PEAs having both high x and y (e.g., x=8, 
y=6) exhibited the lowest transfection.  
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      In this Arg-PEA system, the polymer DNA condensing capability was evaluated 
by the minimum WR required for a completing DNA condensation, i.e., a smaller 
minimum WR suggested a higher condensing capability.  However, the Arg-PEA 
polymer with the highest DNA condensing capability (expressed in terms of the 
smallest minimal WR required) did not show the best transfection. For example, the 8-
Arg-6-S showed a much lower transfection capability than 8-Arg-3-S, even though 8-
Arg-6-S had a better DNA condensing capability. This may be attributed to the fact 
that the Arg-PEA that had the strongest DNA binding capability may not easily release 
DNA after entering cells.  
 
      Figure 3.11 showed the WR of all the Arg-PEAs that achieved the highest 
transfection efficiency. The data in Figure 3.11 show that the WR required for 
achieving the highest transfection was reduced with an increase in x or y. This 
relationship of WR for optimal transfection vs. x and y material parameters of Arg-
PEAs (Figure 3.11) was very consistent with the relationship between Arg-PEA water 
solubility (hydrophilicity) vs. x and y material parameters of Arg-PEA (Figure 3.6).  
For example, from 2-Arg-2-S to 8-Arg-2-S, the WR required for the highest 
transfection was reduced from 2,000 to 200, while the solubility of these two Arg-
PEAs was also decreased from 200 mg/mL to 10 mg/mL. These data suggested that 
less hydrophilic of the Arg-PEA was, the less Arg-PEA macromolecules were needed 
to form a stable and efficient complex with DNA for a better transfection. 
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3.D.4 GFP Expression 
 
      To visually confirm the transfection efficiency obtained from the luciferase 
activity data, SMC A10 cells were transfected by plasmid DNAs encoding for green 
fluorescent protein (GFP). Two days following such a transfection, the SMC were 
examined under a fluorescence microscope for their GFP expression (SMC show 
green). Figure 3.12 shows GFP plasmid DNAs were successfully expressed inside 
SMCs as commercial transfection agent Superfect® did.  
 
3.D.5 Zeta Potential Measurements for DNA/Arg-PEA Complex 
 
      The Zeta potential measurement was used to study the charge property and the 
charge-structure relationship of the Arg-PEA/DNA complex.  Figure 3.13 showed the 
zeta potentials of 3 types of Arg-PEA/DNA complexes as a function of the ratio of 
Arg-PEA to DNA as well as the type of Arg-PEAs. For example, the data in Figure 
3.13(b) (8-Arg-2-S) could be divided into 3 regions, depending on the ratio of Arg-
PEA to DNA.  As the weight ratio of Arg-PEA to DNA increased, the zeta potential of 
the complex increased (from negative to positive), suggesting that as more Arg-PEAs 
added into the DNA, the charge property of the complex changed from negative to 
positive. A further increase in the weight ratio of Arg-PEA to DNA, the zeta potential 
of the complex reached a peak, (WR is around 200), and a further increase in the WR 
resulted in a reduction in zeta potential of the complex. The WR with a peak zeta 
potential suggests that the Arg-PEA/DNA complex must be in the most stable state, 
and should be the optimal condition for gene transfection.  
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Figure 3.9 Transfection efficiency of Arg-PEA/DNA complexes expressed by firefly 
luciferase activity. Plasmid DNA used were COL (-772)/Luc. Superfect® (SF) was 
tested with the optimum weight ratio of SF to DNA. Various WR of Arg-PEA to DNA 
(indicating by the numeric # after sample labels) were tested.  
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Figure 3.10 the effect of x and y material parameters of Arg-PEAs on the normalized 
transfection efficiency against a commercial transfection agent, Superfect® by setting 
the RLU of Superfect as 100. Those Arg-PEAs having greater than 100 have better 
transfection efficiency than the commercial Superfect agent. 
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A comparison of these WR vs. zeta potential data with the effect of WR on 
transfection data described previously (e.g., Figure 3.9), the WR at the peak zeta 
potential coincided with the WR that showed the best transfection efficiency. 
Therefore, this relationship between the zeta potential of the Arg-PEA/DNA complex 
with the weight ratio of Arg-PEA to DNA provides a very solid illustration of the 
charge property and structure change of the Arg-PEA/DNA complex, and the data 
trend was very consistent with transfection (Figures 3.9 and 3.11) and electrophoresis 
data (Figures 3.7 and 3.8). 
 
      The zeta potential data of these 3 types of Arg-PEAs also illustrate the effect of x 
and y in Arg-PEAs on their condensation capability with DNA. For example, 2-Arg-2-
S (Figure 3.13 (a)) required much higher amounts (WR 2,000) of Arg-PEA than 8-
Arg-2-S (WR 200) did (Figure 3.13 (b)) to reach the peak zeta potential. The 
magnitude of the zeta potential peak also depended on x and y of the Arg-PEAs. For 
example, 8-Arg-2-S/DNA complex had the largest peak zeta potential (Figure 3.13 
(b)), while the 8-Arg-6-S/DNA had the smallest peak zeta potential (Figure 3.13 (c)). 
This magnitude of peak zeta potential was found to be related to the transfection 
efficiency. For example, among the 3 Arg-PEA polymers tested (2-Arg-2-S, 8-Arg-2-
S, 8-Arg-6-S), the largest peak zeta potential found in 8-Arg-2-S/DNA at WR 200 
(Figure 3.13 (b)) coincided with its highest transfection efficiency among the 3 
polymers, while the smallest peak zeta potential found in 8-Arg-6-S/DNA complex at 
WR 100 showed the lowest efficiency (Figure 3.10).  
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Figure 3.11 The effect of x and y material parameters of Arg-PEAs on their weight 
ratios of Arg-PEA to DNA (WR) that achieved the highest transfection efficiency. 
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Figure 3.12 Fluorescence microscopic view (10X) of the GFP expression from 
transfected SMC A10 cells under. Green cells are cells successfully transfected with 
GFP DNA.  (a) SMC A10 cells were transfected by Superfect®. (b) SMC A10 cells 
were transfected by Arg-PEA (2-Arg-3-S, WR=2,000). 4hr transfection and the 
images were taken after 48h 
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Figure 3.13 Zeta potential measurements of Arg-PEA/DNA complex in a very wide 
weight ratio (WR) range. Positive value means the complex is positively charged; 
while negative value means the complex is negatively charged. (a), 2-Arg-2-S/DNA 
complex; (b), 8-Arg-2-S/DNA complex; (c)8-Arg-6-S/DNA complex 
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Figure 3.14, Cytotoxicity of Arg-PEA/DNA complexes by MTT assay. The cell 
viability was normalized against blank control by setting the blank control as 100. 
Negative control (NC) is cells only without any transfection agent treatment. Various 
WRs of Arg-PEA to DNA were tested (from 2-Arg-3-S to 8-Arg-3-S). The numerical 
numbers after the sample label indicate the corresponding WR.  
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Figure 3.15 RSMC cell morphology (10x, images taken 48 h after treatment): (a) 
Negative control, no polymer added; (b) cells with 2,000 μg 2-Arg-3-S added for 4 h; 
(c) cells with 15 μg Superfect® added for 4 h. 
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3.D.6 Cytotoxicity of Arg-PEA/DNA Complex by MTT Assay 
 
      Cytotoxicity of Arg-PEA/DNA complexes was evaluated by MTT assay. The 
MTT system is a simple, accurate, reproducible means of detecting living cells via 
mitochondrial dehydrogenase activity. An increase in cell number (cell proliferation) 
results in an increase in the amount of MTT formazan formed and an increase in UV 
absorbance. PEI, PLL and Superfect® were used as the controls.  
 
      All the synthesized Arg-PEAs at different WR of Arg-PEA/DNA were tested by 
MTT assay as shown in Figure 3.14. The MTT data clearly demonstrated that, at 4 h 
treatment, all the Arg-PEA/DNA complexes showed very little toxicity to the SMC 
A10 and RSMC primary cells even at a very large dosage. Although the 3 controls 
(Superfect®, PEI and PLL) required much lower dosages than Arg-PEAs to reach 
optimum transfection efficiency, these 3 controls still showed a significantly higher 
cytotoxicity than Arg-PEAs. Since Arg-PEA had a lower positive charge density than 
these 3 control transfection reagents, a larger dose of Arg-PEA was needed to achieve 
efficient transfection. The statistical data analysis showed that there is no significant 
difference of any Arg-PEA treatment compared to the control at the p 0.05 level by 
Dunnet test of planned comparison. So there is no evidence of toxicity of Arg-PEAs. 
 
In addition to MTT assay, the cytotoxicity of Arg-PEA/DNA complexes can also 
be confirmed by their effect on cell morphology as shown in Figure 3.15. Figure 3.15 
showed the images of RSMC primary cells 48h after treatment in different Arg-
PEA/DNA complexes for 4 h. It can be seen that the RSMC treated by 2-Arg-2-S 
displayed normal RSMC morphology, confirming the non-toxic nature of these Arg-
PEAs. In contrast, those RSMC primary cells treated by Superfect® appeared to be 
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very unhealthy. So we can conclude that these newly developed Arg-PEAs are non-
toxic and very safe to the SMC A10 cells and RSMC primary cell. 
 
3.E Conclusion  
  
      In this work, we prepared a series of water soluble, non-toxic and biodegradable L-
Arginine based poly (ester amide)s (Arg-PEAs) for both an in-depth  study of their 
capability  as a non-toxic and non-viral vector  as well as the elucidation of  the 
relationship between  polymer structure – biological functions. Through various assays 
and methods, we confirmed that Arg-PEAs could condense the DNA and form stable 
complex for a subsequent transfection of aortic smooth muscle cells. Some Arg-PEAs 
showed better transfection efficiency than Superfect®, while exhibiting a much lower 
cytotoxicity. This study revealed a quantitative relationship among Arg-PEA polymer 
structures, their hydrophilicity and transfection capability. For example, increasing the 
length of methylene groups in Arg-PEA repeating unit (x or y) decreases the polymer 
hydrophilicity, and subsequently increases their DNA condensation capability. The 
Arg-PEA hydrophilicity also had a great impact on both the transfection efficiency 
and the optimal weight ratio of Arg-PEA to DNA required for the best transfection 
performance. The zeta potential data of the Arg-PEA/DNA complexes provided a 
further and strong support for such a relationship of Arg-PEA structure – biological 
function. This new Arg-PEA family showed a great potential as a better and safer non-
viral transfection agent. Their ability to deliver therapeutic DNAs with insignificant 
cytotoxicity could be further improved by modifying the polymer structure and 
transfection protocol, such as change polymer molecular weight, the length of 
methylene group in Arg-PEA and the type of salt other than toluenesulfonic acid salt, 
etc. 
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4.A Abstract 
 
       The goals of this study are to evaluate a family of water soluble, cationic L-
arginine based poly (ether ester amide)s (Arg-PEEAs) as non-viral gene delivery 
vectors for cell lines, primary cells and stem cells. These new biodegradable polymers 
consist of 3 non-toxic building blocks: L-arginine, oligoethylene glycols, and 
dicarboxylic acids. The Arg-PEEAs were prepared by the solution polycondensation 
reaction of p-toluenesulfonic acid salt of L-arginine diester from oligoethylene glycol 
and di-p-nitrophenyl esters of dicarboxylic acids. The optimal conditions of the 
synthesis of both monomers and polymers were investigated, and the newly prepared 
monomers and polymers were chemically characterized. Arg-PEEAs were found to 
have very good solubility in water and many other polar solvents. It was found that the 
introduction of oligoethylene glycols into the polymer backbone increased the 
polymer water solubility and decreased the glass transition temperature (Tg) of the 
polymers. The relationship between Arg-PEEAs backbone structure and their gene 
transfection efficiency and Arg-PEEA/DNA cytotoxicity were studied through various 
biological assays, such as gel retardation assay, GFP assay, luciferase assay and MTT 
assay. The transfection results obtained from luciferase and GFP assays for many 
types of cell lines, primary cells and stem cells showed that some Arg-PEEAs had 
higher transfection efficiency than the commercial transfection reagent 
Lipofectamine2000®, but at a much lower cytotoxicity. Zeta potential and particle size 
tests provided more details of the Arg-PEEA/DNA complex properties.  
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4.B Introduction 
 
      Gene therapy can be defined as the treatment of human disease by transferring the 
genetic material into specific cells of patients. During the past several decades, with 
the fast growing molecular biology techniques, gene therapy technology has been 
developed rapidly1-6. Since the first treatment of patients with gene transfer techniques 
under the approved FDA protocols in 1990, more than 1000 gene therapy clinical 
trials have been approved worldwide. However, the successful rate of gene therapy is 
not very encouraging1-6. Based on the reported gene trial results, one of the key 
limitations is that there have not been safe, efficient and controllable methods for gene 
delivery3-8.  
 
      Gene delivery can be mainly accomplished by either virus or non-viral transfer 
methods. The viruses utilized for gene therapy could be divided into retroviruses and 
adenoviruses2. The advantages and disadvantages of viral delivery have been well 
documented2. Based on the aspect of the clinical safety, the non-viral gene delivery 
method appears to be the most promising approach. For the reported non-viral gene 
delivery vectors, most of them can be divided into the following 4 broad categories: 
water soluble cationic polymers, lipids, dendrimers and nanoparticles. Among them, 
the water soluble synthetic and natural polycations have attracted the most attentions7, 
9-11. A large number of cationic polymers have been tested for gene delivery. Among 
them, poly-L-lysine (PLL)11 and polyethylenimine (PEI)9 have been intensively 
studied because of their strong interaction with the plasmid DNA, resulting the 
formation of a compact polymer/DNA complex. Other synthetic and natural 
polycations developed as non-viral vectors includes polyamidoamine dendrimers12, 13 
and chitosan14, 15, imidazole-containing polymers with proton-sponge effect16, 17, 
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membrane-disruptive peptides and polymers like polyethylacrylic acid (PEAA)18, 19, 
poly [alpha-(4-aminobutyl)-L-glycolic acid] (PAGA)20, and poly (amino acid) based 
materials21. However, most of them could not achieve both high transfection 
efficiency and low toxicity simultaneously. 
 
      Recently, many important reported studies focused on how the polycation’s 
property/structure affect the transfection efficiency or decrease the cytotoxicity of 
polycations22-31. Putnam et al reported how to improve the transfection efficiency by 
balancing the side-chain termini of polylysine conjugated with imidazole groups7. 
Anderson et al prepared more than 500 poly (β-amino esters) (PBAEs) with 70 
primary structures to study the polymer structure/properties relationship for gene 
delivery22.They found that certain polymer structural characteristics are important for 
effective gene delivery and the best PBAEs are linear polymers of ׽10 kDa that 
contain hydroxyl side chains and primary amine end groups22. Wong et al did an 
interesting research to explore the relationship between gene delivery efficiency and 
polymer pendant groups’ hydrophilic/hydrophobic properties32. In order to have a 
better understanding of the relationship of polycation structure-function, we have 
reported a simple, but precise model, L- arginine based poly (ester amide) (Arg-PEAs, 
Figure 4.1) to quantitatively study how the polymer structure affect their gene delivery 
performance6.  
 
      This Arg-PEA system has the following unique advantages: (1) The diacid (x) and 
diol (y) parts of the PEA repeating unit could be precisely controlled and adjusted by 
selecting different monomers; (2) L-arginine carries a positive charge at physiological 
pH due to the guanidino group, a very strong basic group with an isoelectric point of 
10.96 and pKa about 12.5, which could have a strong potential to condense negatively 
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charged nuclear acids; (3) Arg-based polymers have been shown to enter cells 
efficiently.  Futaki et al. and Mitchell et al have reported in their in vitro studies that 
the poly (L-arginine) can enter the cells more efficiently than other polycationic 
homopolymers33, 34, however, high molecular weight poly (L-arginine) was found to 
be very toxic to cells35. Our previous results6 have shown that the 1st generation Arg-
PEAs using aliphatic alcohols showed excellent cell membrane penetrating capability, 
high transfection efficiency and low cytotoxicity to cell lines, such as rat smooth 
muscle cell (SMC) A10 cell line, when compared with commercial transfection 
agents: Superfect® and Lipofectamine2000®. However, those 1st generation Arg-PEAs 
could not transfect the primary and stem cells with high efficiency.   
 
 
 
 
 
 
 
 
Figure 4.1 General Chemical Structure of Arginine Based Poly (ester amide)  
 
      Due to the limitation of the cell types that can be transfected properly by the 1st 
generation Arg-PEA, a newer generation of arginine based PEA is needed. According 
to our unpublished results, the Arg-PEAs having double bonds in the polymer 
backbone showed significantly higher Tg and reduced transfection efficiency than 
those having saturated moieties.  
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Therefore, we have the following hypothesis: Flexible Arg-based poly (ester 
amide) s chains could show increased transfection efficiency because the more flexible 
Arg-PEA polymers could wrap around the relatively rigid triple helix plasma DNA 
better for an improved DNA condensation.  For this study, oligoethylene glycols of 
various molecular weights were selected as the candidates for the diol part of the Arg-
PEAs because of their very flexible backbone structure. As we know, PEG chain had 
been widely conjugated to the polycation’s backbone or side chain to form an 
amphiphilic structure of the polycations 15, 29-31, 36, 37. In most of those published 
studies, the conjugation of PEG segments could reduce the cytotoxicity of 
polymer/DNA complex and improve the transfection efficiency. These PEG segments 
used for conjugation had molecular weights ranging from 600 to 5,000 15, 29-31, 36, 37.  
There are very few publications discussed the introduction of short chain PEG, 
oligoethylene glycol (molecular weight below 600, such as diethylene glycol), to the 
polymer repeating units for gene transfection study and other biomedical 
applications25, 38.  
 
      In this paper, we advanced our 1st generation Arg-PEA study for gene transfection 
further by introducing oligoethylene glycols into Arg-PEA polymer backbone to have 
a more flexible chain structure for exploring a better understanding of the relationship 
between the Arg-PEEA structure and their biological functions.  
 
      In this work, a series of Arg-PEEAs (Figure 4.2) having different methylene (x)/ 
ethylene glycol (y) chain length (x=2, 4, 8; y=2, 3, 4, 6, 12) in the repeating unit were 
prepared to test our hypothesis that the oligoethylene glycol based Arg-PEEAs can 
improve the transfecion efficiency. These Arg-PEEAs would have a wide range of 
properties for a systematic evaluation of the relationship between chemical structure of 
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the polymers, their properties and transfection efficiency. The findings could help 
achieve a better understanding of the structure-function relationship of this new family 
of water soluble cationic biodegradable Arg-based cationic polymers. 
 
 
 
 
 
 
 
 
  
 
Figure 4.2 Chemical structure of Arg-PEEAs: x-Arg-yEG-z, where x is the number of 
methylene groups between two adjacent amide bonds, and y is the number of ethylene 
glycol groups between two adjacent ester groups. z stands for salt type 
(toluenesulfonic acid salt, Tos or chlorine salt, Cl). 
 
4.C Experimental 
4.C.1 Materials  
 
      L-Arginine, L-Arginine hydrochloride, p-toluenesulfonic acid monohydrate, 
succinyl chloride, adipoyl chloride, sebacoyl chloride, di-ethylene glycol (DEG), tri-
ethylene glycol (TEG), tetra-ethylene glycol (TTEG), poly (ethylene glycol) (Mn= 
300), poly (ethylene glycol) (Mn= 600), triethylamine and p-nitrophenol were all 
purchased from Alfa Aesar (Ward Hill, MA) and used without further purification. 
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Organic solvents like methanol, toluene, ethyl acetate, acetone, 2-propanol and 
dimethyl sulfoxide (DMSO) were purchased from VWR Scientific (West Chester, PA) 
and were purified by standard methods before use. Other chemicals and reagents if not 
otherwise specified were purchased from Sigma (St. Louis, MO).  
 
      Linear polyethylenimine (PEI) with a weight average molecular weight (Mw) of 
25,000, ethidium bromide, MTT, Dulbecco’s phosphate-buffered saline (PBS, pH 
7.4), TAE, HEPES and other buffers were purchased from Sigma (St. Louis, MO).  
Dulbecco’s modified eagle medium (DMEM), penicillin–streptomycin (PS, 100 
U/mL), trypsin–EDTA (TE, 0.5 % trypsin, 5.3 mM EDTA tetra-sodium), fetal bovine 
serum (FBS) were obtained from Gibco BRL (Rockville, MD). Cell lines (rat SMC 
A10, BAEC endothelial cells), rat primary smooth muscle cells (RSMC), human 
umbilical vein endothelial cells (HUVEC)) and rat Mesenchymal stem cells, MSC) 
and rat bone marrow cells (BM)) were obtained from American Type Culture 
Collection (ATCC, Manassas, VA) or Professor Bo Liu’s lab at Surgery Department 
of Wisconsin University. DNA size marker N3014 was purchased from New England 
Lab (Woburn, MA). A Qiagen endotoxin-free plasmid Maxi kit was purchased from 
Qiagen (Valencia, CA). Lipofectamine2000® was purchased from Invitrogen 
(Carlsbad, CA). Promega Luciferase Assay Kit containing luciferase cell culture lyses 
reagent and luciferase substrates were obtained from Promega (Madison, WI).  
 
4.C.2 Synthesis of Monomers and Polymers  
 
      The general scheme of Arg-PEEA synthesis was divided into the following three 
major steps: 1): the preparation of di-p-nitrophenyl ester of dicarboxylic acids (I) 
(Figure 4.3); 2): the synthesis of p-toluenesulfonic acid salt of L-arginine diester (II) 
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from di- ethylene glycol, tri-ethylene glycol, and tetra-ethylene glycol, PEG300 and 
PEG600 (the preparation of tetra-p- toluenesulfonic acid salts of bis-L-Arginine esters  
(IIa) ( Figure 4.4) and the preparation of di-p- toluenesulfonic acid di-hydrochloride 
acid salts of bis-L-Arginine esters (IIb)) (Figure 4.5); and 3): the synthesis of Arg-
PEEAs (III) (Figure 4.2) via the solution polycondensation of monomers (I) and (IIa 
or IIb).  
 
 
 
 
 
Figure 4.3 Monomer I: di-p-nitrophenyl ester of dicarboxylic acids 
 
 
 
 
 
 
 
 
Figure 4.4 Monomer IIa: tetra-p- toluenesulfonic acid salts of bis-L-Arginine esters  
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Figure 4.5 Monomer IIb: di-p-toluenesulfonic acid di-hydrochloride acid salts of bis-
L-Arginine esters 
       
      Di-p-nitrophenyl esters of dicarboxylic acids (Monomer I) were prepared by 
reacting dicarboxylic acyl chloride varying in methylene length (x) with p-nitrophenol 
based on our previously reported studies39. Three Monomers I were prepared: di-p-
Nitrophenyl Succinate (NSu with x=2); di-p-Nitrophenyl Adipate (NA with x=4); di-
p-Nitrophenyl Sebacate (NS with x=8). x indicates the numbers of methylene group in 
the diacid.  
 
      L-arginine is used for the preparation of tetra-p-toluenesulfonic acid salts of bis-L-
Arginine esters (IIa). Because of the strong positive charge characteristic of L-
arginine, the amounts of p-toluenesulfonic acid used for the synthesis of p-
toluenesulfonic acid salt of L-arginine diester was doubled when compared with the 
prior synthesis of p-toluenesulfonic acid salt of non-ionic hydrophobic amino acids 
diesters.  The need to double the amounts of p-toluenesulfonic acid in the synthesis of 
Monomer IIa is because of the preferential consumption of the p-toluenesulfonic acid 
by the strong basic guanidine group on L-arginine side chain, and additional p-
toluenesulfonic acid was needed to convert the free amine groups at the two ends of 
146 
 
the monomer IIa into the p-toluenesulfonic acid salts for subsequent solution 
polycondensation with monomer I..  
 
      An example of the synthesis of monomer IIa is given here: L-arginine (0.04 mol) 
and di-ethylene glycol (0.02 mol) were directly mixed in a three neck round bottom 
flask with toluene (b.p. 110 ºC) (400 mL) with the presence of p-toluenesulfonic acid 
monohydrate (0.082 mol). The solid-liquid reaction mixture was heated to 130 ºC and 
reflux for 24 hr after 2.16 mL (0.12 mol) of water was generated. The reaction mixture 
(viscous solid) was then cooled to room temperature. Toluene was decanted. The dried 
reacted mixture was finally purified by repeated precipitation in 2-propanol for three 
times. 2-propanol was decanted, and then the white sticky mass was dried in vacuum. 
Five monomers (IIa) were made in this study (Table 4.1): Arg-2E-S, Arg-3E-S, Arg-
4E-S, Arg-6E-S, and Arg-12E-S. 2E, 3E, 4E stand for the di-ethylene glycol , tri-
ethylene glycol and tetra-ethylene glycol, respectively; 6E stands for PEG300 because 
the number of ethylene glycols of PEG300 is around 6-7; 12E stands for PEG600 
because the number of ethylene glycols of PEG600 is around 12-13. The first 3 
monomers (Arg-2E-S, Arg-3E-S, and Arg-4E-S) are white solid powder and the last 
two are transparent or yellow viscous solid. All of them are obtained in high yields 
(80~90 %). 
 
      L-Arginine hydrochloride is used for the preparation of di-p-toluenesulfonic acid 
di-hydrochloride acid salts of bis-L-arginine esters (IIb). Since the basic guanidine 
group on arginine side chain has formed the salt with hydrochloride acid, the amount 
of p-toluenesulfonic acid used for the synthesis of di-p-toluenesulfonic acid di-
hydrochloride acid salts of bis-L-arginine esters (IIb) was the same as the prior 
synthesis of p-toluenesulfonic acid salt of non-ionic hydrophobic amino acids diesters. 
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Five monomers (IIb) were made in this study (Table 4.1): Arg-2E-Cl, Arg-3E-Cl, 
Arg-4E-Cl, Arg-6E-Cl, and Arg-12E-Cl. The definitions of 2E, 3E, 4E, 6E and 12E 
are same as the monomer IIa described above. The first 3 monomers are white solid 
powder and the last two are transparent or yellow viscous solid. All of them are 
obtained in high yields (80~90%).  All the prepared monomers (IIa and IIb) are listed 
in Table 4.1 and labeled as Arg-yEG-z, where y is the number of ethylene glycol units 
in diols and z is the salt type (S for p-toluenesulfonic acid salt or Cl for hydrochloride 
salt). 
 
      Arg-PEEAs (Figure 4.2) were prepared by a solution polycondensation of the 
monomers (I) and (IIa or IIb) of different combinations in DMSO solvent, and the 
synthesized Arg-PEEAs are listed in Table 4.2. An example of the synthesis of 2-Arg-
2E-S via solution polycondensation is given here. Monomers NSu (1.0 mmol) and 
Arg-2E-S (1.0 mmol) in 1.5 mL of dry DMSO were mixed well by vortexing. The 
mixture solution was heated up with stirring to obtain a uniformed solution mixture. 
Triethylamine (0.31 mL, 2.2 mmol) was added drop by drop to the mixture while 
heating up to 75 °C with vigorous stirring until a complete dissolution of the 
monomers. The solution color turned into yellow after several minutes. The reaction 
vial was then kept for 48 hrs at 75 °C in a thermostat oven without stirring. The 2-Arg-
2E-S polymer in the reaction solution was precipitated out by adding cold ethyl 
acetate, decanted, dried, re-dissolved in methanol and re-precipitated in cold ethyl 
acetate for further purifications. Repeat the purification for 2 times before drying in 
vacuo at room temperature. The prepared Arg-PEEAs are white solid powder (for EG 
with number 2, 3 and 4) or transparent/yellow viscous solid (for EG with number 6 
and 12). All of them are obtained in high yields (80~90 %). 
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      All the Arg-PEEAs are labeled as x-Arg-yEG-z, where x and y are the number of 
methylene groups in diacids and ethylene glycol units in diols, respectively, and z is 
the salt type (S for p-toluenesulfonic acid salt or Cl for hydrochloride salt).  
 
4.C.3 Characterizations 
 
      The physicochemical properties of the prepared monomers and polymers were 
characterized by various standard methods. For Fourier transform infrared (FTIR) 
characterization, the samples were ground into powders and mixed with KBr at a 
sample/KBr ratio of 1:10 (w/w). FTIR spectra were then obtained with a Perkin-Elmer 
(Madison, WI) Nicolet Magana 560 FTIR spectrometer with Omnic software for data 
acquisition and analysis. 1H-NMR spectra were recorded with a Varian Unity Inova 
400-MHz spectrometer (Palo Alto, CA). Deuterated water (D2O-d2; Cambridge 
Isotope Laboratories, Andover, MA) with tetramethylsilane as an internal standard or 
deuterated dimethyl sulfoxide (DMSO-d6; Cambridge Isotope Laboratories) was used 
as the solvent. MestReNova software was used for the data analysis. The thermal 
properties of the synthesized Arg-PEEAs were characterized with a DSC 2920 (TA 
Instruments, New Castle, DE). The measurements were carried out from -20 to 200 °C 
at a scanning rate of 10 °C/min and at a nitrogen gas flow rate of 25 mL/min. TA 
Universal Analysis software was used for thermal data analysis. The solubility of Arg-
PEEAs in common organic solvents at room temperature was assessed by using 2.0 
mg/mL as a solubility criterion to determine whether Arg-PEEA polymer is soluble or 
not in a solvent. The quantitative solubility of Arg-PEEAs in distilled water at room 
temperature was measured by adding distilled water drop by drop until a clear solution 
was obtained. The reduced viscosity (ηred) of the polymers synthesized was determined 
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by a Cannon-Ubbelhode viscometer in DMSO solution at a concentration of 0.25 g/dL 
at 25 °C. 
 
4.C.4 Electrophoresis Assay 
 
      The Arg-PEEA/DNA complexes for agarose gel electrophoresis assay were 
prepared by adding the DNA marker (N3014 DNA maker) solution into the Arg-
PEEA aqueous solutions (in 1X PBS buffer). After mixing the two solutions together, 
it was immediately vortex for 2-3 seconds, and then equilibrated at an ambient 
condition for 30 minutes. Arg-PEEA/DNA complexes were analyzed by 
electrophoresis in a 1 % agarose gel stained with ethidium bromide (10 µg/mL) with 
TAE buffer at 100 V for 90 min.  Total injection volume was 15 µL which consisted 
of 2 µL blue dye solution, 2 µL DNA marker solution (500 µg/mL), several µL of the 
Arg-PEEA polymer PBS solution and several µL of pure PBS buffer solution. The 
Arg-PEEA solutions must be made freshly or stored at 4 °C before use. The amount of 
DNA was fixed at 1µg per test. After mixing all the solutions, the final system was 
shaken or centrifuged heavily for several seconds. The N3014 DNA maker solution 
without Arg-PEEA was used as a blank control. The N3014 DNA marker was 
visualized by an UV illumination (FOTO/UV 300 Transilluminator). The migration of 
DNA from the Arg-PEEA/DNA complex was recorded by a digital camera (Panasonic 
WV-BP330).  
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Table 4.1 List of prepared p-toluenesulfonic acid salt of L-arginine diester from 
oligoethylene glycols 
 
Monomer y Naming 
Arg-2E-S 2 tetra-p-toluenesulfonic acid salt of bis (L-arginine) 
diesters of diethylene glycol 
Arg-3E-S 3 tetra-p-toluenesulfonic acid salt of bis (L-arginine) 
diesters of triethylene glycol 
Arg-4E-S 4 tetra-p-toluenesulfonic acid salt of bis (L-arginine) 
diesters of tetraethylene glycol 
Arg-6E-S 6 tetra-p-toluenesulfonic acid salt of bis (L-arginine) 
diesters of PEG300 
Arg-12E-
S 
12 tetra-p-toluenesulfonic acid salt of bis (L-arginine) 
diesters of PEG600 
Arg-2E-Cl 2 di-p- toluenesulfonic acid di-hydrochloride acid salt 
of bis (L-arginine) diesters of diethylene glycol 
Arg-3E-Cl 3 di-p- toluenesulfonic acid di-hydrochloride acid salt 
of bis (L-arginine) diesters of triethylene glycol 
Arg-4E-Cl 4 di-p- toluenesulfonic acid di-hydrochloride acid salt 
of bis (L-arginine) diesters of tetraethylene glycol 
Arg-6E-Cl 6 di-p- toluenesulfonic acid di-hydrochloride acid salt 
of bis (L-arginine) diesters of PEG300 
Arg-12E-
Cl 
12 di-p- toluenesulfonic acid di-hydrochloride acid salt 
of bis (L-arginine) diesters of PEG600 
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Table 4.2 Arg-PEEAs (x-Arg-yEG-z) prepared by different combinations of diacids 
and oligoethylene glycol building blocks 
 
 
 NSu NA NS 
Arg-2EG-S 2-Arg-2EG-S 4-Arg-2EG-S 8-Arg-2EG-S 
Arg-3EG-S 2-Arg-3EG-S 4-Arg-3EG-S 8-Arg-3EG-S 
Arg-4EG-S 2-Arg-4EG-S 4-Arg-4EG-S 8-Arg-4EG-S 
Arg-6EG-S 2-Arg-6EG-S 4-Arg-6EG-S 8-Arg-6EG-S 
Arg-12EG-S 2-Arg-12EG-S 4-Arg-12EG-S 8-Arg-12EG-S 
Arg-2EG-Cl 2-Arg-2EG-Cl 4-Arg-2EG-Cl 8-Arg-2EG-Cl 
Arg-3EG-Cl 2-Arg-3EG-Cl 4-Arg-3EG-Cl 8-Arg-3EG-Cl 
Arg-4EG-Cl 2-Arg-4EG-Cl 4-Arg-4EG-Cl 8-Arg-4EG-Cl 
Arg-6EG-Cl 2-Arg-6EG-Cl 4-Arg-6EG-Cl 8-Arg-6EG-Cl 
Arg-12EG-Cl 2-Arg-12EG-Cl 4-Arg-12EG-Cl 8-Arg-12EG-Cl 
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4.C.5 Cell Culture 
 
      In this report, the following cells were used for tests: cell lines (Bovine aortic 
endothelial cells (BAEC),), primary cells (Rat smooth muscle cells (RSMC), Human 
umbilical vein endothelial cells (HUVEC)and stem cells (Rat Mesenchymal stem cells 
(MSC). All the cells were grown exactly as the recommended ATCC protocols. For 
example, the RSMC was grown as recommended at 37 °C in 5 % CO2 in Dulbecco’s 
minimal essential medium (DMEM) supplemented with 10 % FBS and antibiotics. 
The cell lines were used from passages 6 to 12 and primary cells and stem cells were 
used from passages 2-5. Media was changed every 2 days. Cells were grown to 70 % 
confluence before splitting, harvesting or transfection.  
 
4.C.6 Preparation of Plasmid DNA and Complexes of Arg-PEEA/DNA 
 
      The luciferase encoding reporter plasmids, COL (-772) /LUC and green 
fluorescence protein encoding reporter plasmid DNA (GFP) were all provided by Dr. 
Bo Liu’s lab at Surgery Department of Wisconsin University at Madison. All plasmids 
were prepared using Qiagen endotoxin-free plasmid Maxi kits according to the 
supplier’s protocol. The quantity and quality of the purified plasmid DNA was 
assessed by spectrophotometric analysis at 260 and 280 nm as well as by 
electrophoresis in 1% agarose gel. Purified plasmid DNA were resuspended in TAE 
(Tris-acetate-EDTA) buffer and frozen in -20 °C. The DNA solution obtained had a 
concentration around 1.5-2.0 mg/mL and was diluted to around 0.5 mg/mL before use. 
 
      The Arg-PEEA/DNA complexes were prepared by adding the plasmid DNA 
buffer solution into the freshly prepared Arg-PEEA PBS buffer solutions at a room 
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temperature to obtain a desirable Arg-PEEA to DNA weight ratio (WR). In this report, 
a wide range of WR (from 50 to 3,000) of Arg-PEEA to DNA was tested. The mixed 
solution was immediately and slightly vortex for several seconds and then equilibrated 
at an ambient condition for 20-30 minutes.  All the Arg-PEEA solutions and Arg-
PEEA/DNA complexes were freshly prepared and used within 4 hours.  
 
4.C.7 Zeta Potential and Particle Size Measurements for Arg-PEEA/DNA 
Complexes 
 
      The charge property of the Arg-PEEA/DNA complexes was studied by zeta 
potential measurements. Arg-PEEA solutions (2 mg/mL) were prepared by dissolving 
Arg-PEEAs in 1X PBS buffer solution and the solution was filtered (0.45 µm pore 
size, Whatman®) before experiments. The Arg-PEEA/DNA complexes were prepared 
by adding the plasmid DNA (N3012, New England Lab) buffer solution of pre-
determined amounts to the freshly made Arg-PEEA PBS buffer solutions (1mL 
volume total) to obtain the desirable Arg-PEEA to DNA weight ratio (WR). The 
mixed solution was immediately and slightly vortex for several seconds, and then 
equilibrated at an ambient condition for 20 minutes. After that, the zeta potential of the 
Arg-PEEA/DNA complexes was measured at 25 °C by using a Malvern Zetasizer 
Nano-ZS machine (Worchestershire, UK). Zeta potentials were calculated by using the 
Smoluchowsky model for aqueous suspensions. 2-Arg-6E-Cl was selected for this 
study and the zeta potentials of the 2-Arg-6E-Cl/DNA complexes at a series of WR 
were measured. 
 
      The particle sizes of the Arg-PEEA/DNA complex were studied by the same 
Malvern Instruments Zetasizer Nano ZS instrument, which used light scattering to 
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measure the average hydrodynamic radius of particles in solution. Samples were 
placed in 1.0 mL plastic cuvettes and three measurements consisting of 50 runs with 5 
s duration were performed at 25 °C. The instrument was standardized with 1 mm 
polystyrene beads and particle size was reported as the average of the three 
measurements with an error measurement of one standard deviation. 2-Arg-6E-Cl was 
selected for this study and the particle sizes of the 2-Arg-6E-Cl/DNA complexes at a 
series of WR were measured. 
 
4.C.8 Gene Transfection and Luciferase Assay 
 
       The complexes formed between plasmid DNA and the Arg-PEEAs were assessed 
for their in vitro transfection activity utilizing a transient expression of luciferase 
reporter in cells. First, the transfection protocol for Arg-PEEAs was studied and 
optimized in terms of cell type, cell density, buffer types, transfection time, 
transfection media, and temperature. After optimization, all transfection experiments 
were carried out according to the optimized protocol.  
 
      The details for the optimized transfection protocol for Arg-PEEAs are given 
below. For cell lines, such as rat aortic SMC A10 cells, the cells were seeded in 0.5 
mL complete DMEM (10 % FBS, 1 % Hepes, 1 % penicillin-streptomycin) at 30 x 103 
per well in a 24-well plate 24 hours before transfection (70 % confluent at 
transfection). Before transfection, the cell culture media was removed and the cells 
were washed with PBS buffer twice. Then 1.0 mL warmed serum free DMEM media 
(without antibiotics) was added into each well. For Lipofectamine2000®, the media 
was used according to the manufacturer’s recommendation. The formulated Arg-
PEEA/DNA complex solution was then added into each well. The plasmid DNA 
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amount was fixed at 1 μg per well for 24-well cell culture plate. The transfection 
mixtures were immediately and slightly piped up and down for a few seconds, the 
cells were transfected for 4 h at 37 °C (5 % CO2) in an incubator, and then the media 
solution was removed. After that, 0.5 mL of complete DMEM (10 % FBS, 1 % Hepes, 
1 % penicillin-streptomycin) were added into each well and kept incubated at 37 °C (5 
% CO2) in an incubator. After 48 hours, cells were harvested for luciferase reading. 
Triplicate results were obtained in each data point. The main differences between 
transfection of cell lines and primary cells/stem cells were the transfection time and 
cell culture media. For transfection time: 4 h is needed for cell lines and 12-16 h is 
needed for primary and stem cells; for cell culture media, the transfection media is the 
media recommended by ATCC without serum, the medias before and after 
transfection are the medias recommended by ATCC.    
 
      Gene expression was determined by the luciferase activity using a DT 20/20 
luminometer (Turner Biosystems, Sunnyvale, CA) with Dual Luciferase Assay System 
(Promega) according to the manufacturer’s instruction. Luciferase assay was 
performed according to Promega’s recommendation. Briefly, cells from each well of a 
24-well plate were lysed in 100 μL lysis buffer, transferred to a micro-tube, and then 
centrifuged at 10,000 g for 2 min. Supernatants were collected and analyzed for 
luciferase activity. In a typical experiment, 20 μL of supernatant was added to 
luminometric tubes containing 100 μL of luciferase substrate (Promega). Light 
emission was measured with a Dual-luciferase detection system for periods of 5 sec, 
and the relative light units (RLUs) were determined. Triplicate results were used in 
each experiment. RLUs were normalized to the protein contents of each sample 
measured by spectrophotometric analysis. 
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4.C.9 Green Fluorescence Protein (GFP) Assay 
 
      To visually confirm the transfection obtained from the luciferase activity reading, 
we also transfected many types of cells with a plasmid DNA encodes for Green 
Fluorescent Protein (GFP). The transfection protocol was exactly the same as the one 
used for luciferase assay, except GFP encoded plasmid DNA was used.  Following 48 
h incubation after transfection, cells were examined under a fluorescence microscope 
(Nikon TE2000-U DIC inverted microscope with UV, GFP/FITC and Tx Red filter 
sets) for any GFP expression (cells showed green). The cell images were recorded 
from the random but typical fields of the cell culture wells.  
 
4.C.10 Evaluation of Cytotoxicity of the Arg-PEEA/DNA Complexes 
 
       The evaluation of the cytotoxicity of the Arg-PEEA/DNA complexes was 
performed by MTT assay. All the cell types were tested for this study. The cultured 
cells were seeded at an appropriate cell density concentration (3,000 or 5,000 
cells/well) in 96-well plates and incubated overnight in a 5 % CO2 incubator at 37 oC. 
The cells were, then, treated with various Arg-PEEA/DNA complex solutions for 4 h 
or 12 h. The media was removed after that and complete DMEM was then added. The 
cells treated with normal cell culture media only were used as the negative control 
(NC). PEI and Lipofectamine2000® treated cells (same time as the Arg-PEEA/DNA 
complexes) were used as the positive controls. After 48 h incubation of the treated 
cells at 37 °C and 5 % CO2, 15 μL of MTT solution (5 mg/mL) was added to each 
well, followed by 4 h incubation at 37 °C, 5 % CO2. The cell culture medium 
including complex solution was carefully removed and 150 μL of acidic isopropyl 
alcohol (with 0.1 M HCl) was added to dissolve the formed formazan crystal. OD was 
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measured at 570 nm (subtract background reading at 690 nm) using a VersaMax 
Tunable Microplate reader. The cell viability (%) was calculated according to the 
following equation: Viability (%) = (OD570 (sample)-OD620 (sample))/ (OD570 (control)-OD620 
(control)) × 100 %; where the OD570 (control) represented the measurement from the wells 
treated with medium only, and the OD570 (sample) from the wells treated with various 
Arg-PEEA and Arg-PEEA/plasmid DNA complexes. Thus, the cell viability was 
expressed as the percentage of the blank negative control. Triplicates were used in 
each experiment.  
 
4.C.11 Statistics 
 
      Where appropriate, the data are presented as mean ± standard error of the mean 
calculated over at least three data points. Significant differences compared to control 
groups were evaluated by unpaired Student’s t-test or Dunnet test at p 0.05, and 
between more than two groups by Tukey’s test with or without one-way ANOVA 
analysis of variance.  JMP software (version 8.0, from SAS Company) was used for 
data analysis. 
 
4.D Results and Discussions  
 
      The goal of this study was to examine a new generation of Arg-PEA, 
oligoethylene glycol based Arg-PEA (Arg-PEEA), for gene delivery applications, 
especially for the transfection of primary cells and stem cells, which are hard to be 
transfected with high efficiency and low cytotoxicity simultaneously. And we also 
want to examine the relationship of polymer structure-function so that we could have 
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more understanding for designing of advanced generations of non-viral gene delivery 
vectors.   
 
      In this paper, we focused on a few easily defined chemical structure parameters of 
Arg-PEEAs, i.e., x (the number of -CH2- groups in the diacid part) and y (the number 
of ethylene glycol, -CH2CH2O- groups in the diol part). And how the introduction of 
ethylene glycol groups could affect Arg-PEEAs’ properties and their transfection 
performance when compared with the 1st generation aliphatic diol based Arg-PEAs6. 
The data obtained in this study could advance the understanding of our prior reported 
preliminary biological evaluation and gene delivery of Arg-PEA based biomaterials6 
 
      The incorporation of oligoethylene glycols into Arg-PEAs is different from others’ 
published studies of PEG involved gene transfection which have focused on the 
modification of the side chain of existing polymers (e,g, poly(L-lysine), chitosan and 
PEI) or making amphiphilic block copolymers(e,g, PLA, PLA-b-poly (L-lysine)) to 
increase the transfection efficiency or cell viability 15, 29-31, 36, 37. Based on our 
unpublished results, the very stiff backbone (with double bonds in the backbone 
instead of side chain) in the Arg-PEA main chain would cause significant decreasing 
of transfection efficiency of Arg-PEAs. Here we proposed that more flexible Arg-PEA 
backbone via oligoethylene glycol could have a better transfection performance. 
     
4.D.1 Synthesis and Physicochemical Characterization of Arg-PEEAs 
4.D.1.a Synthesis of monomers  
 
       In this study, the synthesis protocols of all the new monomers and Arg-PEEA 
polymers were optimized.  Three types of di-p-nitrophenyl esters of dicarboxylic acids 
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(Monomer I, NSu, NA and NS) were synthesized here and the details of the synthesis 
and characterization of these Monomers I have been reported previously39. The p-
toluenesulfonic acid salts of L-arginine diester (II) from oligoethylene glycols, 
however, are newly developed for the first time. Twelve types of these new monomers 
II were prepared and the differences among these monomers II are the salt type 
(toluenesulfonic acid salt for the S type, and hydrochloride salt for the Cl type) and 
ethylene glycol unit length (y) in the diol part between the two adjacent ester groups: 
number of ethylene glycol units varies from 2 to 12. The chemical structures of these 
12 types of Arg-based monomers II were all confirmed by 1HNMR, FTIR and 
solubility tests.  All these new bis (L-arginine) diesters are very moisture sensitive and 
should be stored under vacuum at room temperature or below. 
 
      At room temperature, the solubility data showed that these bis (L-arginine) diesters 
have very good solubility in polar solvents, such as water, DMSO, DMF; but insoluble 
in non-polar or weak polar solvents, such as isopropanol, acetone, and ethyl acetate. 
However, it was found that isopropanol can dissolve monomers II at 50 °C or higher 
temperature (boiling point of isopropanol is 82.5 oC). The following are some 1H-
NMR and FTIR details for the Monomers IIa (S salt type). The 1H-NMR data for the 
Monomers IIb (Cl salt type) is the same as the corresponding S salt type Monomer 
IIa, except for the difference of peak intensity of some groups:  
 
Arg-2E-S: Yield of purified product: 81%. Appearance: amorphous white powder. IR 
(cm-1): 1735 [-C(O)-], 1177 [-O-], 1127 [-CH2-O-CH2-];  1HNMR (DMSO-d6, ppm, 
δ): 1.61 [4H, -CH2-CH2-CH2-NH-], 1.77 [4H, -OC(O)-CH(NH3+)CH2-(CH2)2-], 2.29 
[6H, H3C-Ph-SO3-], 3.10 [4H, -(CH2)2-CH2-NH-], 3.60 [4H, -(O)C-O-CH2-CH2-O-], 
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4.07 [2H, +H3N-CH(R)-C(O)-O-], 4.32 [4H, -(O)C-O-CH2-], 7.13, 7.48 [16H, Ph], 
7.59 [10H, -CH2-NH(NH2+)-NH2], 8.42 [6H, +H3N-CH(R)-C(O)-O-];  
 
Arg-3E-S: Yield of purified product: 85%. Appearance: amorphous white powder.  IR 
(cm-1): 1736 [-C(O)-], 1178 [-O-], 1125 [-CH2-O-CH2-];   1HNMR (DMSO-d6, ppm, 
δ): 1.63 [4H, -CH2-CH2-CH2-NH-], 1.78 [4H, -OC(O)-CH(NH3+)CH2-(CH2)2-], 2.28 
[6H, H3C-Ph-SO3-], 3.12 [4H, -(CH2)2-CH2-NH-], 3.55-65 [8H, -(O)C-O-CH2-CH2-
O-CH2-],  4.09 [2H, +H3N-CH(R)-C(O)-O-], 4.31 [4H, -(O)C-O-CH2-], 7.15, 7.49 
[16H, Ph], 7.62 [10H, -CH2-NH(NH2+)-NH2], 8.47 [6H, +H3N-CH(R)-C(O)-O-]; 
 
Arg-4E-S: Yield of purified product: 87%. Appearance: amorphous white powder.  IR 
(cm-1): 1734 [-C(O)-], 1179 [-O-], 1124 [-CH2-O-CH2-];   1HNMR (DMSO-d6, ppm, 
δ): 1.62 [4H, -CH2-CH2-CH2-NH-], 1.79 [4H, -OC(O)-CH(NH3+)CH2-(CH2)2-], 2.27 
[6H, H3C-Ph-SO3-], 3.11 [4H, -(CH2)2-CH2-NH-], 3.60-70 [12H, -(O)C-O-CH2-CH2-
O-CH2-CH2-], 4.08 [2H, +H3N-CH(R)-C(O)-O-], 4.30 [4H, -(O)C-O-CH2-], 7.17, 
7.50 [16H, Ph], 7.63 [10H, -CH2-NH(NH2+)-NH2], 8.49 [6H, +H3N-CH(R)-C(O)-O-]; 
 
Arg-6E-S: Yield of purified product: 89 %. Appearance: amorphous white viscous 
solid. IR (cm-1): 1737 [-C(O)-], 1177 [-O-], 1127 [-CH2-O-CH2-];   1HNMR (DMSO-
d6, ppm, δ): 1.63 [4H,-CH2-CH2-CH2-NH-], 1.80 [4H,-OC (O)-CH (NH3+) CH2-
(CH2)2-], 2.29 [6H, H3C-Ph-SO3-], 3.14 [4H,-(CH2)2-CH2-NH-], 3.60-70 [20H, -(O)C-
O-CH2-CH2-O-(CH2-CH2-)2],  4.10 [2H,+H3N-CH(R)-C(O)-O-], 4.32 [4H, -(O)C-O-
CH2-], 7.16, 7.50 [16H, Ph], 7.64 [10H, -CH2-NH(NH2+)-NH2], 8.50 [6H, +H3N-
CH(R)-C(O)-O-]; 
Arg-12E-S: Yield of purified product: 84 %. Appearance: amorphous white viscous 
solid. IR (cm-1): 1737 [-C(O)-], 1177 [-O-], 1124 [-CH2-O-CH2-];   1HNMR (DMSO-
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d6, ppm, δ): 1.61 [4H,-CH2-CH2-CH2-NH-], 1.78 [4H,-OC(O)-CH(NH3+)CH2-(CH2)2-
], 2.29 [6H, H3C-Ph-SO3-], 3.10 [4H, -(CH2)2-CH2-NH-], 3.60-70 [44H, -(O)C-O-
CH2-CH2-O-(CH2-CH2-)5], 4.09 [2H, +H3N-CH(R)-C(O)-O-], 4.31 [4H, -(O)C-O-
CH2-], 7.15, 7.49 [16H, Ph], 7.61 [10H, -CH2-NH(NH2+)-NH2], 8.47 [6H, +H3N-
CH(R)-C(O)-O-]; 
 
4.D.1.b Synthesis of Arg-PEEA Polymers  
 
      One major distinction of the Arg-PEEAs (Figure 4.2) synthesized in this study is 
that they are in the p-toluenesulfonic acid salt or chlorine salt form, while all other 
PEAs from prior reported studies were not in any salt form38, 40-46. The formation of 
salt in these Arg-PEEAs is because of the strong base nature of the guanidine group in 
L-Arginine. The guardinine group has a much higher 12.5 pKa value than the amine 
groups of PEI and PLL-HBr, suggesting a stronger interaction with anionic DNA 
chain. The p-toluenesulfonic acid or hydrochloride acid counter ions, however, were 
found not to adversely affect the DNA binding capability of Arg-PEEAs, and the 
following cytotoxicity tests showed that all the Arg-PEEAs are nontoxic to the cells 
even at large dosages.  
 
      The reaction conditions for the Arg-PEEA synthesis were optimized in terms of 
reaction temperature and time, catalyst and its concentration, the molar ratio between 
2 monomers, and monomer concentrations. The optimal polycondensation reaction 
conditions for the Arg-PEEAs are: reaction temperature: 75 °C; duration: 48 h, 
concentration of each monomer: 1.0-1.5 mol/L; DMSO solvent; catalyst (acid 
acceptor): NEt3.  The molar ratio of the two monomers (I and IIa or b) should be 
exactly equal to 1: 1, and the molar ratio between the monomer and acid receptor must 
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be 1.0: 1.1. The final product yields are high (> 80%) under the optimized reaction 
conditions.  
 
      For the chemical structure identification of all the synthesized Arg-PEEAs, their 
structures were confirmed by both 1H-NMR and FTIR spectra. For FTIR data, the 
carbonyl bands at 1648–1650 cm-1 (amide I), 1538–1542 cm-1 (amide II), and 1738–
1742 cm-1 (ester), and NH vibrations at 3290 cm-1 are typical for all Arg-PEEAs 
obtained. Figure 4.6 showed an example of the 1H-NMR spectrum of 2-Arg-2E-S. All 
the 1H-NMR peaks of 2-Arg-2E-S were well identified, and the integration area ratio 
is consistent with the calculated theoretical ratio. The 1H-NMR peaks marked with 
numbers from 1 to 12 are assigned to the corresponding protons of 2-Arg-2E-S as 
shown in Figure 4.6. 
 
      For the thermal property of the Arg-PEEAs, DSC results indicated that the Arg-
PEEAs did not have melting points (Tm).  For the glass transition temperature (Tg) of 
Arg-PEEAs, an examination for the effect of the number of methylene groups in the 
diacid part (x) of the Arg-PEEAs revealed that an increase in x at a constant y led to a 
decrease in Tg. For example, at y = 2, the Tg decreased from 31 oC (2-Arg-2E-S) to 29 
oC (4-Arg-2E-S) then to 25 oC (8-Arg-2E-S), when x decreased from 2, 4 to 8. When 
the y value was increased from 2 to 12 at a fixed x value, the same decreasing trend in 
Tg was observed.  
 
      According to our unpublished data, unsaturated Arg-PEAs (double bonds in the 
PEA backbone) would significantly increase the Tg value because of the stiff polymer 
backbone. For example, 2-Arg-2-S has a Tg around 52 oC, while 2-UArg-2-S has a Tg 
around 112 oC. Therefore, the introduction of more flexible segments like 
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oligoethylene glycol in this study to the PEA polymer backbone would be expected to 
make the whole Arg-PEEA polymer chain structure much more flexible and lower Tg 
than those Arg-PEA having fatty diols. For example, the Tg of Arg-PEEA (2-Arg-2E-
S) is near 50% lower than the Arg-PEA (2-Arg-4-S), 31 oC vs. 46 oC, and the only 
chemical structure difference between 2-Arg-2E-S and 2-Arg-4-S is an extra oxygen 
atom from the ethylene glycol per each repeating unit in the 2-Arg-2E-S. Thus, the 
introduction of a flexible oligoethylene glycol moiety significantly decreased the Tg 
value in Arg-PEEAs.  
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Figure 4.6 1H-NMR spectra of 2-Arg-2E-S 
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      The solubility of Arg-PEEAs in water and common organic solvents at room 
temperature was tested. Solubility was assessed at 2.0 mg/mL at a room temperature 
as an index whether a polymer is soluble or not. Due to their strong polar nature, Arg-
PEEAs tended to dissolve in polar solvents (Table 4.3). All of the Arg-PEEAs 
synthesized were soluble in polar organic solvents like DMSO, DMF, methanol or 
water, but did not dissolve in non-polar or weak polar organic solvents like ethyl 
acetate, THF or chloroform. The effect of x and y material parameters on Arg-PEEA 
water solubility revealed that both x and y had a major impact on the water solubility 
of Arg-PEEAs; and an increase in the methylene chain length in the dicarboxylic acid 
part (x) reduced the water solubility significantly due to the increasing hydrophobicity. 
For example, the solubility of Arg-PEEAs decreased from 200 mg/mL to 15 mg/mL as 
x increased from 2 (2-Arg-2E-S) to 8 (8-Arg-2E-S) at a constant y=2.  
 
      A similar solubility – structure relationship was also found with an increase in y 
(from 2 to 6 in the diol segment) at a constant x. However, the relationship broke 
down at a large y value, such as y =12.  Thus, the water solubility could be used as an 
index of hydrophilicity vs. hydrophobicity of Arg-PEEA polymers. By adjusting the x 
or y, the hydrophilicity of Arg-PEEA polymers can be shifted toward more 
hydrophilic or hydrophobic for meeting specific needs. 
 
      Compared with the saturated aliphatic diol-based Arg-PEAs, Arg-PEEAs showed 
a significant increase in water solubility due to the introduction of relative hydrophilic 
and flexible ethylene glycol units. For example, the 2-Arg-2E-S showed much higher 
water solubility than 2-Arg-4-S, and the solubility difference is more than 150 mg/mL 
as the only chemical structure difference of these two polymers is one oxygen atom in 
the repeating unit. All the prepared Arg-PEEAs were obtained in fairly good yields (> 
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75 %) with ηred (reduced viscosity) ranging from 0.11 to 0.39 dL/g (Table 4.3).  The 
molecular weight data of Arg-PEEA were not available because all arginine based 
PEAs cannot be dissolved in THF, which is the only solvent for the central GPC 
facility available to us. 
 
4.D.2 Gel Retardation Assay  
 
      Gel Retardation Assay is a widely used method for measuring DNA condensing 
capability of polymeric transfection candidates. The DNA condensation capability of a 
transfection agent is known to have a profound effect on the subsequent gene delivery 
efficiency, but is not the only factor that is responsible for the outcome of gene 
delivery efficiency. In this study, the main goal is to determine the proper weight ratio 
(WR) of Arg-PEEA to DNA required for a completely condensing of DNA during the 
polyplex formation, the first key step toward non-viral gene transfection.   
 
      Figures 4.7 and 4.8 showed some examples of the electrophoresis data for the Arg-
PEEA/DNA complexes. These results demonstrated the DNA condensation capability 
of Arg-PEEAs, and provided the basic formulation information for subsequent 
transfection experiments. Most important of all, the electrophoresis data showed that 
different types of Arg-PEEAs (in terms of x and y parameters) required different 
amounts of Arg-PEEAs for a complete DNA condensation as indicated by the 
different WR.  
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Table 4.3 Water solubility and reduced viscosity (in DMSO) at room temperature of 
Arg-PEEAs (x-Arg-yEG-z), part A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arg-PEEA S(mg/mL) ηred(dL/g) 
2-Arg-2EG-S 200±10 0.15±0.01 
2-Arg-3EG-S 100±10 0.19±0.03 
2-Arg-4EG-S 
40±5 0.13±0.01 
2-Arg-6EG-S 40±5 0.21±0.01 
2-Arg-12EG-S 100±10 0.26±0.02 
4-Arg-2EG-S 100±10 0.25±0.01 
4-Arg-3EG-S 60±5 0.21±0.02 
4-Arg-4EG-S 15±2 0.29±0.01 
4-Arg-6EG-S 15±2 0.27±0.01 
4-Arg-12EG-S 20±2 0.35±0.03 
8-Arg-2EG-S 15±2 0.27±0.03 
8-Arg-3EG-S 10±2 0.25±0.01 
8-Arg-4EG-S 6±1 0.35±0.02 
8-Arg-6EG-S 6±1 0.32±0.01 
8-Arg-12EG-S 10±2 0.36±0.02 
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Table 4.3 Water solubility and reduced viscosity (in DMSO) at room temperature of 
Arg-PEEAs (x-Arg-yEG-z), part B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arg-PEEA S(mg/mL) ηred(dL/g) 
2-Arg-2EG-Cl 200±10 0.13±0.02 
2-Arg-3EG-Cl 200±10 0.11±0.01 
2-Arg-4EG-Cl 80±5 0.17±0.02 
2-Arg-6EG-Cl 60±5 0.19±0.01 
2-Arg-12EG-Cl 100±10 0.20±0.01 
4-Arg-2EG-Cl 150±10 0.21±0.02 
4-Arg-3EG-Cl 100±10 0.25±0.03 
4-Arg-4EG-Cl 50±5 0.20±0.01 
4-Arg-6EG-Cl 30±2 0.22±0.02 
4-Arg-12EG-Cl 50±5 0.19±0.01 
8-Arg-2EG-Cl 40±5 0.35±0.01 
8-Arg-3EG-Cl 30±5 0.30±0.01 
8-Arg-4EG-Cl 15±2 0.23±0.01 
8-Arg-6EG-Cl 10±2 0.33±0.01 
8-Arg-12EG-Cl 15±2 0.39±0.01 
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Figure 4.7 Effect of methylene chain length (x) of Arg-PEEAs on their condensation 
ability to DNA: B means blank, (only 1 µg N3014S DNA, no Arg-PEEA); the other 
numeric numbers are the weight ratio of Arg-PEEA to DNA. The Arg-PEAs tested 
are: 2-Arg-2E-Cl, 4-Arg-2E-Cl, 8-Arg-2E-Cl (from left to right) 
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Figure 4.8 Effect of oligoethylene glycol chain length (y) of Arg-PEEAs on the 
condensation ability to DNA: B means blank, (only 1 µg N3014S DNA, no Arg-
PEEA); the other numbers are the WR of Arg-PEEA to DNA. The Arg-PEAs are: 2-
Arg-2E-Cl, 2-Arg-3E-Cl, 2-Arg-4E-Cl, 2-Arg-6E-Cl and 2-Arg-12E-Cl (from left to 
right) 
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      In order to have a better quantitative comparison of the DNA condensation 
capability of Arg-PEEAs, the minimum WR of Arg-PEEA to DNA that could 
completely condense DNA was selected and compared. For example (Figure 4.7), 2-
Arg-2E-Cl needed a minimum WR of 30 to completely condense the DNA marker; 
while 4-Arg-2E-Cl and 8-Arg-2E-Cl needed a minimum WR of 15 and 10 for a 
complete condensation, respectively. Thus, the minimum WR required for a complete 
DNA condensation decreased when the x value in the Arg-PEEA increased. The same 
trend was also observed when y value was increased from 2 to 4. This relationship, 
however, did not hold at a large y values, such as y=6 and 12 (Figure 4.8).  
 
      We also found that the Arg-PEEA buffer solutions, if stored at 4 °C, could retain 
their DNA condensing capability for about 1 month or even longer time, suggesting 
there was no obvious structure change or degradation of Arg-PEEAs in the buffer 
solution at 4 °C. It is important to recognize that precise Arg-PEEA polymer 
concentration and volume, and a complete Arg-PEEAs dissolution are critical for 
reproducible transfection experiments. In this study, the Arg-PEEA polymers must be 
dissolved completely and the volume should be in the range of 2-5 µL to avoid any 
possible experimental errors. Some Arg-PEEAs have lower water solubility and would 
take a long time for a complete dissolution.  
 
4.D.3 Transfection Efficiency  
 
      In this paper, the plasmid DNA that encodes for a firefly luciferase driven by a 
collagen promoter was used. By measuring luciferase activities in cell lysates, which 
in this case is mainly determined by the amounts of DNA transferred into the cells, we 
compared the transfection efficiency of Arg-PEEAs with a commercial transfection 
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agent, Lipofectamine2000®, for determining the transfection feasibility of Arg-
PEEAs.  
 
      In any transfection protocol development, cell density, transfection time, 
transfection temperature, transfection media and buffer types are important parameters 
for optimization to achieve the best transfection data.  In the Arg-PEEA/DNA system, 
the optimized transfection protocol of Arg-PEEA/DNA system was: transfection time: 
3-4 h for cell lines and 12-16 h for primary cells and stem cells; transfection 
temperature: 37 °C; transfection media: serum free DMEM media without antibiotics; 
buffer for Arg-PEEA/DNA: HEPES (20 mM) or PBS buffer (1X); cell density: 
10,000-30,000 per well for 24-well cell culture plate. At this optimized condition, it 
was observed that the luciferase activity could reach the peak value over a range of 
WR of Arg-PEEA to DNA.  
 
      Figure 4.9 showed an example of the transfection results from 4 types of Arg-
PEEA/DNA at various WR: 2-Arg-4E-S, 2-Arg-6E-S, 2-Arg-4E-Cl and 2-Arg-6E-Cl. 
The data show that all the Arg-PEEA/DNA could show good transfection ability over 
a very broad WR range, and each type of Arg-PEEA/DNA showed a peak transfection 
at a specific WR as indicated by a maximum bell curve on one of the 4 Arg-PEEAs as 
an example.  The 2-Arg-6E-Cl/DNA showed transfection capability over WR from 
200 to 2000, but the highest transfection capability was around the WR of 1000. For 
the 2-Arg-4E-S/DNA system, the peak transfection, however, occurred at WR 500. 
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Figure 4.9 Effects of type of Arg-PEEAs and weight ratio of Arg-PEEAs to DNA on 
transfection efficiency of Arg-PEEA/DNA complexes expressed by firefly luciferase 
activity. The cells used here were primary rat smooth muscle cells (RSMC). Plasmid 
DNA used were COL (-772)/Luc. Lipofectamine2000® was tested with the suggested 
optimum WR to DNA by Invitrogen. The numeric numbers at the end of each polymer 
sample label are the weight ratio of polymer to DNA. 
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Figure 4.10 Effects of rigidity/flexibility of Arg-PEA backbone and weight ratio of 
Arg-PEAs to DNA on transfection efficiency of Arg-PEA/DNA complexes expressed 
by firefly luciferase activity. The cells used here were primary rat smooth muscle cells 
(RSMC). Plasmid DNA used were COL (-772)/Luc. The numeric numbers at the end 
of each polymer sample label are the weight ratio of polymer to DNA. 
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Table 4.4 Relative transfection efficiency of Arg-PEEAs  
 
 
 
 
 
 
2-Arg-2EG-
S 
105 
2-Arg-3EG-
S 
112 
2-Arg-4EG-
S 
85 
2-Arg-6EG-
S 
97 
2-Arg-12EG-
S 
78 
4-Arg-2EG-
S 
21 
4-Arg-3EG-
S 
35 
4-Arg-4EG-
S 
44 
4-Arg-6EG-
S 
41 
4-Arg-12EG-
S 
17 
8-Arg-2EG-
S 
73 
8-Arg-3EG-
S 
115 
8-Arg-4EG-
S 
107 
8-Arg-6EG-
S 
81 
8-Arg-12EG-
S 
69 
2-Arg-2EG-
Cl 
87 
2-Arg-3EG-
Cl 
130 
2-Arg-4EG-
Cl 
91 
2-Arg-6EG-
Cl 
195 
2-Arg-12EG-
Cl 
75 
4-Arg-2EG-
Cl 
31 
4-Arg-3EG-
Cl 
27 
4-Arg-4EG-
Cl 
14 
4-Arg-6EG-
Cl 
39 
4-Arg-12EG-
Cl 
22 
8-Arg-2EG-
Cl 
103 
8-Arg-3EG-
Cl 
98 
8-Arg-4EG-
Cl 
94 
8-Arg-6EG-
Cl 
140 
8-Arg-12EG-
Cl 
75 
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      These transfection results also showed that the WR of Arg-PEEAs to DNA 
reaching the optimum transfection efficiency was much higher than the minimal WR 
required for completely condensing DNA in the electrophoresis data. For example, 2-
Arg-6E-Cl required a WR of 20 for a completely condensing DNA, but needed a WR 
of 1000 for a maximum DNA transfection. This finding may be attributed to the need 
of excess amounts of Arg-PEEAs to achieve not only a stable Arg-PEEA/DNA 
complex system in the transfection media but also provided additional cationic charge 
to the Arg-PEEA/DNA complex for its proper penetration into the cells membranes.  
The larger dosages of Arg-PEEA required for the optimized transfection, however, 
didn’t impose any adverse cytotoxicity as described later. 
 
      To compare the transfection efficiency of all the Arg-PEEAs, the highest or peak 
RLU/mg (relative light unit/mg) of each polymer was selected and normalized against 
the RLU/mg value of the commercial control (Lipofectamine2000®), i.e., setting the 
RLU/mg value of the control at 100 (Table 4.4).  This normalization process removed 
the batch to batch variation.  The normalized transfection data in Table 4.4 showed 
that many of these Arg-PEEAs had comparable or better transfection efficiency (i.e., 
those Arg-PEEAs having 100 or greater normalized values) than the commercial 
transfection reagent Lipofectamine2000®. Those Arg-PEEAs having the low or high x 
(2, 3 and 8) and low and medium y (2, 3 and 6) values in this study showed one of the 
most favorable high transfection efficiency. For those Arg-PEEAs having medium x 
(4)value, regardless of y value and type of salts,  would provided the poorest 
transfection. The reason is not very clear and further study may focus on the 
investigation of polymer structure. Those Arg-PEEAs having, the highest y value, 
(y=12), also showed the poorest transfection relative to Lipofectamine2000®. The 
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reason could be due to the significantly reduced charge density and further 
investigation is need. 
 
      In the introduction, we hypothesized that more flexible Arg-PEA backbone would 
be, a better transfection would be achieved.  As a result, an introduction of a stiff Arg-
PEA backbone should lead to a reduction in transfection efficiency of Arg-PEAs. In 
order to prove this hypothesis, we engineered unsaturated Arg-PEAs (UArg-PEA) to 
provide rigid backbone and examined their transfection level in a luciferase assay.  In 
this report, we chose the 2-UArg-4-S, which had unsaturated >C=C< double bonds in 
the diacid segment of the UArg-PEA backbone, as the most rigid Arg-PEA and 
examined its transfection efficiency against two other more flexible Arg-based PEAs: 
2-Arg-4-S and 2-Arg-2E-S. These three types of Arg-based PEAs have very similar 
repeating unit formula (e.g., same x and y) and molecular weight, charge density and 
molecular weight. The repeating unit formula difference between 2-UArg-4-S and 2-
Arg-4-S is 2 hydrogen atoms, while the repeating unit formula difference between 2-
Arg-2E-S and 2-Arg-4-S is one oxygen atom. Therefore, the only main difference 
among these three Arg-based PEAs is the rigidity of their polymer backbone, which 
has also been verified by their Tg data in the previous thermal property discussion part. 
The Tg of 2-Arg-2E-S, 2-Arg-4-S and 2-UArg-4-S are 31 oC, 46 oC and 94 oC, 
respectively. We could find that the Tg difference between 2-Arg-4-S and 2-UArg-4-S 
is 48 oC, which is much bigger than the Tg difference between 2-Arg-4-S and 2-Arg-
2E-S (15 oC difference)  
 
      Figure 4.10 showed the comparison of transfection efficiency among these three 
PEAs: 2-Arg-2E-S, 2-Arg-4-S and 2-UArg-4-S. The data in Figure 4.10 show that all 
of these three Arg-based PEAs reached a peak transfection efficiency value at the 
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weight ratio of Arg-PEA/DNA of 500. However, the 2-UArg-4-S showed lowest peak 
transfection value (i.e., the poorest transfection efficiency); while the 2-Arg-2E-S 
showed the highest value (best transfection efficiency). These differences in peak 
transfection data are consistent with the Tg data of these 3 Arg-based PEAs. The 2-
Arg-2E-S has the lowest Tg (most flexible backbone chain), while 2-UArg-4-S has the 
highest Tg (most rigid backbone chain). Therefore, we could conclude that Arg-PEA 
with the most flexible chain could show the best transfection efficiency, while the 
least flexible chain could show the worst transfection efficiency. All the above data 
and discussion strongly supported our hypothesis about the relationship between Arg-
PEA chain structure and transfection efficiency.  
 
4.D.4 GFP Expression 
 
      To visually confirm the transfection efficiency obtained from the luciferase 
activity data, all the cells [Bovine aortic endothelial cell lines (BAEC), primary cells 
(Rat smooth muscle cells (RSMC) and Human umbilical vein endothelial cells 
(HUVEC) ) and stem cells (Rat Mesenchymal stem cells (MSC))] were transfected by 
plasmid DNAs encoding for green fluorescent protein (GFP). Two days following the 
transfection, the cells were examined under a fluorescence microscope for their GFP 
expression (transfected cells would show green). Figure 4.10 shows that the GFP 
plasmid DNAs were successfully expressed inside different cell types (right pane) as 
commercial transfection agent Lipofectamine2000® did (left pane). And the BAEC 
cells treated by Lipofectamine2000® showed some morphology change, while the Arg-
PEA treated cells did not show any obvious changes. 
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4.D.5 Zeta Potential and Particle Size Measurements for Arg-PEEA/DNA Complex 
 
      The Zeta potential measurement was used to study the charge property and the 
charge-structure relationship of the Arg-PEEA/DNA complex.  Figure 4.11 showed 
the zeta potentials of some Arg-PEEA/DNA complexes as a function of the weight 
ratio of Arg-PEEA to DNA. The data in Figure 4.11 (2-Arg-6E-Cl) could be divided 
into 3 regions, depending on the weight ratio of Arg-PEEA to DNA.  As the weight 
ratio of Arg-PEEA to DNA increased, the zeta potential of the complex increased 
(from negative to positive), suggesting that as more Arg-PEEAs added into the DNA, 
the charge property of the complex changed from negative to positive. A further 
increase in the weight ratio of Arg-PEEA to DNA, the zeta potential of the complex 
reached a peak, (WR is around 1000), and a further increase in the WR resulted in a 
reduction in zeta potential of the complex. The WR with a peak zeta potential suggests 
that the Arg-PEEA/DNA complex must be in the most stable state, and should be the 
optimal condition for gene transfection, which is consistent with transfection data, 
especially for the optimized WR data (Figures 7 and 8).  
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Figure 4.11 GFP expression of transfected cells under fluorescence microscope 
(10X).Green cells are the cells successfully transfected with GFP DNA.  The cells 
transfected by lipofectamine2000® were used as controls (left) and by Arg-PEEA (2-
Arg-6E-Cl, WR=1,000) (right). The cell types from top to bottom are: bovine aortic 
endothelial cells (BAEC), rat primary smooth muscle cells (RSMC) and rat 
mesenchymal stem cells (MSC); 4 h treatment for cell lines and 12 h treatment for 
primary and stem cells, and images were taken 48 h after transfection treatment. 
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Figure 4.12 Zeta potential of 2-Arg-6E-Cl/DNA complex over a very wide weight 
ratio (WR) range. Positive value means the complex is positively charged; while 
negative value means the complex is negatively charged.  
 
      The particle size measurement was used to study the particle size of the Arg-
PEEA/DNA complex in the buffer solution and the size-structure relationship of the 
Arg-PEEA/DNA complex.  Figure 4.12 showed the particle sizes of some Arg-
PEEA/DNA complexes from 2-Arg-6E-Cl as a function of the weight ratio of 2-Arg-
6E-Cl to DNA. The particle size data in Figure 4.12 could be divided into 3 regions, 
depending on the ratio of Arg-PEEA to DNA.  As the weight ratio of Arg-PEEA to 
DNA increased, the particle size of the complex decreased, suggesting that as more 
Arg-PEEAs added into the DNA, the DNA molecules were going to collapse. A 
further increase in the weight ratio of Arg-PEEA to DNA, the particle size of the 
complex reached a minimum value, (WR is around 1000), and a further increase in the 
WR resulted in an increase in particle size of the complex. For the relationship 
between Figures 4.11 and 4.12, the data from the 2 figures were very consistent, when 
the complex had the larger particle size, the zeta potential value was smaller, both of 
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them mean that the complex was in the more unstable state. The highest zeta potential 
value is corresponding to the smallest particle size and the complex is in the most 
stable state under this weight ratio. The WR for achieving a smallest particle size 
(Figure 4.12) suggests that the Arg-PEEA/DNA complex must be in the most stable 
state, and should be the optimal condition for gene transfection, which is also 
consistent with transfection data, especially for the optimized WR data.  
 
4.D.6 Cytotoxicity of Arg-PEEA/DNA Complex by MTT Assay 
 
      Cytotoxicity of Arg-PEEA/DNA complexes was evaluated by MTT assay. The 
MTT system is a simple, accurate, reproducible means of detecting living cells via 
mitochondrial dehydrogenase activity. An increase in cell number (cell proliferation) 
results in an increase in the amount of MTT formazan production and hence an 
increase in UV absorbance. PEI, Lipofectamine2000® were used as the controls. All 
the synthesized Arg-PEEAs at different WR of Arg-PEEA/DNA were tested by MTT 
assay and some of the results were shown in Figure 4.13. Three types of cells were 
used for MTT assay and they were BAEC, RSMC Primary and MSC.  The MTT data 
clearly demonstrated that at 12 h treatment, all the Arg-PEEA/DNA complexes 
showed very little toxicity to the tested cells even at a very large dosage. The 
statistical data analysis showed that there is no significant difference of any Arg-
PEEA treatment compared to the control at the p value of 0.05 level by Dunnet test of 
planned comparison. So there is no evidence of toxicity of Arg-PEEAs.      
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Figure 4.13 Particle size measurements of 2-Arg-6E-Cl/DNA complex over a very 
wide weight ratio (WR) of 2-Arg-6E-Cl to DNA 
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Figure 4.14 MTT cytotoxicity of 4 types of Arg-PEEA (2-Arg-2E-S, 2-Arg-6E-S, 2-
Arg-2E-Cl, 2-Arg-6E-Cl) and their DNA complexes over a wide range of weight ratio 
of Arg-PEEA to DNA. Negative control (NC) is cells only without any transfection 
agent treatment. Lipofectamine2000® and PEI were used as the positive controls.  The 
numbers after the PEI and Arg-PEEAs indicate the corresponding weight ratio of 
polymer to DNA. BAEC, RSMC primary cells and Rat Mesenchymal stem cells 
(MSC) cells were tested.  
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Figure 4.15 Human umbilical vein endothelial cells (HUVEC) morphology (10 x, 12 h 
treatment, after 48 h): (A) Negative control HUVEC, no polymer added;   (B) HUVEC 
cells with 2 μL Liopfectamine2000® and 1 μg DNA added; (C) HUVEC cells with 
1,000 μg 2-Arg-6E-Cl and 1 μg DNA added. 
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Figure 4.16 Rat Mesenchymal stem cells (MSC) morphology (10 x, 12 h treatment, 
after 48 h): (A) Negative control MSC, no polymer added;  (B) MSC cells with 2 μL 
Liopfectamine2000® and 1 μg DNA added; (C) MSC cells with 1,000 μg 2-Arg-6E-Cl 
and 1 μg DNA added.  
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      Although the 2 controls (Lipofectamine2000® and PEI) required lower dosages 
than Arg-PEEAs to reach optimum transfection efficiency, they still showed a 
significantly higher cytotoxicity than Arg-PEEAs. Since Arg-PEEA had a lower 
positive charge density than the 2 control transfection reagents, a larger dose of Arg-
PEEA was needed to achieve efficient transfection.  
 
      The cytotoxicity of Arg-PEEA/DNA complex can also be confirmed by observing 
cell morphology under light microscope as shown in Figures 4.15 and 4.16 in addition 
to MTT assay. Figures 4.15 and 4.16 showed the images of HUVEC primary cells and 
MSC stem cells 48h after treatment of different Arg-PEEA/DNA complexes for 12 h. 
It can be seen that the cells treated by Arg-PEEA/DNA displayed normal HUVEC 
(Figure 4.15C) and MSC (Figure 4.16C) morphology, confirming the nontoxic nature 
of these Arg-PEEAs. In contrast, those HUVEC primary cells and SMC stem cells 
transfected with Lipofectamine2000® (Figure 4.15B and 4.16B) appeared to be 
somewhat unhealthy. Thus, we can conclude that these newly developed Arg-PEEAs 
are non-toxic and very safe to a variety of different cell types.  
 
 
 
 
 
 
 
 
 
 
 188 
 
4.E Conclusion   
 
      In this work, we tested the hypothesis that the flexibility of the polymers could 
affect their plasma DNA condensation capability and hence affect their transfection 
efficiency.  A series of water soluble, biocompatible and biodegradable L-Arginine 
and oligoethylene glycol based poly (ester amide)s (Arg-PEEAs) was prepared and 
studied for their feasibility as a gene delivery vehicle and cytotoxicity for a variety of 
cell types, from cell lines to primary cells and stem cells.  The relationship of Arg-
PEEA polymer structure-function was investigated in terms of the number of 
methylene and ethylene glycol units. Through various assays and methods, we 
confirmed that Arg-PEEAs could condense the DNA and form stable complex easily. 
Some Arg-PEEAs showed better transfection efficiency than Lipofectamine2000®, 
and achieved better transfection at a much lower cytotoxicity. The polymer structure-
property relationship was revealed and correlated to the transfection performance. This 
new Arg-PEEA family showed a great potential as a better and safer non-viral 
transfection agent. Their ability to deliver therapeutic DNAs could be further 
improved by modifying the polymer structure and transfection protocol. 
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5.A Abstract 
 
      Hydrogels are very important biomaterial forms for many clinical and 
pharmaceutical applications. Hydrogels fabricated from a photocrosslinking means 
have shown particular promising applications due to the ease of fabrication. In this 
study, we reported a new family of biodegradable and biocompatible cationic hybrid 
hydrogels synthesized in an aqueous solution via UV- photocrosslinking of two water 
soluble precursors: arginine-based unsaturated poly(ester amide) (Arg-UPEA) and 
Pluronic diacrylate (Pluronic-DA). The pH-sensitive Arg-UPEA was prepared via 
solution polycondensation method and the temperature-sensitive Pluronic-DA was 
prepared by reacting acryloyl chloride with the end hydroxyl groups of Pluronic. Both 
precursors have been proved to be non-toxic to cells via MTT assay. The gel fraction 
(Gf), equilibrium swelling ratio (Qeq), compressive modulus and interior morphology 
of the hybrid hydrogels were fully investigated. It was found that the incorporation of 
Arg-UPEA into Pluronic-DA hydrogels significantly changed their Qeq, mechanical 
strength and interior morphology. The effect of weight feed ratio of these two 
precursors on the hybrid hydrogels were investigated, and the structure-function 
relationship of the hybrid hydrogel was studied in terms of the number of methylene 
groups in Arg-UPEA repeating unit (y in diol segment). The results indicated that 
increasing methylene groups in the Arg-UPEA repeating unit increased the 
equilibrium swelling ratio (Qeq) and decreased the compressive modulus of the 
hydrogels. The cationic nature of the Arg-UPEAs component in the hybrid hydrogels 
greatly improved the attachment and proliferation of fibroblast cells when comparing 
with pure Pluronic hydrogel. The bovine aortic endothelial cells (BAEC) viability test 
in the interior of the hydrogels showed that the positively charged hybrid hydrogel 
could significantly improve the endothelial cell viability compared with the pure 
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Pluronic-DA hydrogel. The controlled release of hydralazine (Apresoline) via the 
hybrid hydrogel system was investigated by HPLC and LC-MS methods.  The 
excellent biocompatibility of these hybrid hydrogels and release profile of hydralazine 
showed that the hybrid cationic hydrogels developed in this study would have the 
potential for wound healing and other biomedical applications. 
 
5.B Introduction  
 
      Hydrogels refer to certain materials that are able to swell and hold large amounts 
of water in the wet state1-4. Hydrogels generally consist of three-dimensional polymer 
networks that are cross-linked chemically and/or physically. Because of their 
significant water contents, hydrogels also possess a degree of flexibility and softness 
similar to natural tissues1-4. In recent years, hydrogels have attracted many interests 
from clinicians, scientists and engineers in the field of tissue engineering and 
controlled drug delivery because of their biocompatibility, high water content, 3D 
microporous structure, permeability for oxygen and nutrients, and tissue-like elastic 
properties1-4. 
 
      For drug delivery applications, certain hydrogels could have stimuli-responsive 
drug release capability (for examples, pH sensitive hydrogel) synchronized with 
enzymatic or hydrolytic degradation3, 5. One of the very important advantages of 
hydrogels as drug carriers is that hydrogels could significantly increase the stability of 
many types of protein/nucleic acid drugs1. For many tissue engineering applications, it 
is often desirable to encapsulate cells directly inside hydrogels2, 6, 7.  For medical 
device applications, the most promising applications may involve lens, muscle models, 
and artificial cartilage 2, 6, 7. Hydrogels can also be integrated with microdevices for 
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various applications including biosensors and diagnostic imaging using 
photolithographic or other approaches1, 8, 9.  
 
      Although natural hydrogels fabricated by physical methods have been widely 
utilized for biomedical and clinical applications, chemically crosslinked hydrogels 
offer better control over the structure, physical and mechanical properties2, 5, 10. These 
hydrogels are fabricated by crosslinking precursors having 
difunctional/multifunctional groups, such as poly (ethylene glycol) diacrylate (PEG-
DA), one of the most used in biomedical field2, 3, 11. Depending on the chemical 
structure of the precursors, the resulting hydrogels may be responsive to pH, 
temperature, solvents, and other environmental factors2, 3, 11. By controlling those 
environmental factors, the hydrogel volume and other related properties could also 
change and be utilized for varieties of biomedical applications2, 3, 11. 
 
      Among the chemical approaches, photo and thermal crosslinking have been widely 
used to prepare hydrogels. Compared with other approaches, photocrosslinking 
method has the following advantages2, 12: First, it allows for better spatial and temporal 
control over the reaction. Second, it will have more rapid entrapment of cells with 
minimal cell death due to fast curing rates ranging from less than a second to a few 
minutes. Third, some gelation reactions can be performed under very mild conditions, 
such as aqueous solution, room temperature, body pH, and even in situ in a minimally 
invasive manner. Above all, photocrosslinking is the preferred approach for 
preparation of chemically crosslinked hydrogels2, 12. 
 
       Among the commercial precursors reported in the literature, Pluronic, also known 
as [poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide)] tri-block 
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copolymers] (PEO-PPO-PEO), is one of the most common because it dissolves in cold 
water, forming a viscous solution and self-associate to form micelles in a diluted 
aqueous solution13-17. At high concentrations above ca. 20 % (w/v), they exhibit a 
temperature-dependent sol-gel transition behavior13-17. The thermo-sensitive properties 
of Pluronic hydrogels can be attributed to lower critical solution temperature (LCST) 
behavior that is mainly caused by a delicate balance between hydrophilic and 
hydrophobic moieties of the polymer. Pluronic derivatives with suitable end functional 
groups were shown to retain their LCST behavior13-17. For biotechnology area, 
Pluronic is one of the widely used biocompatible polymers with excellent water 
solubility, low toxicity and immunogenicity13-17. Based on that, Pluronic-based 
hydrogels are also widely used systems for biomedical applications13-17.  
 
      In this study, we report a new hybrid hydrogel family fabricated from Pluronic and 
a new cationic and water soluble precursor synthesized from the amino acid-based 
biodegradable poly(ester amides) (AA-PEAs).  Hybrid hydrogels refer to hydrogel 
systems that contain two or more components of distinct classes of molecules. One of 
the main purposes of a hybrid hydrogel is to bring new properties/functionalities, such 
as charge property, hydrophobic/hydrophilic property and functional groups, to the 
current hydrogel systems by introducing a second precursor component. 
 
      AA-PEAs are a newly developed biodegradable biomaterial family that have 
shown very low cytotoxicity and inflammatory response property, and support natural 
wound healing . In recent years, AA-PEAs have been widely tested for biomedical 
applications, such as controlled drug and protein delivery, non-viral gene delivery, and 
tissue engineering scaffolds18-28. Although unsaturated AA-PEAs have been reported 
as the precursors to fabricate hybrid hydrogels via photo-means21, 22, these Phe-based 
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AA-PEA precursors are organic solvent soluble only. A new type of water soluble 
unsaturated AA-PEAs that are based on L-arginine (Arg) (Arg-UPEA) has been 
prepared to overcome the water solubility problem of the Phe-based AA-PEA 
precursors as shown in Figure 5.1. Arg-UPEAs precursor could bring pH sensitivity 
and positive charge to the resulting hybrid hydrogels.  
 
 
 
 
 
 
 
 
 
Figure 5.1 Chemical Structure of Unsaturated Arg-PEA (Arg-UPEA) 
 
      In this study, a series of novel biodegradable hybrid hydrogels were fabricated 
from four types of Arg-UPEAs and Pluronic-DA (F127-DA was selected for this 
study, Figure 5.3) by UV photocrosslinking. The newly synthesized biodegradable 
Arg-UPEA/Pluronic-DA hydrogels were characterized by gel fraction (Gf), 
equilibrium swelling ratio (Qeq), compressive modulus and interior morphology. The 
effects of the precursor’s feed ratio (Arg-UPEA to Pluronic-DA) and the type of Arg-
UPEA precursor on the property of the hybrid hydrogels were studied. By varying the 
weight feed ratio of Arg-UPEA to Pluronic-DA, we were able to tune the swelling 
ratio, mechanical property and pore sizes of the resulting hybrid hydrogels.  MTT 
assay, live-dead assay, cell attachment assay and cell proliferation assay were 
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conducted to evaluate the cytotoxicity and cellular response of precursors and the 
resulting Arg-UPEA/Pluronic-DA hydrogels. Our results indicated that Arg-UPEA 
were nontoxic to the cells even at large dosage treatment. The Arg-UPEA/Pluronic-
DA hybrid hydrogels showed a significant improvement of cell attachment, 
proliferation and viability when compared with pure Pluronic-DA hydrogel. These 
Arg-UPEA/Pluronic-DA hydrogels were also tested for controlled release of 
hydralazine shown in Figure 5.2. 
 
 
 
 
 
 
 
Figure 5.2 Chemical Structure of Hydralazine 
 
5.C Experimental 
5.C.1 Materials 
 
     Pluronic (F127, MW 12,600 and 70% PEG content) and acryloyl chloride were 
purchased from Aldrich Chemical Co. (Milwaukee, WI) and used without further 
purification. Triethylamine from Fisher Scientific (Fairlawn, NJ) was dried via 
refluxing with calcium hydride and then distilled before use. 2-Hydroxy-l- [4- 
(hydroxyethoxy) phenyl]-2-methyl-l-propanone (Irgacure 2959) was donated by Ciba 
Specialty Chemicals Corporation.  L-Arginine (L-Arg), p-toluenesulfonic acid 
monohydrate, fumaryl chloride, ethylene glycol, 1,3-propanediol, 1, 4-butanediol, 1,6-
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hexaniol and p-nitrophenol were all purchased from Alfa Aesar (Ward Hill, MA) and 
used without further purification. 3- (4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyl 
tetrazolium bromide (MTT) purchased from Sigma (St. Louis, MO) was used to 
evaluate the cell toxicity of Arg-UPEA and Arg-UPEA/Pluronic-DA hydrogel. 
Hydralazine chlorine salt used for controlled release test was also purchased from 
Sigma (St. Louis, MO).  Other chemicals and reagents if not otherwise specified were 
purchased from Sigma (St. Louis, MO). 
 
5.C.2 Synthesis of Hydrogel Precursors 
5.C.2.a Synthesis of Pluronic-Diacrylate (Pluronic-DA)  
 
      Pluronic-DA (F127-DA) was synthesized according to a modified procedure based 
on a previously reported method16 (Figure 5.3).  In brief, 2.0 mmol of F127 was 
dissolved in 150 mL of benzene and heated to 45 °C with stirring until a complete 
dissolution. After the solution was cooled to room temperature, 1.67 mL (12.0 mmol) 
of triethylamine, at a threefold molar excess concentration (based on the mole amount 
of F127 diol end groups), was added to the F127 solution. Then, 0.97 mL (12.0 mmol) 
of acryloyl chloride, also at a threefold molar excess concentration, was dissolved in 
50 mL benzene solution and added dropwise to the F127 solution through a dropping 
funnel. The mixture was stirred and cooled to 0 °C for 12 h with nitrogen protection. 
After that, the reaction was stopped and the insoluble triethylamine salt was removed 
by filtration. The F127-DA product was then precipitated out by pouring the reaction 
solution into 800 mL cold hexane. The F127-DA precipitate was collected and 
purified by filtration, re-dissolved in 50 mL of benzene, and precipitated in 500 mL of 
cold hexane, then repeated the above steps twice. The F127-DA polymer was finally 
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dried for 24 h in a vacuum oven at 25 °C and the dried product was sealed and stored 
in the refrigerator (approximately 4 °C) for future use. 
 
5.C.2.b Synthesis of Unsaturated Arginine Poly (ester amide) (Arg-UPEA) 
  
      The unsaturated Arg-based poly (ester amide) s (Arg-UPEAs) were synthesized by 
the same procedures reported before19, 25, 28. Briefly, the synthesis could be divided 
into the following three major steps: the preparation of unsaturated di-p-nitrophenyl 
ester of dicarboxylic acid (I) (Figure 5.4); the preparation of tetra-p-toluenesulfonic 
acid salts of bis (L-arginine), α, ω　 -alkylene diesters (II) (Figure 5.5); and the 
synthesis of Arg-UPEAs (III) via solution polycondensation of (I) and (II) (Figure 
5.6)  
 
      Unsaturated di-p-nitrophenyl esters of dicarboxylic acid (Monomer I), di-p-
Nitrophenyl Fumarate (NF), was prepared by reacting fumaryl chloride with p-
nitrophenol as previously reported25.  Four types of p-toluenesulfonic acid salt of L-
arginine diesters (Monomer II) were prepared in this study: tetra-p-toluenesulfonic 
acid salt of bis (L-arginine) ethane diesters Arg-2-S (y=2); tetra-p-toluenesulfonic acid 
salt of bis (L-arginine) propane diesters, Arg-3-S (y=3); tetra-p-toluenesulfonic acid 
salt of bis (L-arginine) butane diesters, Arg-4-S (y=4); tetra-p-toluenesulfonic acid 
salt of bis (L-arginine) hexane diesters, Arg-6-S (y=6). 
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Figure 5.3 Synthesis of Pluronic-DA 
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Figure 5.4 Synthesis of Monomer I, Di-p-nitrophenyl Ester of Dicarboxylic Acids 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Synthesis of Monomer II, Tetra-p-toluenesulfonic Acid Salt of Bis (L-
arginine) Alkylene Diesters 
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Figure 5.6 Synthesis of Arg-UPEAs from monomers I and II
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      Arg-UPEAs were prepared by the solution polycondensation of (I) and (II) 
monomers (NF and Arg-2-S, Arg-3-S, Arg-4-S, Arg-6-S) at different combinations. 
The Arg-UPEAs are labeled as x-UArg-y-S, where x and y are the number of CH and 
CH2 groups in diacid and diol segments, respectively, and U means the Arg-PEA is 
unsaturated. In this report, x was fixed at 2 because only one type of monomer I (NF) 
was used. An example of the synthesis of 2-UArg-6-S via a solution polycondensation 
is given here. Monomers NF (1.0 mmol) and Arg-6-S (1.0 mmol) in 2.0 mL of dry 
DMSO were mixed well by vortexing. The mixture solution was heated up to 75 °C 
with stirring to obtain a uniformed mixture. Triethylamine (0.31 mL, 2.2 mmol) was 
added drop by drop to the mixture at 75 °C with vigorous stirring until the complete 
dissolution of the monomers. The solution color turned into yellow after several 
minutes. The reaction vial was then kept for 48 hrs at 75 °C in a thermostat oven 
without stirring. The resulting solution was precipitated in cold ethyl acetate, 
decanted, dried, re-dissolved in methanol and re-precipitate in cold ethyl acetate for a 
further purification of 3 times before drying under vacuum at room temperature. The 
final Arg-UPEAs are yellow or pale yellow solid powder. The Arg-UPEAs 
synthesized with different combinations of diacids and diols building blocks are: 2-
UArg-2-S, 2-UArg-3-S, 2-UArg-4-S and 2-UArg-6-S.  
 
5.C.3 Fabrication of Arg-UPEA/Pluronic-DA Hybrid Hydrogels 
 
      Arg-UPEA/Pluronic-DA hybrid hydrogels were prepared by the photo-
polymerization of two precursors (Arg-UPEA and Pluronic-DA) at different weight 
ratios in water with an initiator. The Arg-UPEA and Pluronic-DA precursors were 
purified first by dissolving the precursors in distilled water and were dialyzed against 
deionized water (MW cut off 4,000) for 2 days. After that, the solutions were 
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lyophilized for 3 days using a Virtis Freeze Drier (Gardiner, NY) under vacuum at -48 
°C. An example of the fabrication of a hybrid hydrogel was given below: 0.08 g of 2-
UArg-2-S and 0.32 g F127-DA (1/4 weight ratio of 2-UArg-2-S/F127-DA) were 
added into a glass vial and dissolved in 2.0 mL of deionized water to form a clear 
homogeneous solution with light yellow color, which was brought by Arg-UPEA. 
0.004 g of photoinitiator Irgacure 2959 (1 wt% of total amount of precursors) was 
added into the precursors’ solution and dissolved completely. The hydrogel precursor 
solution was transferred to a custom-made 20 well Teflon mold (diameter 12 mm and 
thickness ≈ 4 mm for each well) using a micropipette. The precursor solution in the 
molds was irradiated by a long-wavelength UV lamp (365 nm, 100 W) for specified 
time (15 min) at room temperature. The irradiation distance is 5-10 cm.  The resultant 
hydrogels were moved from the mold and immersed in distilled water at room 
temperature for 48 hr to remove any residual chemicals.  The distilled water was 
replaced periodically. After this purification process, the hydrogel was soaked in 
distilled water to reach swelling equilibrium, and dried in vacuum at room temperature 
for 48 hr before further characterization and application.  
The gel fraction (Gf) of the resulting hydrogels was calculated by the following 
equation: 
Gf = (Wd/ Wp) ×100 % 
where Wd is the weight of dry hydrogel and Wp is the total weight of the two 
precursors and the photoinitiator. 
 
5.C.4 Measurements  
 
      The physicochemical properties of the monomers, polymers and hydrogels were 
characterized by various standard methods. For Fourier transform infrared (FTIR) 
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characterization, the dried samples were ground into powders and mixed with KBr at a 
sample/KBr ratio of 1:10 (w/w). FTIR spectra were then obtained with a PerkinElmer 
(Madison, WI) Nicolet Magana 560 FTIR spectrometer with Omnic software for data 
acquisition and analysis. 1H NMR spectra were recorded with a Varian Unity Inova 
400-MHz spectrometer (Palo Alto, CA). Deuterated water (D2O-d2) or deuterated 
dimethyl sulfoxide (DMSO-d6) (Cambridge Isotope Laboratories, Andover, MA) with 
tetramethylsilane as an internal standard was used as the solvent. MestReNova 
software was used for the data analysis. Elemental analyses of the polymers/hydrogels 
were performed with a PE 2400 CHN elemental analyzer by Atlantic Microlab 
(Norcross, GA).  The thermal property of the synthesized precursors (Arg-UPEAs and 
Pluronic) was characterized with a DSC 2920 (TA Instruments, New Castle, DE). The 
measurements were carried out from -10 to 200 °C at a heating rate of 10 °C/min and 
at a nitrogen gas flow rate of 25 mL/min. TA Universal Analysis software was used 
for thermal data analysis. The solubility of Arg-UPEAs in common organic solvents at 
room temperature was assessed by using 1.0 mg/mL as solubility criteria. The 
quantitative solubility of Arg-UPEAs in distilled water at room temperature was also 
measured by adding distilled water to the polymer sample step by step until the clear 
solution was obtained. Slight heating was need for some types of Arg-UPEAs.  
 
      For the molecular weight measurement, Arg-UPEAs were prepared at a 
concentration of 1 mg/mL in a 0.1 % (w/v) LiCl in DMAc solution. The sample 
molecular weights were determined from a standard curve generated from polystyrene 
standards with molecular weights ranging from 841.7 kDa to 2.93 kDa that were 
chromatographed under the same conditions as the samples. The standard curve was 
generated from a 3rd order polynomial fit of the polystyrene standard molecular 
weights. 
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       Interior morphology of Arg-UPEA/Pluronic-DA hydrogels was investigated by 
SEM. The swollen hydrogel samples, after reaching their maximum swelling ratio in 
distilled water at room temperature, were quickly frozen in liquid nitrogen and then 
freeze-dried under vacuum at -48 °C for 3 days until all water inside the hydrogel was 
sublimed. The freeze-dried hydrogel samples were then cut and fixed on aluminum 
stubs and then coated with gold for 30 seconds for interior morphology observation 
with a scanning electron microscope instrument (Leica S440, Germany).  
 
5.C.5 Hydrogel Swelling Ratio & Swelling Kinetics  
 
      The equilibrium swelling ratio (Qeq) of the hydrogel is calculated by the following 
equation:  
Qeq = [(We -Wd)/ Wd] ×100 % 
where Ws is the weight of a swollen hydrogel at equilibrium and Wd  is the weight of 
the corresponding dry hydrogel at t = 0.  
 
      The swelling kinetics of the Arg-UPEA/F127-DA hydrogels was measured over a 
period of 4 days at room temperature. Each dry Arg-UPEA/F127-DA gel sample was 
weighed and immersed in 20 mL of solutions with different parameters for 
predetermined periods. Before weighing, the samples were taken from the solutions 
and blotted with filter papers to remove excess surface water. The swelling ratio (Q) of 
the hydrogel at time t is calculated by the following equation:  
Q = [(Wt -Wd)/ Wd] ×100 % 
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where Wt is the weight of swollen hydrogel at time t and Wd  is the weight of the dry 
hydrogel at t = 0. All swelling ratio results were obtained from triplicate samples and 
data were expressed as the means ± standard deviation. 
 
5.C.6 Compressive Modulus Measurement by Dynamic Mechanical Analyzer 
(DMA) 
 
      The mechanical property of the Arg-UPEA/F127-DA hydrogels was measured by 
a DMA 2980 Dynamic Mechanical Analyzer (TA Instruments Inc., New Castle, DE) 
in  a ‘‘controlled force’’ mode (CF-mode). The swollen hydrogel samples in circular 
disc shape were submerged in distilled water and mounted between the movable 
compression clamp (diameter 30 mm) and the fluid cup with a 0.1 N preloading force. 
A force ramp from 0.1 N at a rate of 0.3 or 0.5 N/min was applied. All measurements 
were carried out at room temperature. The compression elastic modulus (E) of the 
swollen hydrogel was extracted by plotting the compressive stress versus strain. All 
compression elastic modulus data in this study were obtained from triplicate samples 
and data were expressed as the means ± standard deviation. 
 
5.C.7 Cell Culture Study  
 
      Bovine endothelial aorta cells (BAECs) were purchased from VEC Technologies, 
kindly offered by Professor Cynthia Reinhart-King at Department of Biomedical 
Engineering of Cornell University. BAECs were cultured at 37 °C in 5 % CO2 in 
Medium 199 (Invitrogen, Carlsbad, CA) supplemented with 10 % Fetal Clone III 
(HyClone, Logan, UT), and 1 % each of penicillin–streptomycin, MEM amino acids 
(Invitrogen, Carlsbad, CA), and MEM vitamins (Mediatech, Manassas, VA). BAECs 
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were used from passages 8–12. Media was changed every 2 days. BAECs were grown 
to 70 % confluence before splitting or harvesting. Cell culture plates were coated with 
2 wt% gelatin aqueous solution before using. 
 
      Detroit 539 human fibroblast cells were purchased from ATCC. The fibroblast 
cells were maintained at 37 °C in 5 % CO2 in Dulbecco’s minimal essential medium 
(DMEM) supplemented with 10 % FBS (Germini, Woodland, CA) and 1 % each of 
penicillin–streptomycin, MEM amino acids (Invitrogen, Carlsbad, CA), and 0.1 % 
lactalbumin hydrolysate. Fibroblast cells were used from passages 10-20. Cell media 
was changed every 2 days. Cells were grown to 70 % confluence before splitting or 
harvesting. 
 
5.C.8 Cytotoxicity Evaluation of Precursors by MTT Assay 
 
      The cytotoxicity evaluation of the Arg-UPEA and F127-DA precursors was 
performed by MTT assay. Arg-UPEA or F127-DA aqueous solutions (2 wt% for Arg-
UPEA and 10 wt % for F127-DA) were obtained by dissolving the purified polymer in 
PBS buffer solution. Cultured bovine endothelial aorta cells (BAEC) were seeded cell 
medium at an appropriate cell density concentration (3,000 cells/well) in 96-well 
plates and incubated overnight. After 12 h, the BAECs were treated with the freshly 
prepared aqueous Arg-UPEA or F127-DA PBS solution with various volumes, the 
BAEC without any polymer were used as the control.  After 48 h treatment and 
incubation, 20 μL of MTT solution (5 mg/mL) was added to each well, followed by 4 
h incubation at 37 °C, 5 % CO2. Then the cell culture medium including polymer 
solution was carefully removed and 200 μL of acidic isopropyl alcohol (with 0.1 M 
HCl) was added to dissolve the formed formazan crystal. The plate was slightly 
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shaken for 20 mins to make sure that the purple crystal dissolved completely.  
Absorbance (OD) was measured immediately at 570 nm (subtract background reading 
at 690 nm) using a microplate reader (VersaMax Tunable Microplate reader Molecular 
Devices, USA). The BAECs viability (%) was calculated according to the following 
equation: 
Viability (%) = (OD570 (sample)-OD620 (sample))/ (OD570 (control)-OD620 (control)) × 100% 
Where the OD570 (control) represented the measurement from the wells treated with 
medium only and the OD570 (sample) represented the measurement from the wells treated 
with various polymer volumes.  
 
5.C.9 Cell Attachment and Proliferation on Arg-UPEA/F127-DA Hybrid Hydrogels 
Surface 
 
      The cell attachment and proliferation on the Arg-UPEA/F127-DA hybrid hydrogel 
surfaces was evaluated by cell morphology. Pure F127-DA hydrogel was selected as 
the hydrogel control and the cell culture plate without any treatment was used as the 
negative control.  The cells used for this study were Detroit 539 human fibroblasts. 
The purified hydrogels were cut into round shape with the diameter that just filled the 
well of 24-well cell culture plates.  Before being put into the 24-well cell culture 
plates, the hydrogels were sterilized under UV light (from the cell culture hood) for 1 
h. After that, the hydrogels were washed twice by PBS buffer and cell culture media. 
Then, the hydrogels were placed into the wells of the cell culture plate and fixed by 
sterilized rubber ring which has the same diameter as the well of cell culture plate. 
Detroit 539 human fibroblasts were seeded at an appropriate cell density (10,000 
cells/well) and incubated overnight. After 48 h incubation, the cell attachment and 
proliferation on the hydrogel surface was record by an optical microscope. For MTT 
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assay, the attached cells were first detached from the hydrogel surface or cell culture 
plate surface by trypsin (0.1 mg/mL) treatment, then the detached cells were 
transferred into a new 96 cell culture place, after 12 h incubation, the MTT assay were 
processed.   
 
 5.C.10 Cell Viability inside Arg-UPEA/F127-DA Hybrid Hydrogels  
 
       In order to test the cell viability inside the Arg-UPEA/F127-DA hybrid hydrogels, 
the BAEC cells were encapsulated into these hydrogels by the following steps: 
Purified hydrogel precursors and initiators were dissolved in a PBS buffer, and then 
the cells (107/mL in media), FBS, antibiotics and other nutrients of the complete cell 
culture media were added. The final mixture solution has 20 wt % precursors, 60,000 
cells/mL, and 10 wt % FBS inside. All other components of the complete cell culture 
media in the mixture have the exactly same concentration as the normal BAEC cell 
culture media recommended by ATCC.  The mixture were injected into 24-well cell 
culture plate (0.5 mL per well) by a pipette and crosslinked under 100 W UV 
irradiation for 5 mins and the irradiation distance is 5 cm. After crosslinking, 0.5 mL 
complete cell culture media was added into each well. The BAEC-loaded hydrogels 
were incubated for 2 weeks at 37 °C, 5 % CO2. Cell culture media was changed every 
other day. The live-dead assay was then performed according to the manufacturer 
protocol (LIVE/DEAD® Cell Viability Assay Kit from Invitrogen). 
 
5.C.11 Controlled Release of Hydralazine (Apresoline) via Arg-UPEA/F127-DA 
Hybrid Hydrogels 
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      The release of hydralazine from the Arg-UPEA/Pluronic-DA hydrogels were 
carried out in a PBS buffer at 37 °C. Hydralazine was preloaded into the hydrogel 
samples (in small pellet form) by two different means: a) hydralazine was directly 
mixed with Arg-UPEA and Pluronic-DA precursors and photo-initiators in distilled 
water, and the solution mixture was UV irradiated to form drug-impregnated 
hydrogels; or b) hydralazine was first mixed with cationic (such as chitosan or Arg-
PEA/Arg-UPEA) and anionic (such hyaluronic acid and alginate) polymers; then the 
above polyelectrolyte-drug complex would mix with precursors/initiators in distilled 
water, and UV irradiated to form hydrogel. The drug loaded hydrogels from a or b 
method above were then placed inside small vials containing 10.0 mL PBS solution 
(one piece of hydrogel per vial). The vial was incubated at 37 °C with a constant 
reciprocal shaking (ca. 100 rmp). The hydralazine contents were then analyzed by a 
high performance liquid chromatography (HPLC). To determine the release amounts 
of the drug at predetermined time points, 50 µL of the immersion solution was 
removed from the vial and added into a HPLC vial followed by adding 950 µL PBS 
buffer to dilute the solution. The solution was thoroughly vortexed before tested by a 
HPLC (HP 1100 model, Palo, Alto, CA, USA) equipped with a diode array detector. 
A C18 reversed phase column (5 um, 4.6X250 nm, Alltech Adsorbosphere XL) was 
used as the stationary phase, while the mobile phase consisted of acetonitrile and 
water (pH 3.0) in the volume ratio 63:37. The injection volume was 50 or 100 µL 
based on the released hydralazine concentration and the mobile phase was pumped at a 
flow rate of 2.0 mL/min. Detection was at 365 nm with a UV detector. ChemStation 
(Palo, Alto, CA, USA) software was used for data analysis. All drug release tests at 
each time point were carried out in triplicate and variation was expressed as a standard 
error of the mean. The confirmation of hydralazine chemical structure was carried out 
by GC-MS method and the major diagnostic MS fragments were analyzed.    
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5.C.12 Statistics 
 
      Where appropriate, the data are presented as mean ± standard error of the mean 
calculated over at least three data points. Significant differences compared to control 
groups were evaluated by unpaired Student’s t-test or Dunnet test at p 0.05, and 
between more than two groups by Tukey’s test with or without one-way ANOVA 
analysis of variance.  JMP software (version 8.0, from SAS Company) was used for 
data analysis.  
 
5.D Results and Discussions  
 
      The goal of this study is to expand the applications of Arg-PEA, especially for the 
areas of tissue engineering and drug delivery. The previous tests indicated that the 
Arg-PEAs had excellent water solubility, positive charge and good biocompatibility, 
which greatly arouse our interests28. However, the reported Arg-PEAs did not have 
any functional groups for further chemical modifications28, in order to chemically 
incorporate the Arg-PEA to the scaffolds; double bonds were introduced to the Arg-
PEA backbone so that crosslinking method could be applied.  
 
5.D.1 Preparation and Characterization of Precursors 
5.D.1.a Synthesis and Characterization of Pluronic-DA 
 
      The Pluronic (F127) with an average molecular weight of 12,600 was used here to 
prepare the precursor for the photo-crosslinking. The synthesis of F127-DA was 
followed the previous report16. It was found that the reaction temperature and N2 
protection were important for the successful preparation of F127-DA. The optimized 
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reaction temperature is 0 °C and the reaction time would need 12-16 h under this 
temperature. High temperature, such as 60 °C or even higher, would reduce the 
reaction time to 2-3 h. However, the final product would show some yellow color 
because of the side reactions. In order to obtain final product with white color, 0 °C, 
N2 protection and magnetic bar stirring were suggested for the F127-DA synthesis. 
The product should be re-purified by dialysis method before any biological 
applications. The final product was white powder and could dissolve in distilled water 
to form clear and transparent solution at room temperature or 4 °C. Vigorous 
stirring/shaking was not suggested for making the solutions because of the production 
of bubbles. The chemical structure of F127-DA was confirmed by 1HNMR and FTIR. 
The FTIR peak of the ester bond is around 1725 cm-1, which indicated the successfully 
acrylation of Pluronic polymers. To avoid the self-crosslinking, the final product 
should be vacuum sealed and stored at 4 °C or -20 °C in dark place. And it was 
suggested that the Pluronic-DA should be used within 3-4 months after preparation.  
    
5.D.1.b Synthesis and Characterization of Arg-UPEAs 
 
      The unsaturated di-p-nitrophenyl esters of dicarboxylic acids (NF) was 
synthesized and characterized as previous reports (Figure 5.3)25. The tetra-p-
toluenesulfonic acid salts of bis (L-arginine) alkylene diesters have been recently 
designed and synthesized28. The amounts of p-toluenesulfonic acid used was the main 
difference of monomer synthesis between the current Arg-based monomers and other 
hydrophobic amino acid based monomers19-23, 25, 28-32. The excessive p-toluenesulfonic 
acid was needed because of the strong alkalinity of the guanidine group of Arginine. 
The p-toluenesulfonic acid preferred to react with guanidine group first to form a 
stable salt, then reacted with the amine group of arginine. Four types of monomer II 
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were prepared (figure 5.5): Tetra-p-toluenesulfonic acid salt of L-Arginine ethane-1,2-
diester (Arg-2-S), Tetra-p-toluenesulfonic acid salt of L-Arginine propane-1,3-diester 
(Arg-3-S), Tetra-p-toluenesulfonic acid salt of L-Arginine butane-1,4-diester (Arg-4-
S), and Tetra-p-toluenesulfonic acid salt of L-Arginine hexane-1,6-diester (Arg-6-S). 
The only difference among these monomers is the methylene chain length (y) in the 
diol part between the two adjacent ester groups: number of CH2 varies from 2 to 6 
(Arg-2-S to Arg-6-S).  The chemical structures of these 4 types of Arg-based 
monomer II were all confirmed by FTIR and 1HNMR. The details of characterization 
data were discussed elsewhere28.  
 
      Arg-UPEAs were prepared according to the reaction scheme in figure 5.6. Four 
types of Arg-UPEAs were prepared with varying y values: 2-UArg-2-S, 2-UArg-3-S, 
2-UArg-4-S, and 2-UArg-6-S. The yield of final product was high and more than 85 
%. The chemical structure of Arg-UPEAs was confirmed by FTIR and HNMR. The 
yields, water solubility, charge density, glass transition temperature (Tg), molecular 
weight of repeating unit, molecular weight were given in Table 5.1. The Arg-UPEAs 
were moisture sensitive and should be stored in sealed bottles at 4 °C or lower 
temperature in dark place. 
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Table 5.1 Chemical and Physical Properties of Arg-UPEAs 
 
 2-UArg-2-S 2-UArg-3-S 2-UArg-4-S 2-UArg-6-S 
Yield (%) 87 % 91 % 93 % 89 % 
Charge Density 
(mol/kg) 
2.50 2.46 2.42 2.34 
Molecular 
Weight of 
Repeating Unit 
(g/mol) 
798.9 812.9 826.9 855.0 
Molecular 
Weight (Mn, 
kg/mol) 
12.93 14.56 15.71 14.82 
Molecular 
Weight (Mw, 
kg/mol) 
14.01 16.14 17.49 16.33 
PDI (Mw/Mn) 1.08 1.11 1.11 1.10 
Tg (°C) 112 103 94 88 
Water Solubility 
(mg/mL) 
20±2 30±2 10±1 2±0.5 
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      For the solubility of Arg-UPEA in common organic solvents, 1.0 mg/mL was used 
as a standard whether a polymer is soluble or insoluble at room temperature. Due to 
their strong polar nature, Arg-UPEAs tended to dissolve in polar solvents. All the 
synthesized Arg-UPEAs were soluble in polar organic solvents like DMSO, DMF and 
methanol, but did not dissolve in non-polar or weak polar organic solvents like ethyl 
acetate or chloroform. And the Arg-UPEAs showed decreased water solubility 
compared to the reported saturated Arg-PEAs.  The effect of y material parameters on 
Arg-UPEA water solubility (Table 5.1) revealed that y had a major impact on the 
water solubility of Arg-UPEAs; and an increase in the methylene chain length in the 
diols (y) part reduced the water solubility significantly due to the increasing 
hydrophobicity. By adjusting the y, the Arg-UPEAs’ solubility 
(hydrophilicity/hydrophobicity) could be fine tuned to meet specific needs. 
 
       The molecular weight (Mn and Mw) of 2-UArg-2-S, 2-UArg-3-S, 2-UArg-4-S, 2-
UArg-6-S were obtained with the help of MediVas, LLC.  The MW data in Table 5.1 
indicated that all the Arg-UPEAs had Mn between 12.5 kg/mol and 16.0 kg/mol with 
narrow polydispersity (PDI) of 1.07 – 1.10. The y values did not have any significant 
impact on MW and PDI of Arg-UPEAs. Compared with saturated Arg-PEAs, the MW 
of the Arg-UPEAs did not show any big difference and were in the same range.   
 
      For the thermal property of the Arg-UPEAs, they did not have melting points (Tm), 
which were consistent with the reported saturated Arg-PEAs.  The glass transition 
temperature (Tg) of Arg-UPEAs (Table 5.2) were in the range of 85-115 oC, which had 
the same range as the Tg of phenylalanine-based unsaturated PEAs25. Due to the 
presence of double bonds in the repeating unit of Arg-UPEA backbone, much higher 
Tg values were observed when compared with the saturated Arg-PEAs. For example, 
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2-UArg-2-S had a Tg 112 oC, while 2-Arg-2-S had a Tg 52 oC, a 100% increase in Tg 
by simply introducing unsaturated C=C bond in the backbone. Pang et al.  reported 
that the location of C=C bonds may also have a significant effect on Tg30. For 
example, if the C=C bonds were located in the side chain, the Tg value may decrease 
significantly30.  Similar magnitude of Tg change was also reported for the Phe based 
PEAs19, 25. An examination for the effect of the number of methylene groups in the 
diol (y) part of the Arg-UPEAs revealed that an increase in y led to a lower Tg. The Tg 
decreased from 112 oC to 88 oC when the y value was increased from 2 to 6.   This 
relationship is consistent with non-ionic hydrophobic amino acid-based and many 
other PEA systems, such as the saturated Phe-PEAs, for example,  if x value was fixed 
at 4, the Tg decreased from 59 oC  to 49 oC  when the y value was increased from 4 to 
619 (4-Phe-4 vs. 4-Phe-6). 
 
5.D.2 Fabrication and Characterization of Arg-UPEA/Pluronic-DA Hybrid 
Hydrogels 
 
     Theoretically, Arg-UPEA should be able to undergo free radical crosslinking using 
an initiator because of its double bond moiety. In this study, however, we found that 
Arg-UPEA itself could not form a hydrogel network with good 3-D shape easily even 
at a high concentration. (e.g. 50.0 wt% solution) The difficulty in self-crosslinking 
between double bonds could be caused by the side guanidino groups of arginine. 
Therefore, Pluronic-DA was selected as a second crosslinker to facilitate 
polymerization of Arg-UPEA, with Irgacure 2959 as the photoinitiator in an aqueous 
system via the UV photo-polymerization. The initiator was previously reported to 
cause minimal toxicity (cell death) over a broad range of mammalian cell types and 
species ranging from human fetal osteoblasts to bovine chondrocytes33. 
 222 
 
 
      All the fabricated Arg-UPEA/F127-DA hydrogels were transparent after reaching 
their swelling equilibrium. Figure 5 shows an example of the 2-UArg-2-S/F127-DA 
hydrogel (feed weight ratio: 1/4). The right image was a dried hydrogel and the left 
was the same hydrogel at a swelling equilibrium. The properties of these hydrogels, 
such as the swelling behavior, compression modules and interior morphology were 
systematically examined. And the dependence of these properties on the precursor 
property and feed ratios of Arg-UPEA to F127-DA were examined as well. The data 
are summarized in Table 2. The successful fabrication of Arg-UPEA/F127-DA hybrid 
hydrogels was confirmed by elemental analysis. By measuring the nitrogen element 
percentage of dried hydrogels, it was confirmed that most of the Arg-UPEA was 
successfully crosslinked with F127-DA.  The measured N contents in Table 2 were 
slightly higher than the theoretical value (in the parentheses), suggesting that the 
hybrid hydrogels had Arg-UPEA precursor incorporated since F127-DA didn’t have 
any N content. The gel fraction data (Gf) data showed that pure F127-DA hydrogel has 
a higher Gf value (more than 90 %) than the Arg-UPEA/F127-DA hybrid hydrogel 
(around 80 %). The reason for this Gf difference is that F127-DA has higher activity 
than Arg-UPEA. The low Gf value of Arg-UPEA/F127-DA hybrid hydrogel means 
more uncrosslinked precursors inside the hydrogel and the purification for the Arg-
UPEA/F127-DA hybrid hydrogel need a longer time.     
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Figure 5.7 Image of hybrid hydrogel of 2-UArg-2-S/F127-DA with a feed ratio of 1: 4; 
right: dried hydrogel; left: hydrogel at swelling equilibrium 
 
5.D.3 Equilibrated Swelling Ratio & Swelling Kinetics of Arg-UPEA/Pluronic-DA 
in DI Water and Buffers 
 
      The swelling kinetics of the Arg-UPEA/Pluronic-DA hydrogel was studied over a 
period of 4 days in deionized (DI) water at room temperature. For example, Figure 5.8 
showed the hydrogels of varied compositions (different types of Arg-UPEAs, fixed 
feed weight ratio of Arg-UPEA to F127-DA) had a high swelling rate during the initial 
3 hours. From Figure 5.8, for the pure F127-DA hydrogel and hybrid hydrogels, the 
swelling rate difference among them was not big. After the initial 3 hours, the swelling 
rate leveled off, and finally reached their swelling equilibrium within about 12-18 
hours. The swelling ratios at equilibrium were summarized in Table 5.2.   
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Table 5.2 Arg-UPEA/F127-DA Hybrid Hydrogels and Their Physicochemical  
Properties 
 
*Qeq (%) and compressive modulus was measured in DI water at room temperature. 
 
Sample Weight 
Ratio 
Gf 
(%) 
Qeq (%)* Compressive 
Modulus* (KPa) 
N (%) 
F127-DA 100:0 92 
 
1144±17 
 
12.27±0.34 
 
0.00 (0.00) 
 
F127-DA/2-
UArg-2-S 
4:1 
 
83 
 
1785±74 
 
4.85±0.41 
 
2.80 (2.61) 
 
F127-DA/2-
UArg-3-S 
4:1 
 
80 
 
1843±77 
 
4.43±0.23 
 
2.76 (2.54) 
 
F127-DA/2-
UArg-4-S 
4:1 
 
81 
 
1917±59 
 
3.77±0.24 
 
2.71 (2.55) 
 
F127-DA/2-
UArg-6-S 
4:1 
 
79 
 
2158±98 
 
2.58±0.25 
 
2.62 (2.50) 
 
F127-DA/2-
UArg-2-S 
3:2 
 
77 
 
2014±63 
 
1.97±0.21 
 
5.61 (5.40) 
 
F127-DA/2-
UArg-3-S 
3:2 
 
79 
 
2191±94 
 
1.91±0.11 
 
5.52 (5.44) 
 
F127-DA/2-
U-Arg-4-S 
3:2 
 
76 
 
2287±63 
 
1.63±0.19 
 
5.43 (5.27) 
 
F127-DA/2-
UArg-6-S 
3:2 75 2407±117 0.77±0.17 5.24 (5.10) 
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Figure 5.8 Swelling kinetics of Arg-UPEA/Pluronic-DA hydrogels in DI water at 
room temperature 
 
     The equilibrium swelling ratio tests were performed in both deionized water (DI 
water) and 1X PBS solution. Figure 5.9 showed the equilibrated swelling ratios at 
room temperature for the hybrid hydrogels with varied compositions. The swelling 
ratios of Arg-UPEA/Pluronic-DA hybrid hydrogels in DI water were always higher 
than that of the corresponding hydrogels in PBS solution (Figure 5.9). No significant 
difference in swelling ratio between PBS and DI media was observed for the pure 
F127-DA hydrogel (Figure 5.9, a). This observation suggests that the electrolytes in 
PBS might interfere with the interaction between water molecules and guanidino 
groups in the hybrid hydrogels. The equilibrated swelling ratios of the hybrid 
hydrogels generally increase with an increase in the weight feed ratio of Arg-UPEA to 
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F127-DA either in DI water or PBS solution. For example, in DI water and at room 
temperature, the hydrogel of 2-UArg-2-S/F127-DA (1/4, w/w) had an equilibrated 
swelling ratio of 1785±74 %, while the hydrogel of 2-UArg-2-S/F127-DA (2/3, w/w) 
had an increased equilibrated swelling ratio of 2014±63 %.  
 
      We further investigated the effect of molecular structure (y value) of the Arg-
UPEA on the swelling property of the hybrid hydrogels at a constant weight ratio of 
Arg-UPEA to F127-DA. As shown in Table 5.2 and Figure 5.7, the swelling ratio 
increased as the number of methylene groups in the repeating unit of Arg-UPEA 
increased. For example, at the feed weight ratio of 1 to 4, in DI water and at room 
temperature, from 2-UArg-2-S/F127-DA (1/4, w/w) to 2-UArg-6-S/F127-DA (2/3, 
w/w), the equilibrated swelling ratio increased from 1785±74 % to 2158±98 %. The 
same trend was observed in PBS buffer, at the feed weight ratio of 1 to 4, from 2-
UArg-2-S/F127-DA (1/4, w/w) to 2-UArg-6-S/F127-DA (2/3, w/w), the equilibrated 
swelling ratio increased from 2407±117 % to 2158±98 %. 
 
      The swelling ratio of all Arg-UPEA/Pluronic-DA hybrid hydrogels were higher 
than that of pure Pluronic-DA hydrogel (1,144 ± 17% and 1,150 ± 24 % in DI water 
and PBS, respectively), implying that the incorporation of guanidine group moieties in 
Arg-UPEA segment did enhance the hydrophilicity and hence swelling of the hybrid 
hydrogels. This relationship of the effect of precursors’ feed ratio and molecular 
structure on swelling ratio was also found to be consistent with the effect of 
precursors’ feed ratio and molecular structure on the compressive modules of the 
hydrogels as described later. 
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Figure 5.9 Equilibrated swelling ratio of Arg-UPEA/Pluronic-DA hydrogels in PBS 
(pH=7.4) solution and DI water. a) Pure F127-DA hydrogel (control); b) 2-UArg-2-
S/F127-DA (1/4, w/w); c) 2-UArg-3-S/F127-DA (1/4, w/w); d) 2-UArg-4-S/F127-DA 
(1/4, w/w); e) 2-UArg-6-S/F127-DA (1/4, w/w); f) 2-UArg-2-S/F127-DA (2/3, w/w); 
g) 2-UArg-3-S/F127-DA (2/3, w/w); h) 2-UArg-4-S/F127-DA (2/3, w/w); i) 2-UArg-
6-S/F127-DA (2/3, w/w)  
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      The fast swelling kinetics and high water retention capability of these hybrid 
hydrogels are due to their hydrophilic characteristic of the hybrid hydrogels. Not all 
hybrid hydrogels reported in the literature show such fast and high levels of swelling. 
For example, Guo et al. reported that a relatively hydrophobic hybrid hydrogel family 
containing phenylalanine based poly (ester amide)/ PEG-DA had much slower 
swelling kinetics (around 12 hours before the swelling rate leveled off) and lower 
equilibrium swelling ratios (between 1 and 2,400% in DI water)21, 25.  
 
      To further understand the effect of ions on the equilibrium swelling ratio of these 
hybrid hydrogels, the effect of pH (varied H+ concentration) on the equilibrium 
swelling ratios of the Arg-UPEA/Pluronic-DA hybrid hydrogels was examined as 
shown in Figure 5.10. As expected, the swelling ratios of the hybrid hydrogels were 
sensitive to the change of pH, and the level of pH sensitivity depended on the feed 
ratio of Arg-UPEA to Pluronic-DA. In general, all the hybrid hydrogels showed an 
increase in swelling ratio with a decrease in pH values. The effect of pH on swelling 
ratio became more pronounced as the Arg-UPEA to Pluronic-DA feed ratio increased 
because of the increasing of ion density. For example, for the hybrid hydrogels at a 
feed ratio of 1:4, the equilibrium swelling ratio of 2-UArg-2-S/F127-DA at an acidic 
pH (pH = 4) was almost 2 times than that at a basic condition (pH = 10). This pH 
dependent equilibrium swelling ratio of hydrogels was also discussed and reported in 
other polymeric systems, including PEG-grafted poly (methacrylic acid) (PMAA)34, 
maleic chitosan hydrogels 35, maleic dextran hydrogels36 and poly (vinyl alcohol)-co-
maleic anhydride hydrogels37.  
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Figure 5.10 the equilibrium swelling ratios of the hybrid hydrogels in aqueous solution 
as a function of the pH value.  a): 2-UArg-2-S/F127-DA (1:4,w/w); b) 2-UArg-2-
S/F127-DA (2:3,w/w) 
 
5.D.4 Mechanical Property (Compressive Modulus) of Arg-UPEA/F127-DA Hybrid 
Hydrogels 
 
      For the effect of molecular structure (y value) of Arg-UPEA on the compressive 
modulus of the hybrid hydrogels, it was found that the compressive modulus 
decreased with an increase in y value. For example, at a fixed feed weight ratio of 
Arg-UPEA to F127-DA of 1:4, an increase of y from 2 (2-UArg-2-S/F127-DA), 4 (2-
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UArg-4-S/F127-DA) to 6 (2-UArg-6-S/F127-DA), their compressive moduli 
decreased from 4.85±0.41, 3.77±0.24 to 2.58±0.25 KPa, respectively. The 
compressive modulus of Arg-UPEA/F127-DA hydrogel is much less than our 
previous reported Phe-UPEA/PEG8000-DA system21, 22. For example, for the hybrid 
hydrogel system of Arg-UPEA/F127-DA with a weight feed ratio of 1:4, the 
compressive moduli is in the range of 2-5 KPa;  while for the Phe-UPEA/PEG8000-
DA, the compressive moduli is in the range of 150-900 KPa, which is about 100 times 
of the Arg-UPEA/F127-DA system. The huge difference is mainly caused by the 
significant difference between Arg-UPEA and Phe-UPEA. As we know, the 
mechanical property of hydrogel was very important for the cellular interaction with 
hydrogel2, this Arg-UPEA/Pluronic-DA hybrid hydrogel system offered a variety of 
mechanical property choices for tissue engineering applications by adjusting the 
material parameter of the precursor as well as its feed ratio to the co-precursors. 
 
5.D.5  Interior Morphology (SEM) of Arg-UPEA/F127-DA Hydrogels 
 
      To further understand the 3-D structure of the Arg-UPEA/F127-DA hybrid 
hydrogels, the cross-sectional interior morphology of the hybrid hydrogels was 
examined and shown in Figure 5.11. Compared with a pure F127-DA hydrogel, these 
Arg-UPEA/F127-DA hybrid hydrogels have larger average pore size and thinner cell 
wall. For example, a pure F127-DA hydrogel had an average pore size 9 µm, while all 
Arg-UPEA/F127-DA hybrid hydrogels had the average pore size 11-13 µm.  At a 
fixed feed ratio of precursors, no significant difference of the pore size among the 
Arg-UPEA/F127-DA hybrid hydrogels due to different y material parameter in the 
Arg-UPEA precursor. One distinctive morphology of these Arg-UPEA/F127-DA 
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hybrid hydrogels from a pure F127-DA hydrogel was that the Arg-UPEA/F127-DA 
hybrid hydrogels showed some nanosize fiber webs entangled with the cells.  
 
5.D.6  Cytotoxicity of Hydrogel Precursors  
 
      In this study, the cytotoxicity of hydrogel precursors (Arg-UPEA and Pluronic-
DA) was evaluated by MTT assay. As shown in Figure 5.12, under phase-contrast 
microscopy, no significant morphology change of the fibroblast cell was observed 
after 48 hrs’ treatment with precursors. There were no visible signs of cell rounding or 
membrane blebbing which would indicate cell death.   Results from the MTT assay 
indicated that more than 95 % cells remain viable when treated with precursor 
solutions after 48 hrs (Figure 5.13). The minimal cytotoxicity of Arg-UPEAs implies 
the great potential as a new biomaterial for various biomedical applications. 
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Figure 5.11 SEM images of Arg-UPEA/F127-DA hybrid hydrogels at weight feed 
ratios of Arg-UPEA/F127-DA of 1/4. A, Pure F127-DA hydrogel; B, 2-UArg-2-
S/F127-DA hybrid hydrogel; C, 2-UArg-4-S/F127-DA hybrid hydrogel; D, 2-UArg-6-
S/F127-DA hybrid hydrogel. The scale bar (green bar) is 5 µm. 
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Figure 5.12 Representative micrographs of fibroblast cells after 48 hr culture, 10x. A) 
cells without any polymer treated (control); B) cells treated with 10 μL 10 mg/mL 
F127-DA PBS solution; C) cells treated with 10 μL 10 mg/mL 2-UArg-2-S PBS 
solution.  
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Figure 5.13 Fibroblast cell viability (%) after incubation in various amount of F127-
DA and 2-UArg-2-S solution for 48 hours, respectively. NC means negative control: 
cells without any polymer treatment. Error bars represent mean + SEM, * P<0.05. The 
number after precursor name means the volume of polymer solution and the 
concentration for both of precursors is 10 mg/mL.  
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5.D.7 Human Fibroblast Cell Attachment and Proliferation on Hydrogel Surfaces 
 
      To study the cellular interaction with Arg-UPEA/F127-DA hybrid hydrogels, the 
Detroit 539 human fibroblast cells were cultured on the surface of Arg-UPEA/F127-
DA hybrid hydrogels to investigate the cell attachment and proliferation performance. 
Detroit 539 human fibroblast cells cultured in the 24 well cell culture plate without 
any other treatment were used as the blank control, and fibroblast cells cultured on the 
pure F127-DA hydrogel was used as hydrogel control. Figure 5.14 showed one 
example of the Detroit 539 human fibroblast cells cultured on the surface of 2-UArg-
2-S/F127-DA (1/4, w/w) hybrid hydrogel. As shown in Figure 5.14, compared with 
the pure F127-DA hydrogel control, the hybrid hydrogel had much higher amounts of 
the attached/proliferated fibroblast cells, and the amounts of the attached/ proliferated 
fibroblast cells were in the same level as the negative control. These cell 
morphological data were also confirmed by the MTT assay for the 
attached/proliferated fibroblast cells (Figure 5.15). Both Figures 5.14 and 5.15 showed 
that the negative and the hybrid hydrogel have the similar amounts of the attached 
Detroit 539 human fibroblast cells and both of them had the higher amounts of 
attached cells than the pure F127-DA hydrogel.   
 
      From the aspect of the fibroblast cell morphology, no significant morphology 
change was detected between the hybrid hydrogel surface (Figure 5.14 C) and the 
blank control (Figure 5.14 A) after 48 hrs’s culture. There were no visible signs of cell 
rounding or membrane blebbing which would indicate cell death. The Detroit 539 
human fibroblast cells attached onto the pure F127-DA hydrogel surface, however, did 
show some morphology change (Figure 5.14 B). From Figure 5.14 B, we could find 
that the Detroit 539 human fibroblast cells did not completely attach and spread on the 
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F127-DA hydrogel surface.  Therefore, the introduction of Arg-UPEA to Pluronic-DA 
hydrogel could enhance the hydrogel’s cell attachment and proliferation. For the 2-
UArg-2-S/F127-DA hydrogel of a feed ratio of 2 to 3, although the charge density of 
hydrogel is higher that the 2-UArg-2-S/F127-DA hydrogel with feed ratio of 1 to 4, 
the cell could not attach and proliferate on the hydrogel surface. The reason could be 
due to the decreased mechanical property of the hydrogel, further investigation is need 
for this phenomenon.  
 
      The possible reasons for the observed encouraging Detroit 539 human fibroblast 
cell attachment and proliferation data from the 2-UArg-2-S/F127-DA hybrid hydrogel 
system could be due to the excellent biocompatibility and cationic nature of the Arg-
UPEA component rather than the F127. Many reported studies have used F127 or 
F127 derivatives to fabricate hydrogels for tissue engineering applications38-46. 
However, those reported studies indicated that F127 hydrogel itself could not support 
the cell attachment/proliferation well, and many chemical modification methods have 
been applied to F127 hydrogel system to improve the cellular interaction of F127 
hydrogels38-46. For examples, Lippens et al reported using alanine modified F127 
hydrogel for mesenchymal stem cells culture46. Vashi et al also reported the stem cells 
culture on F127 hydrogel surface39. Jung et al reported using TGF-β1-conjugated 
biodegradable Pluronic F127 hydrogel for adipose-derived stem cells culture44. Park et 
al reported using chitosan-F127 hydrogels for cartilage regeneration38. Lin et al 
reported using poly (dimethyl siloxane-urethane)/Pluronic F127 for L929 fibroblast 
cell culture41. However, most of the reports indicated that the cell attachment and 
proliferation performance were not very good on the modified F127 hydrogel 
surface38-46. When compared with other reported positively charged hydrogel systems, 
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such as chemically modified PEGDA and HEMA hydrogel47, Arg-UPEA/Pluronic-DA 
hydrogel system showed much better fibroblast cell attachment performance.  
 
      Therefore, this paper reported a different chemical means to modify F127 hydrogel 
for a significant improvement of BAEC cell attachment and proliferation by the 
chemical incorporation of cationic Arg-UPEA component. These excellent cell 
attachment and proliferation performances of Arg-UPEA/F127-DA hybrid hydrogels 
suggest they may have a great potential as a new type of scaffolds for various 
biomedical applications. Of course, these cationic Arg-UPEA/Pluronic-DA hybrid 
hydrogel systems can be further improved with cell-adhesive ligands for additional 
enhanced cell adhesion. 
 
 
 
 
 
 
 
 
Figure 5.14 Representative micrographs of fibroblast cells after 48 hrs’ culture, 10x. 
A) cells cultured in 24 well cell culture plate without any treatment (control); b) cells 
cultured on the surface of pure F127-DA hydrogel; c) cells cultured on the surface of 
2-UArg-2-S/F127-DA(1/4, w/w) hydrogel. 
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Figure 5.15 MTT Assay for fibroblast cells after 48 hrs’ culture on hydrogel surface. 
2-UArg-2-S/F127-DA hydrogel had a feed weight ratio of 1 to 4. NC means negative 
control and the fibroblast cells were cultured directly in the cell culture plate.  
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5.D.8 BAEC Cell Viability inside Arg-UPEA/F127-DA Hybrid Hydrogels   
 
      In order to fully understand the effects of Arg-UPEA on long-term cell behavior, 
we tested the long term cell viability inside the Arg-UPEA/F127-DA hybrid hydrogel 
and BAEC cells were encapsulated into the hydrogel and cultured for 2 weeks at 37 
°C and 5 % CO2.  The live-dead assay was used to evaluate the BAEC cell viability 
and was performed according to the manufacturer protocol (LIVE/DEAD® Cell 
Viability Assay Kit from Invitrogen). As shown in Figure 5.16, after 2 weeks, both 
inside the pure F127-DA hydrogel and 2-UArg-2-S/F127-DA hybrid hydrogel (1:4 
weight feed ratio), almost all of the remaining encapsulated BAEC cells were viable 
and healthy (stained in green) and no remaining cells were dead or unhealthy (stained 
in red). The green dots with different sizes mean that the living BAEC cells were in 
the different sites of the hydrogel.  From Figure 5.16, we could found that the hybrid 
hydrogel had more living cells than the pure F127-DA hydrogel. So the introduction 
of Arg-UPEA to F127-DA hydrogel could help to increase long term cell viability a 
lot.  And our unpublished data showed that the purity of the precursors, 
irradiation/crosslinking time and UV power/intensity were very important for the cell 
viability. High purity and less irradiation time were suggested for the fabrication of 
cell encapsulated hydrogels. High UV power/intensity normally required less 
crosslinking time.     
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Figure 5.16 live-dead assay for BAEC cells encapsulated in the pure F127-DA 
hydrogel (A and B) and 2-UArg-2-S/F127-DA hybrid hydrogel (C and D). Green dots 
in the A and C are for the living cells and red dots in B and D are for the dead cells 
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Figure 5.17 Controlled Release of Hydralazine Chlorine Salt via Arg-UPEA/F127-DA 
Hydrogel: A, hydralazine directly mix with hydrogel precursors; B, hydralazine was 
preloaded into Hyaluronic acid/Chitosan complex; C, hydralazine was preloaded into 
Hyaluronic acid/2-UArg-2-S complex 
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      Because of the good biocompatibility, enormous surface area and 3D microporous 
network structure, hydrogels have been widely used to encapsulate cells to build 
artificial organs or for other clinical applications2, 48-52. For the fabrication of cell 
encapsulated hydrogels, many reported studies focused on the collagen or alginate 
based hydrogels, which were crosslinked by ionic interaction2, 48, 49, 53. In addition to 
the fact that they can be processed in an aqueous medium, the collagen- or alginate-
based hydrogels showed very good cell viability for the encapsulated cells2, 48, 49, 53. 
Some chemically crosslinked hydrogel systems (such as dextran and hyaluronic based 
hydrogels) have also been used for encapsulation of fibroblast and macrophage cells 
and showed good biocompatibility and cell viability50, 54. For example, Weng et al 
reported using oxidized dextran/hyaluronic acid hybrid hydrogel for the encapsulation 
of fibroblast cells and macrophage cell lines. After 3 days and one week, the live-dead 
assay results showed that the encapsulated cells still had pretty high viability50, 54 but 
with some dead cells, and the cell viability was not as good as our UArg-PEA/F127-
DA hybrid hydrogel system.  The study for a longer cell encapsulation time, such as 2 
weeks or longer, was seldom reported as we did in this study.  Therefore, the 2 week 
BAEC cell viability data in the current study offered very useful data for a longer 
duration of cell encapsulation in the hydrogel system, which is very important for 
tissue engineering area.  
 
      In this study, the newly formulated Arg-UPEA/Pluronic-DA hybrid hydrogel 
system could offer many choices in terms of water soluble precursors, cationic charge 
for better cell attachment and proliferation,, mechanical property, hydrophobicity vs. 
hydrophilicity balance, and pore size.  
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5.D.9 Controlled Release of Hydralazine (Apresoline) via Arg-UPEA/F127-DA 
Hybrid Hydrogels 
 
     Our preliminary data indicated that the Arg-UPEA/Pluronic-DA hybrid hydrogels 
had excellent biocompatibility. In order to further expand the applications of Arg-
UPEA/Pluronic-DA hybrid hydrogels, we investigated the controlled release of 
hydralazine (Apresoline) for potential wound healing and other applications. The drug 
was preloaded into the hydrogel samples (small pellet) by direct mixing and indirect 
mixing methods. For direct mixing, hydralazine directly mixed with 
precursors/initiators in distilled water before UV crosslinking.  For indirect mixing, 
hydralazine mixed with cationic polymer (such as chitosan and Arg-PEA/Arg-UPEA) 
and anionic polymer (such hyaluronic acid and alginate). Then the hydralazine would 
be loaded into the precipitated polyelectrolyte. Then the polyelectrolyte would mix 
with precursors/initiators for UV crosslinking. Figure 5.17 showed some release data 
of hydralazine via Arg-UPEA/F127-DA hydrogels in PBS buffer at 37 °C. The drug 
content was analyzed by high performance liquid chromatography (HPLC). The 
elution time of the hydralazine chlorine salt peak is around 2.35-2.37 mins, which was 
consistent with the previous reports55, 56. The release data from pure F127-DA 
hydrogel would not be discussed here. From Figure 5.17, it was found that direct 
mixing hydralazine would lead burst release; all the drugs were released within 4-6 
hours. For indirect mixing, around 20-25 % hydralazine would be released within 4-6 
hours, which means the burst release was not heavy, and the release time would be 
within one week or more than two weeks depending on the complex formation. For 
example, the HA/Chitosan complex showed a slower release trend compared with the 
Hyaluronic acid/2-UArg-2-S. The reason could be that the chitosan (Mn is around 50 
kDa) has higher molecular weight than the 2-UArg-2-S (Mn is around 15 kDa). The 
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confirmation of the chemical structure of the released hydralazine was carried out by 
LC-MS method and the major diagnostic MS fragments were analyzed (Table 5.3)55, 
56. The result showed that the released hydralazine chlorine salt did not have any 
change. 
 
Table 5.3 LC-MS Test of Released Hydralazine 
 
m/z Relative abundance Structure 
161 100% M+. 
 
5.E Conclusions  
 
      A new family of pH-sensitive and positively charged biocompatible Arg-
UPEA/Pluronic-DA hybrid hydrogel was successfully fabricated via UV-
photocrosslinking in an aqueous solution with photo-initiator. The physicochemical, 
swelling, mechanical, and morphological properties were intensively investigated. We 
demonstrated that by varying the feed ratio of Arg-UPEA to Pluronic-DA and the type 
of Arg-UPEA, we could finely tune the swelling, mechanical, and morphological 
properties of a hybrid hydrogel. These results contribute to the understanding of the 
structure-properties relationship of Arg-UPEA. Biological tests indicated that the 
introduction of Arg-UPEA to Pluronic-DA hydrogel significantly increase the cell 
attachment, proliferation and viability. And the controlled release of hydralazine was 
studied to enlarge the applications of Arg-UPEA/Pluronic-DA hybrid hydrogel, such 
as the wound healing area.   
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6.A Abstract 
 
      In order to expand the properties and applications of aliphatic polyesters and poly 
(ester amide) s (PEAs), a new biodegradable block copolymer family, poly (ester 
amide)-b-poly (ε-caprolactone) (PEA-b-PCL), were synthesized. The resulting 
copolymers would have both enzymatic biodegradation and hydrolytic degradation 
properties. These new copolymers were synthesized by first preparing L-
Phenylalanine based PEAs (Phe-PEA) with free amine end groups via the solution 
polycondensation. These amine-terminated PEAs were used to initiate the ring 
opening polymerization of the ε-caprolactone for the synthesis of the PEA-b-PCL 
copolymers. The molecular weight of the PEA-b-PCLs block copolymers could be 
well controlled by adjusting the PEA molecular weight and weight ratio of ε-
caprolactone and Phe-PEA and ranged from 7 to 50 kg/mol. The new block 
copolymers’ structure and properties were characterized by various physicochemical 
methods, such as NMR, GPC, and solubility test. To test the polymer’s processing 
capability, PEA-b-PCLs were fabricated into different formulations, such as 
microspheres and electrospun fibers. The in vitro enzymatic biodegradation and some 
biological studies of PEA-b-PCLs were conducted to assess their biological property 
like supporting for cell attachment and proliferation, and inflammation. The 
preliminary biological data showed that these new block PEA-PCL copolymers were 
nontoxic and the bovine aortic endothelial cells (BAEC) showed very good 
attachment, proliferation and low inflammation response. So the PEA-b-PCLs 
combined the favorable properties of PEA and PCL and expanded the potential 
applications in biomedical and pharmaceutical areas. The reported synthesis routes of 
PEA-b-PCL could be easily applied to other absorbable aliphatic polyesters to obtain a 
variety of PEA-b-Polyesters. 
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6.B Introduction 
 
      In the past several decades, many absorbable and biocompatible polymers have 
been developed for biotechnology and pharmaceutical industries1-7. Among them, 
absorbable aliphatic polyesters like polylactide, polyglycolide, poly(ε-caprolactone) 
and their copolymers are the most well-known and widely used because of their good 
biocompatibility, degradability, consistent mechanical and processing properties1-15.   
Although these FDA approved absorbable aliphatic polyesters have been widely used 
as scaffolds in tissue engineering, drug delivery vehicles and surgical implants, the 
rapid development of biotechnology needs the new generation polyesters or their 
derivatives with improved or expanded physicochemical, biological and mechanical 
property1-17.  
 
      In recent years, many new aliphatic polyester derivatives have been prepared to 
meet the increasing demands of biomedical field1. One such new approach is the 
incorporation of polyether segment into aliphatic polyesters like polyester-b-
polyether18-22 (e.g., PLA-b-PEG) which have been widely investigated in the areas of 
antibiofouling, self-assembly, drug/gene delivery and nanotechnology18, 19. Another 
interesting approach is to introduce the natural amino acids into these aliphatic 
polyester backbones1, 6, 15, 23-26. The incorporation of natural amino acids would bring 
these aliphatic polyesters many new properties, such as functionality and charge 
property. One example of this approach is polyester-b-poly (amino acid) s, such as 
PLA-b-PLL and PCL-b-PLL, which have been widely used as drug delivery vehicles 
and tissue engineering scaffolds15, 23, 24.However, after such a modification, many of 
aliphatic polyester derivatives or copolymers lost most of their original properties, 
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especially the very important mechanical and processing property, which largely 
limited their applications. 
 
      Therefore, a newer approach of integrating absorbable aliphatic polyester with 
amino acid containing polymers is reported in this study. Instead of using pure poly 
(amino acid)s to integrate with absorbable aliphatic polyesters, the amino acid-based 
poly (ester amide) (PEA, Figure 6.1) is used here because of their well-known 
biological property, biocompatibility and enzymatic biodegradability. Amino acid 
based PEAs are a family of newly developed biodegradable and biocompatible 
polymers with ester and amide linkages on the backbones, and have shown very low 
inflammation response and controllable biodegradability6, 27-30. The PEA backbone 
consists of nontoxic building blocks like α-amino acids, fatty diols and dicarboxylic 
acids. The variety of combinations of these 3 building blocks offer many different 
generations of PEAs for different purposes. The incorporation of PEA into 
commercially available absorbable aliphatic polyesters could be beneficial to both 
PEAs and absorbable aliphatic polyesters.  To PEAs, the integration with aliphatic 
polyesters could bring hydrolytic degradation mode in addition to enzymatic 
biodegradation mode of PEAs. Such integration could also bring stronger mechanical 
property to PEAs.  To aliphatic polyesters, the integration with PEAs could 
significantly improve the biological property of aliphatic polyesters, such as low 
inflammation and supporting cell growth. In addition, PEAs could bring useful 
functional groups like –COOH, -NH2 to aliphatic polyesters which are well-known for 
the lack of functional groups30. 
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Figure 6.1 Chemical Structure of Poly (ester amide) 
 
      In this study, we reported the synthesis, characterization and properties of such a 
new hybrid block copolymer from aliphatic polyesters and amino acid-based PEAs 
(PEA-b-PCL).  The resulting new hybrids could be fabricated into microspheres and 
electrospun fibrous membranes. These PEA-b-PCLs were also tested by many 
biological assays to determine their cellular responses, such as enzyme 
biodegradation, cell attachment, cell proliferation and in vitro inflammation assays. 
The biological data obtained suggest that these new hybrid copolymers were nontoxic 
to cells and the introduction of PEA into PCL could promote the cell attachment and 
proliferation, and significantly reduce the inflammation response of PCL.  
 
6.C Experimental 
6.C.1 Materials 
 
      L-Phenylalanine (L-Phe), p-toluenesulfonic acid monohydrate, adipoyl chloride, 
sebacoyl chloride, 1, 4-butanediol, 1, 6-hexaniol and p-nitrophenol were all purchased 
from Alfa Aesar (Ward Hill, MA) and used without further purification. ε-
carprolactone, Tin(II) 2-ethylhexanoate (Sn(Oct)2), Poly (ε-carprolactone) (PCL, Mn= 
80,000) were purchased from Aldrich and used directly. Poly (n-butyl methacrylate) 
(PBMA) was purchased from Polysciences and used directly. Triethylamine from 
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Fisher Scientific (Fairlawn, NJ) was dried by refluxing with calcium hydride, and then 
distilled before use. Solvents like toluene, ethyl acetate, acetone; 2-propanol, dimethyl 
formamide (DMF) and dimethyl sulfoxide (DMSO) were purchased from VWR 
Scientific (West Chester, PA) and were purified by standard methods before use. 
Other chemicals and reagents if not otherwise specified were purchased from Sigma 
(St. Louis, MO). 
 
      α-Chymotrypsin (Type II, from bovine pancreas, 66 units/mg, solid) was 
purchased  from Sigma Chemical Co. (St. Louis, MO) and chosen as the model 
enzyme because it could hydrolyze ester linkages at C-terminal of hydrophobic α-
amino acids like L-phenylalanine. PBS buffer (0.1M, pH 7.4) was used for the 
biodegradation study of PEA-b-PCL block copolymers.   
 
6.C.2 Synthesis of monomers and polymers 
 
      The general scheme of the synthesis of PEA-b-PCL was divided into the following 
two major tasks: 1) the synthesis of poly (ester amide)s with free amine end groups via 
a solution polycondensation; 2) the synthesis of PEA-b-PCL block copolymers 
through the ring opening polymerization of ε-caprolactone via the initiation by the free 
amine end groups of the PEA.  For the synthesis of PEA, two types of monomers were 
synthesized and then polycondensed in a solvent.  The two monomers were: di-p-
nitrophenyl ester of dicarboxylic acids (I) (Figure 6.2), and tetra-p-toluenesulfonic 
acid salts of bis (L-phenylalanine), α, ω-alkylene diesters (II) (Figure 6.3). These 2 
monomers, I and II were then polycondensed into low molecular weight PEAs having 
free amine end groups (III) (Figure 6.4). The details of the PEA monomers and 
polymer synthesis could be found in our prior publications27. The main difference 
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from the prior published procedures is the reaction time.  In this study, the reaction 
time was shorten so that low molecular weight PEAs having free amine end groups 
could be obtained. 
 
 
 
 
Figure 6.2 Synthesis of Monomer I: Di-p-nitrophenyl Ester of Dicarboxylic Acids 
 
 
 
 
 
 
 
Figure 6.3 Synthesis of Monomer II: Di-p-toluenesulfonic Acid salt of Bis (L-
Phenylalanine) Alkylene Diesters 
 
 
 
 
 
 
 
 
Figure 6.4 Synthesis of PEAs via solution polycondensation of monomers I and II. 
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6.C.2.a Synthesis of Monomers: Di-p-nitrophenyl Ester of Dicarboxylic Acids (I) 
and Di-p-toluenesulfonic Acid salt of Bis (L-Phenylalanine) Alkylene Diesters (II) 
 
      Di-p-nitrophenyl esters of dicarboxylic acids were prepared by reacting 
dicarboxylic acyl chloride varying in methylene length with p-nitrophenol as 
previously reported6, 27-32. Two monomers I were made in this study: di-p-Nitrophenyl 
Adipate (NA), x=4; and di-p-Nitrophenyl Sebacate (NS), x=8 (x indicates the numbers 
of methylene group in the diacid). The preparation of di-p-toluenesulfonic acid salt of 
bis (L-phenylalanine) alkylene diesters was also followed the previous publications6, 
27-32. Two monomers II were made in this study: tetra-p-toluenesulfonic acid salt of 
bis (L-arginine) butane diesters, Phe-4, x=4, and tetra-p-toluenesulfonic acid salt of 
bis (L-arginine) hexane diesters, Phe-6, x=6.  
 
6.C.2.b Synthesis of PEA (III) by Solution Condensation of (I) and (II) 
 
      PEAs were prepared by the solution polycondensation of the above monomers I 
and II (Phe-4, Phe-8 and NA, NS) at different combinations and molar ratios. The 
PEAs synthesized are summarized in Table 6.1 and are labeled as x-Phe-y, where x 
and yare the number of methylene group in diacid and diol, respectively. In this report, 
each type of PEA was made at two different molecular weights, one at 4-5,000; and 
another at 7-9,000.  An example of the synthesis of 8-Phe-4 of number average 
molecular weight (Mn) around 4,000 via solution polycondensation was given here. 
Monomers NS (0.8 mmol) and Phe-8 (1.0 mmol) in 1.5 mL of dry DMSO were mixed 
well and the mixture solution was then heated up to 75 °C under magnetic bar stirring 
to obtain a uniformed mixture. Triethylamine (0.31 mL, 2.2 mmol) was added drop by 
drop to the mixture at 75 °C with vigorous stirring until the complete dissolution of 
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the monomers. The solution became viscous and the color turned into yellow within 
several minutes. The reaction vial was then kept for 12 hrs at 75 °C in a thermostat 
oven without stirring. The resulting PEA polymer was precipitated from the reaction 
solution by adding 300 mL cold ethyl acetate, and the product was purified by Soxhlet 
extractor using ethyl acetate as solvent for 24 h. The final dried Phe-PEA products are 
yellow or pale yellow solid and dried in vacuo at room temperature.  
 
Table 6.1 Phe-PEAs prepared by different combination of monomers 
 
 y=4 y=6 
x=4 4-Phe-4 4-Phe-6 
x=8 8-Phe-4 8-Phe-6 
 
6.C.3 Synthesis of Phe-PEA-b-PCL 
 
       The PEA-b–PCL block copolymers were synthesized by the ring-opening 
polymerization of ε-caprolactone (ε-CL) using the free NH2 end groups of Phe-PEA as 
the macro-initiator with Sn (Oct) 2 as the catalyst (Figure 6.5). In this report, all PEAs 
used for preparing PEA-b-PCL were phenylalanine based PEAs. The polymerization 
was carried out in a 100 mL 3-neck round bottom flask under dry nitrogen atmosphere 
at 130 °C.  
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Figure 6.5 Synthesis of PEA-b-PCL from the ring-opening polymerization of ε-
caprolactone via the macro-initiator, H2N-PEA-NH2 
      
       An example of the synthesis of 8-Phe-4-b-PCL from 8-Phe-4 of Mn 4,000, and ε-
caprolactone at the 8-Phe-4 to ε-CL feed weight ratio of 1 to 6 is given here. 8-Phe-4 
(2.00 g) and ε-CL (12.00 g) were added into a 100 mL 3-neck round bottom flask 
under dry nitrogen atmosphere. The catalyst, Sn (Oct) 2, was dissolved in dried THF to 
make a 10 wt% solution and was added to the reaction mixture with a weight ratio of 
1:500 [Sn (Oct)2 to ε-CL]. Then, the temperature of the flask was increased to 130 °C 
under slow magnetic bar stirring and the duration time for the polymerization is 16 h. 
After that, the final solid product was dissolved in chloroform and precipitated in cold 
ethyl ether, purified twice, and the final product (white-yellow solid powder) was 
dried under vacuum at room temperature to constant weight. The yield is around 90-95 
%.     
 
6.C.4 Characterization  
 
      The physicochemical properties of the prepared monomers and polymers were 
characterized by various standard methods. For Fourier transform infrared (FTIR) 
characterization, the samples were ground into powders and mixed with KBr at a 
sample/KBr ratio of 1:10 (w/w). FTIR spectra were then obtained with a Perkin-Elmer 
(Madison, WI) Nicolet Magana 560 FTIR spectrometer with Omnic software for data 
H2N-PEA-NH2 + n O
O
PEA
H
N C (CH2)5 O n/2
O
H
NC
O
OH
n/2
(CH2)5 H
Sn(Oct)2
130 oC, N2
 262 
 
acquisition and analysis. NMR spectra were recorded with a Varian (Palo Alto, CA) 
Unity Inova 400-MHz spectrometer operating at 400 for 1H NMR. Deuterated 
chloroform (CHCl3-d; Cambridge Isotope Laboratories, Andover, MA) with 
tetramethylsilane as an internal standard or deuterated dimethyl sulfoxide (DMSO-d6; 
Cambridge Isotope Laboratories) was used as the solvent. MestReNova software was 
used for the data analysis. The solubility of the polymers in common organic solvents 
at room temperature was assessed by using 10.0 mg/mL as a solubility standard to 
determine whether a polymer was soluble or not in a solvent. The thermal properties 
of the synthesized PEA-b-PCLs were characterized with a DSC 2920 (TA 
Instruments, New Castle, DE). The measurements were carried out from -30 to 200 °C 
at a scanning rate of 10 °C/min and at a nitrogen gas flow rate of 25 mL/min. TA 
Universal Analysis software was used for thermal data analysis.   
 
      The number-average molecular weight (Mn), weight-average molecular weight 
(Mw), and polydispersity (MWD) of the synthesized PEAs and PEA-b-PCLs were 
determined with a model 510 gel permeation chromatograph (GPC, Waters 
Associates, Inc., Milford, United States) equipped with a high-pressure liquid 
chromatography pump, a Waters 486 UV detector, and a Waters 2410 differential 
refractive index detector. Tetrahydrofuran (THF) was used as the eluent (1.0 mL/min). 
The columns were calibrated with polystyrene standards with a narrow MWD.  
 
      The static contact angle of the polymers was measured by a Ramé-Hart Model 500 
Advanced Goniometer/Tensiometer. The round micro cover glasses (diameter, 12 mm, 
no.2,VWR, West Chester, PA) were coated with the polymer in DMF solutions (2 
wt%) and vacuum drying before testing. The static contact angle was measured by 
dropping the distilled water (4 μL) on the polymer coated surface. Each polymer 
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coating was measured for triple times.  
 
6.C.5 Formulation of PEA-b-PCL into Microspheres 
 
      PEA-b-PCL microspheres were formulated by an oil-in-water (O/W) 
emulsion/solvent evaporation technique. For the PEA-b-PCL used here, the PEA was 
from 8-Phe-4 with Mn of 4,000, and the feed weight ratio of 8-Phe-4/ ε-CL = 1:6). A 
predetermined amount of PEA-b-PCL polymer was first dissolved in 5.0 mL 
dichloromethane (DCM) or chloroform. The resultant polymer solution was then 
poured rapidly into 100.0 mL of aqueous PVA solution with a predetermined 
concentration. The O/W emulsion was achieved by a thorough stirring with a 
homogenizer (PowerGen Model 35, Fisher Scientific) at 10,000 or 20,000 rpm for 5-
10 min. The emulsified system was then stirred with a magnetic stirrer for the 
evaporation of the organic solvent (DCM or chloroform) for 3 h, the dispersed 
microdroplets finally solidified in the aqueous PVA solution. The microspheres were 
washed by the distilled water three times to remove residual PVA and then collected 
by centrifugation (13,000 rpm). After the microspheres were freeze-dried in a 
Labconco FreeZone Benchtop Freeze Dry System (Kansas City, MO) under vacuum 
at -48 °C for 72 h, they were stored in a refrigerator at 4 °C for the future 
characterizations and tests.  
 
6.C.6 Formulation of Phe-PEA-b-PCL into Microfibers by Electrospun Method 
 
      A mixed solvent of chloroform and DMF with a weight ratio of 4.0 (chloroform/ 
DMF) was used to dissolve the PEA-b-PCL to form a 20 wt% polymer solution. For 
the PEA-b-PCL used here, the PEA was from 8-Phe-4 with Mn of 4,000, and the feed 
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weight ratio of 8-Phe-4/ ε-CL = 1:6). The polymer solution was delivered by a 
programmable pump (Harvard Apparatus, MA) to the exit hole of the electrode 
(needle with a hole having a diameter of 0.7 mm). The flow rate was set at 50.0 µL 
/min. A positive high-voltage supply (Glassman High Voltage Inc.) was used to 
supply the voltage in a range of 15-20 kV. The fibers were collected on a collection 
plate. The distance of electric field (from the electrode to collector) was fixed at 120 
mm. Scanning electron microscopy (SEM) was used to examine the surface 
morphology of PEA-b-PCL microspheres and electrospun fibers. The dried 
microsphere or fiber samples were fixed on aluminum stubs and coated with gold 
under vacuum for 30 s for SEM observation (Leica S440, Germany). 
 
6.C.7 In Vitro Enzymatic Biodegradation of PEA-b-PCL 
 
      Polymer film samples (around 200 mg, round shape and same thickness) was 
added into a small vial containing 10 mL of PBS buffer (pH= 7.4, 0.1 M) with T. The 
mixture was then incubated at 37 °C with a constant reciprocal shaking (ca. 100 rpm). 
At the end of predetermined period, the polymer film samples were removed by 
filtration, then washed with distilled water for 3 times, and dried in vacuum at 35 °C 
for 24 h to completely remove the residue water. The immersion media were refreshed 
at every test time and every 48 h in order to maintain the enzymatic activity. The 
degree of biodegradation was estimated from the weight loss of the polymer based on 
the following equation:  
Wt ( % ) = ( Wo- Wt )/ Wo ×100 
Where Wo is the original weight of the dry polymer sample before immersion, and Wt 
is the dry polymer sample weight after incubation for t hours/days (with or without 
enzyme). The averaged weight loss of three specimens was measured for each sample.  
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6.C.8 Cell Culture  
 
      The interaction of PEA-b-PCLs with cells was preliminarily studied to determine 
the level of cell attachment, proliferation and inflammation. Bovine Aorta Endothelial 
Cells (BAEC) was used as the model cells for attachment and proliferation tests.  
BAEC were purchase from VEC Technologies and maintained at 37 °C in 5 % CO2 in 
Medium 199 (Invitrogen, Carlsbad, CA) supplemented with 10 % Fetal Clone III 
(HyClone, Logan, UT), and 1 % each of penicillin–streptomycin, MEM amino acids 
(Invitrogen, Carlsbad, CA), and MEM vitamins (Mediatech, Manassas, VA). BAECs 
were used from passages 8–12. J774 mouse peritoneal macrophages were used as the 
model cells for in vitro inflammation response tests, which were obtained from ATCC 
and cultured at 37 ºC in 5 % CO2 in DMEM supplemented with 10 % FBS. J774s 
were used from passage 5-10.  For all the cells, the cell media was changed every 2 
days. Cells were grown to 70 % confluence before splitting or harvesting. 
 
6.C.9 Cell Attachment and Proliferation on PEA-b-PCL 
 
      The evaluation of the endothelial cell attachment and proliferation capability on 
the PEA-b-PCL surface was performed by cell proliferation assay with subsequent 
MTT assay. The round micro cover glasses (diameter, 12 mm, no.2,VWR, West 
Chester, PA) were coated with polymer DMF solution (2 wt%) and vacuum drying. 
The following polymers were tested: PCL, PEA-b-PCL, mixtures of PEA and PCL. 
Commercial available PBMA was selected as the control. After drying, the polymer 
coated glass coverslips were placed onto the bottom of the 24-well cell culture plates 
and were sterilized for overnight under a UV irradiation before use.  
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      Cells at an appropriate cell density concentration (20,000 cells/well) were seeded 
onto each test well in 24-well plates (BD FalconTM, polystyrene treated) and then 
incubated in a 37 °C, 5 % CO2 incubator. Cell media was changed every day. After the 
predetermined periods (48 h and 96 h), the cell culture plates were removed from the 
incubator. Cell morphology was recorded under an optical microscope. The media 
from the wells were then aspirated, and 0.5 mL fresh media were added to each well. 
After that, 40 μL of MTT solution (5 mg/mL) was subsequently added to each well, 
followed by 4 hr incubation at 37 °C, 5 % CO2. The cell culture medium was carefully 
removed and 400 μL of acidic isopropyl alcohol (with 0.1 M HCl) was added to 
dissolve the formed formazan crystals. The plate was slightly shaken for 30 mins and 
100 μL solution was transferred from each well to a 96 well cell culture plate. Optical 
density (OD) of each well was measured at 570 nm (subtract background reading at 
690 nm) by using a microplate reader. 
 
6.C.10 In Vitro Measurement of Inflammatory Response of PEA-b-PCL  
 
      J774 macrophages were seeded at 10,000 cells/well onto 12 mm polymer-coated 
glass coverslips in 24-well tissue culture plates.  A plain glass coverslip was used as a 
negative control.  Positive controls were glass coverslips in media containing 
Lipopolysaccharide (LPS, from E. coli 0111:B4, Sigma-Aldrich, St. Louis, MO) at 
final concentrations of 1.25 µg/mL and 5 µg/mL33. A plain glass coverslip in media 
alone was used as a cell-free negative control. PEA-b-PCL (PEA was from 8-Phe-4 
with Mn of 4,000, and the feed weight ratio of 8-Phe-4/ ε-CL = 1:6) was selected for 
this test. PCL and PBMA were used as polymer control. Macrophage activation after 
48 hours incubation was measured using an ELISA kit to measure mouse TNF-α 
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release (Invitrogen, Carlsbad, CA) according to the manufacturer’s suggested protocol 
and N = 3. TNF-α concentrations were calculated from a standard curve using a 4-
parameter standard curve-fitting algorithm (Gen5 software, BioTek Instruments, 
Winooski, VT).  All samples and controls were read in duplicate on a 96-well plate 
reader at 450 nm and referenced against a chromogen blank. 
 
6.C.11 Statistics 
 
      Where appropriate, the data are presented as mean ± standard error of the mean 
calculated over at least three data points. Significant differences compared to control 
groups were evaluated by unpaired Student’s t-test or Dunnet test at p 0.05, and 
between more than two groups by Tukey’s test with or without one-way ANOVA 
analysis of variance.  JMP software (version 8.0, from SAS Company) was used for 
data analysis.  
 
6.D Results and Discussion  
6.D.1 Synthesis and Characterization of PEAs with Functional End Groups 
 
      In this study, four types of monomers (two monomers I, NA, NS; and two 
monomers II, Phe-4 and Phe-6) were synthesized according to our previously 
published procedures for preparing PEA with free amine end groups27. All these 
monomers were prepared with high yields and easily purified by re-crystallization. 
The chemical structure and purity had been confirmed by 1HNMR, FTIR and DSC. All 
the data were consistent with the published data27, 29, 34.  
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      Unlike the previous reported Phe-PEAs, which had higher molecular weight (Mn 
25-30 kg/mol measured by GPC in THF) and less active end groups, in this study, 
Phe-PEAs with active end amine groups and controlled molecular weight (MW) were 
required as a macro-initiator to successfully prepare the PEA-b-PCL via ring-opening 
polymerization.  
 
H2N-PEA-NH2 was prepared according to the reaction scheme in Figure 6.4. 
Based on the Carothers Equation [Xn= (1+r)/ (1+r-2rp)], the molecular weight and end 
functional groups of polymers made from polycondensation method could be affected 
or controlled by the following parameters: the molar ratio between 2 monomers (r = 
monomer II/monomer I in this study), reaction temperature (T) and time (t), catalyst 
type and its concentration, monomer concentration, etc. For example, according to the 
Carothers Equation, if the molar ratio r was changed, the MW of the prepared PEA 
would be affected and the end groups could be controlled. For examples, if r=1.0, the 
molecular weight will be maximum and the end groups would be one free amine 
group and one acid group; if r>1.0, the molecular weight will decrease with the 
increasing of r value, and the end groups would be 2 free acid groups; if r<1.0, the 
molecular weight will decrease with the decreasing of r value, and the end groups 
would be 2 free amine groups. The details of the relationship between r and end 
groups are summarized in Table 6.2. All these reaction parameters were intensively 
studied, and it was found that r and t were the key factors affecting the PEA MW and 
end functional groups. In this study, we only focused on r, the other parameters were 
fixed at the same values as the previous study27. After optimization, the reaction 
conditions are: reaction temperature: 70 °C; concentration of each monomer: 1.0-1.5 
mmol/mL; the reaction medium: DMA; catalyst (acid acceptor): NEt3, reaction time: 6 
h.   For r, after optimization, it was found that the MW and end functional groups have 
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the following relationships with r as shown in Table 6.3. In Table 6.3, the Phe-PEAs 
used to make PEA-b-PCL are 8-Phe-4 with r value equals to 0.8 and 0.9.   
 
      In this study, all the prepared Phe-based PEAs have 2 free NH2 end groups and 
hence the subsequent PEA-b-PCL synthesized are A-B-A type (A: PCL; B, PEA) 
block copolymer.  All the PEAs are prepared with high yields (> 80 %) under the 
optimized reaction conditions. For the chemical structure identification of the prepared 
Phe-PEAs, the structure was confirmed by DSC, 1H-NMR and FTIR spectra. The 1H-
NMR and FTIR spectra were consistent with the previous reports27.  
 
6.D.2 Synthesis and Characterization of PEA-b-PCL   
 
   As shown in Figure 6.5, the PEA-b-PCLs were prepared by ring opening 
polymerization of ε-carprolactone with H2N-PEA-NH2 as the macro-initiator and Sn 
(Oct)2 as catalyst. The polymerization conditions were optimized and it was found that 
the following conditions were good for the PEA-b-PCLs copolymer synthesis: 
reaction temperature: 130 °C; polymerization duration time: 16 h; molar ratio of 
catalyst to monomer=1:500; N2 protection. The chemical structure and molecular 
weight of the new copolymers were characterized and confirmed by 1H-NMR (Figure 
6.6) and GPC (Table 6.4). Figure 6.6 showed an example of the 1H-NMR spectrum of 
PEA-b-PCL (8-Phe-4-b-PCL synthesized from 8-Phe-4 of Mn 4.1k and PEA/ε-CL=1: 
1, w/w); all the 1H-NMR peaks of PEA-b-PCL were identified, and the integration 
area ratios were consistent with the calculated theoretical ratios. The 1H-NMR peaks 
marked with numbers from 1 to 11 are assigned to the corresponding protons of 8-Phe-
4-b-PCL as shown in Figure 6.6.   
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      For the GPC data, the GPC traces are unimodal with no signal of coexisting low or 
high molecular weight species that may be produced from uncontrolled 
polycondensation. It was found that a successfully prepared PEA-b-PCL copolymer 
only showed one main GPC peak; if the polymerization was failed or did not 
complete, the GPC would show two or more peaks. For the two peak case, one peak 
was from PCL and the other one was PCL-b-PEA, which were observed when the 
weight ratio of ε-CL to H2N-PEA-NH2 (8-Phe-4) was too large (more than 6) or the 
Mn of PEA was too big.    
 
      The key factors for the successful PEA-b-PCL synthesis are the MW and end 
functional NH2 groups of the H2N-PEA-NH2. It was found that if the Mn of H2N-PEA-
NH2 was greater than 15 kg/mol, the side reaction would happen during the synthesis 
of PEA-b-PCL and significant amounts of byproducts existed in the final product, 
which could not be separated from the PEA-b-PCL. The majority of the byproduct 
was PCL prepared from the polymerization of ε-CL monomers without PEA initiation. 
All these evidences have strongly supported the anticipated molecular structure of 
PEA-b-PCL. 
 
Table 6.2 Relationship between r and end groups of Phe-PEAs 
 
r value End groups of Phe-PEAs 
=1.0 One NH2 group and one COOH group 
>1.0 Two COOH groups 
<1.0 Two NH2 groups 
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Table 6.3 Information of some prepared Phe-PEAs 
 
PEA r Reaction 
Time(h) 
Mn (kg/mol) End Functional 
Groups 
Yield (%) 
4-Phe-4 0.8 8h 3.5-4.5 2 NH2 groups 85 
4-Phe-4 0.9 8h 7-8 2 NH2 groups 87 
4-Phe-6 0.8 8h 3.5-4.5 2 NH2 groups 93 
4-Phe-6 0.9 8h 7-8 2 NH2 groups 84 
8-Phe-4 0.8 8h 3.5-5 2 NH2 groups 91 
8-Phe-4 0.9 8h 7-9 2 NH2 groups 89 
8-Phe-6 0.8 8h 3.5-5 2 NH2 groups 85 
8-Phe-6 0.9 8h 7-9 2 NH2 groups 83 
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      Many types of PEA-b-PCL were prepared and some examples were given in Table 
6.4. The data in Table 6.4 indicate that an increase in the feed weight ratio (WR) of ε-
CL/ H2N-PEA-NH2 in the ring polymerization would lead to an increase in the Mn of 
the PEA-b-PCL obtained and was consistent with the calculated theoretical Mn (from 
the Mn of PEA (8-Phe-4) and feed weight ratio of 8-Phe-4 to ε-CL ). When the feed 
WR reached certain values (such as 1:9), the Mn of PEA-b-PCL would also reach a 
peak value and would not increase with the increasing of WR. The peak Mn values of 
PEA-b-PCL were found to be affected by the Mn of H2N-PEA-NH2 (8-Phe-4). For 
example, for 8-Phe-4 with Mn of 7-9,000, it’s around 50 kg/mol. The type of H2N-
PEA-NH2, however, did not show any obvious effect on such a molecular weight 
relationship. For this phenomenon, it’s reasonable that the PEA-b-PCL ‘s MW has 
some limitations because if the WR of ε-CL / H2N-PEA-NH2 (8-Phe-4) is too high, the 
polymerization will need longer time; and density of the active NH2 is not high 
enough, then ε-CL could be polymerized without the initiation from the NH2 of PEA. 
All the MWD of PEA-b-PCL is around the range of 1.30-1.60, which is similar to the 
MWD of Phe-PEA27.  
 
6.D.3 Solubility 
 
      The solubility of PEA-b-PCL can greatly affect their potential biomedical 
applications. All the PEA-b-PCL polymers synthesized in this study were insoluble in 
non- polar or weak polar solvent like ether and ethanol; but soluble in polar organic 
solvent like chloroform, DMF and THF (Table 6.5). The PEA-b-PCL copolymers did 
not show significant solubility difference from either the PEA or PCL. Among all the 
PEA-b-PCL copolymers, they did not show significant difference in the solubility 
property, even though these copolymers had different types of PEAs and feed weight 
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ratio to PCL. This is because the solubility difference between PCL and x-Phe-y PEA 
is not big. The PEA-b-PCLs showed similar solubility as the pure PCL since the 
majority part of the copolymer is PCL. When compared with 8-Phe-4, 8-Phe-4-b-
PCLs dissolved in acetone; while 8-Phe-4 could not.   
 
6.D.4 Static Contact Angle 
 
      The contact angle of 8-Phe-4, PEA-b-PCL (PEA was from 8-Phe-4 with Mn of 
4,000, and the feed weight ratio of 8-Phe-4/ ε-CL = 1:6), and PCL were measured and 
compared (Table 6.6). It was found that all three types of polymers showed high water 
contact angles (around or above 80 degree).  The contact angle is the angle formed by 
a liquid at the three phase boundary where the liquid, gas, and solid intersect. The 
small contact angle means that the adhesive forces are dominating, while the high 
contact angle means the cohesive forces are dominating. Based on the obtained contact 
angle data, the introduction of PEA into the PCL backbone brought about 10 % 
reduction in wettability from pure PCL (from 90.86 to 81.58o). The contact angle of 
the 8-Phe-4-b-PCL, however, is only marginally higher than the pure 8-Phe-4. 
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Table 6.4 Information of some PEA-b-PCLs 
 
 
 
 
 
 
 
 
 
 
 
 
 
PEA  Mn  
(KDa) 
PEA/ ε-CL 
(w/w) 
Mn 
(theoretical) 
Mn 
(measured)
PDI Yield 
(%) 
8-Phe-4 4.1 1:1 8.2 7.7 1.42 85 
8-Phe-4 4.1 1:3 16.4 17.2 1.55 87 
8-Phe-4 4.1 1:6 28.4 31.6 1.37 93 
8-Phe-4 4.1 1:8 36.9 32.0 1.36 81 
8-Phe-4 7.7 1:1 15.4 14.7 1.45 85 
8-Phe-4 7.7 1:2 23.1 23.7 1.41 91 
8-Phe-4 7.7 1:3 30.8 28.8 1.59 89 
8-Phe-4 7.7 1:6 53.9 45.6 1.50 94 
PCL 80.0 NA NA NA NA NA 
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Figure 6.6 1H-NMR spectrum of 8-Phe-4-b-PCL synthesized from 8-Phe-4 of Mn 
4,000 and 8-Phe-4/ε-CL=1.0:1.0, w/w) 
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Table 6.5 Solubility of PEA-b-PCLs* 
 
PEA-b-PCL 
MW 
Ethyl 
ether 
Ethanol Acetone THF Chloroform DMF DMSO 
7.7 - - - + + + + 
17.2 - - - + + + + 
31.6 - - - + + + + 
PCL - - + + + + + 
8-Phe-4 - - - + + + + 
* The PEA-b-PCLs are all 8-Phe-4-b-PCL (Mn of 8-Phe-4 is around 4,000; + means 
soluble, - means insoluble 
 
Table 6.6 static contact angle of polymers 
 
Polymer Name PCL 8-Phe-4 PEA-b-PCL(1) 
Static Angle(o) 90.86±0.77 79.62±1.03 81.58±0.94 
 
6.D.5 Thermal Property of PEA-b-PCLs  
 
      The reported melting temperature (Tm) and glass transition temperature (Tg) of 
pure PCL are around 64-65 oC and -60 oC respectively. For pure Phe-based PEA of Mn 
25,000-30,000, such as 8-Phe-4, the Tm and Tg are around 111 oC and 47 oC 
respectively27. For the 8-Phe-4-b-PCL, no obvious Tg peaks could be detected in the 
DSC scanning range from -30 oC to 150 oC.  
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      It was found that PEA-b-PCL could have 2 Tm peaks from PCL part and PEA part 
respectively. And the Tm values for PEA (8-Phe-4) part are: 98-100 oC for PEA with 
Mn around 4,000; and 110-112 oC for PEA (8-Phe-4) with Mn around 7-9,000. The 
thermal data indicated that the Tm values of PEA (8-Phe-4) part are mainly affected by 
the Mn of PEA. However, the Tm peak from the PCL part was found that it was 
significantly affected by the copolymer composition. Figure 6.7 and Table 7 showed 
an example that how the block copolymer composition affected the Tm of PCL part. 
Pure PCL and 3 types of PEA-b-PCL were selected for Tm comparison. All of the 
PEA-b-PCL were 8-Phe-4-b-PCL and Mn of 8-Phe was 4.1k. The only difference is 
that the weight ratio of ε-CL/8-Phe-4 was from 3.0 to 6.0 and 8.0.  The data in Figure 
6.7 show that the Tm value of the PCL part in the 8-Phe-4-b-PCL copolymer increased 
with an increase in the feed weight ratio of ε-CL/8-Phe-4 and this composition effect 
on the Tg is consistent with the reported polyester systems35. 
 
6.D.6 Formulation of PEA-b-PCL into Microspheres and Electrospun Fibers  
 
      In order to test the processing capability of these newly synthesized PEA-b-PCL 
copolymers, two fabrications methods, microspheres and electrospun micro/nano 
fibers, were used. Figure 6.8 is an example for the PEA-b-PCL (PEA was from 8-Phe-
4 with Mn of 4,000, and the feed weight ratio of 8-Phe-4/ ε-CL = 1:6) microspheres 
with a diameter around 1-2 µm. For the microsphere fabrication, the following 
different parameters were examined: polymer concentration, PVA concentration, and 
homogenizer speed 36. The optimized conditions for the PEA-b-PCL microspheres are: 
1 wt% PVA in 100 mL water; 10 wt% polymer in 10 mL CHCl3; homogenizer speed: 
10,000 rpm for 5-8 min. PVA and polymer concentration could affect the microsphere 
size, while lower speeds or longer time may reduce the yield or cause the aggregation.  
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Figure 6.7 the effect of the ε-caprolactone (CL) to PEA feed ratio on the melting 
temperature (Tm) of PEA-b-PCL copolymers 
 
Table 6.7 Tm and Tg of polymers 
 
Polymer Name Tm Tg 
PCL 64-65 oC -60 oC 
8-Phe-4 111oC 47 oC 
8-Phe-4-b-PCL(1/3,w/w) 55 oC NA 
8-Phe-4-b-PCL(1/6,w/w) 60 oC NA 
8-Phe-4-b-PCL(1/8,w/w) 63 oC NA 
 
Note: The thermal data of PCL37 and 8-Phe-427 are from the references.  
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Figure 6.8 SEM image of PEA-b-PCL microspheres. The PEA was from 8-Phe-4 
with Mn 4,000, and the feed weight ratio of 8-Phe-4/ ε-CL was 1:6 
 
 
 
 
 
 
 
 
Figure 6.9 SEM image of PEA-b-PCL electrospun fibers. The PEA was from 8-
Phe-4, of Mn 4,000, and the feed weight ratio of 8-Phe-4/ ε-CL was 1:6 
 
      Figure 6.9 is an example for the PEA-b-PCL electrospun micro/nano fibers with a 
fiber diameter around 0.3-1 µm. The fiber fabrication conditions were also 
optimized38.  From Figures 6.8 and 6.9, we could state the new PEA-b-PCL 
copolymers could be fabricated into different physical forms.    
 
 280 
 
6.D.7 In vitro Enzymatic Biodegradation of PEA-b-PCL 
 
      Four types of polymer films were selected for the enzymatic biodegradation study: 
8-Phe-4 (Mn=30,000), PCL (Mn= 80,000), 8-Phe-4-b-PCL (Mn of 8-Phe-4: 4,000; 
PEA/ε-CL=1:3, w/w), 8-Phe-4-b-PCL (Mn of 8-Phe-4: 4,000; PEA/ε-CL=1:6, w/w). 
Figure 6.10 showed the enzymatic biodegradation results of the 4 polymers during the 
one month period. The weight loss data show that the pure PCL film as expected did 
not biodegrade during the 1 month period, while the 8-Phe-4 film was completely 
biodegraded within 2 weeks and the linear biodegradation curve suggested that the 
biodegradation mechanism of 8-Phe-4 was of surface erosion mechanism. For the 2 
types of 8-Phe-4-b-PCL, both of them showed smaller weight loss than the pure 8-
Phe-4, but higher than the pure PCL. The 8-Phe-4-b-PCL copolymer having a higher 
PCL component (i.e., PEA/ε-CL=1:6, w/w), the block copolymer film showed almost 
no degradation, just like the pure PCL. With relatively more PEA component (PEA/ε-
CL=1:3, w/w); the block copolymer film showed almost the same weight loss pattern 
as the pure PCL. According to the previous publications27, 28, 39-41, the Phe-PEA could 
be biodegraded by α-chymotrypsin within a few days or several weeks, and the 
degradation rate depends on the enzyme concentration and the physical form of the 
PEAs (powder, particle or solid film). The weight loss data also showed that an 
introduction of PCL into PEA did significantly alter the enzymatic biodegradation 
property of PEA, and the resulting PEA-b-PCL’s degradation property became closer 
to PCL, and the level of change depended on the PEA to PCL feed ratio during the 
copolymer synthesis.  
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Figure 6.10 Effect of PEA to PCL feed ratio on the enzymatic biodegradation of the 
PEA-b-PCL copolymers. Pure PEA and PCL served as the controls. 8-Phe-4 
(Mn=30,000), PCL (Mn=80,000), 8-Phe-4-b-PCL (Mn of 8-Phe-4: 4,000; PEA/ε-
CL=1:3, w/w), 8-Phe-4-b-PCL (Mn of 8-Phe-4: 4,000; PEA/ε-CL=1:6, w/w). Enzyme 
solution is 0.2 mg/mL of α-chymotrypsin in PBS solution. 
 
6.D.8 Cell Attachment and Proliferation Assays 
 
      Six types of polymers and their copolymers and mixtures were tested here. They 
are: pure PCL, PEA/PCL (8-Phe-4 with Mn of 4,000; at the mixing ratio of 1:3; w/w), 
PEA/PCL (8-Phe-4 with Mn of 4,000; at the mixing ratio of 1:6; w/w), PEA-b-PCL (8-
Phe-4 with Mn of 4,000,PEA/ε-CL=1:3; w/w), PEA-b-PCL (8-Phe-4 with Mn of 4,000, 
PEA/ε-CL=1:6; w/w), and pure PEA (8-Phe-4, Mn=30,000). The pure PEA and PCL 
were used as the controls. From microscopic cell morphology images (Figure 9), it 
was found that after coating on the glass coverslips, the mixture of PEA/PCL could 
not form a good coating with smooth or well organized surface. Meanwhile, the pure 
0 3 6 9 12 15 18 21 24 27 30 33
0
20
40
60
80
100
Degradation Time(d)
W
ei
gh
t L
os
s(
%
)
 8-Phe-4
 PCL
 8-Phe-4-PCL(1:3)
 8-Phe-4-PCL(1:6)
 282 
 
PEA or PCL could form a good and smooth coating. For the PEA-b-PCL, the 
copolymer coating showed some organized microstructure, which could be due to the 
self-assembly happened during the drying process. The self-assembly of the 
copolymers was induced because of the chemical difference of the PEA and PCL 
segments toward dissolution and drying processes.  This surface microstructure of the 
PEA-b-PCL copolymers had been confirmed by many repeated trials.  
 
      The data in Figure 6.11 and the MTT assay (Figure 6.12) show that this self-
assembly of PEA-b-PCL copolymers did not affect BAEC cell 
attachment/proliferation.  Figure 6.11 showed that the PEA-b-PCL copolymers could 
significant increase cell attachment and proliferation when compared to pure PCL, 
almost reaching the same level as pure Phe-PEA. For PCL, the cell attachment was not 
as good as pure 8-Phe-4 and other coatings. For the PEA/PCL mixture, the cell 
attachment was poor when comparing to PEA-b-PCL. According to the previous 
reports, many types of PEA coatings could promote the cell attachment and 
proliferation30, 42-44, while pure PCL was not a very good material for this purpose45-50. 
For example, Amato et al reported the poor human osteoblasts attachment on pure 
PCL surface, while the introduction of functional groups, such as amine groups, could 
significantly improve the human osteoblasts attachment performance on modified PCL 
surface.50  The above results indicated that the cell attachment and proliferation 
performance of PCL could be significantly improved by introducing the PEA 
segments into PCL chain. The cell data also showed that the PEA-b-PCL copolymers 
have totally different cellular response from the PEA/PCL mixture. These data suggest 
that a simple coating of the PEA/PCL mixture could not improve the cellular response 
of PCL.  
 
 283 
 
      A comparison of the cell data among PEA-b-PCL, pure PCL and pure PEA shows 
that the cell data are consistent with the contact angle data (Table 6). For the pure 
PCL, the contact angle is around 91 o, while 8-Phe-4 and 8-Phe-4 have the contact 
angles of 79 o and 81 o, respectively. 8-Phe-4 has showed excellent cell attachment and 
proliferation performance. The chemical incorporation of 8-Phe-4 into PCL 
significantly changed the surface property of PCL (i.e., reduce its contact angle from 
91o to 81o), and significantly improved the cell attachment and proliferation 
performance of PCL. The 8-Phe-4-b-PCL has a similar contact angle as the pure 8-
Phe-4, so it’s not surprising that both polymers showed similar good cell attachment 
and proliferation performance.    
       
      For the proliferation tests, an increase in cell number results in an increase in the 
amount of MTT formazan formed and an increase in UV absorbance. Figure 6.12 
showed that the PCL and the PEA/PCL mixture could not support the bovine aortic 
endothelial cell (BAEC) proliferation well, while PEA-b-PCL and pure PEA could 
support the cell proliferation pretty well, and the PEA-b-PCL copolymers showed 
almost the same proliferated cell # as the pure PEA did.  Thus, the chemically 
incorporation of PEA into PCL could significantly promote the cell proliferation of 
PCL-based biomaterials. 
 
6.D.9 In Vitro Inflammatory Response of PEA-b-PCL  
 
      In this study, macrophage activation after 48 h incubation was measured using an 
ELISA kit to test mouse TNF-α production so that a quantitative inflammatory 
response could be determined. The PEA-b-PCL copolymer tested was synthesized 
from 8-Phe-4 with Mn of 4,000 at the PEA/ε-CL=1:6; w/w. PMBA was used here as a 
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control because it’s a widely used FDA approved polymer in medical devices like 
drug-eluting stents.  The in vitro inflammatory data show that PEA-b-PCL copolymer 
had a significantly lower level inflammation response than PBMA and PCL control. 
For example, from Figure 6.13, the PEA-b-PCL show only 40 pg/mL TNF-α 
production by J774 mouse macrophages from 150 pg/mL TNF-α of a pure PCL, a 
reduction to less than 1/3 of the original TNF- α production of a pure PCL.  For the 
pure PCL, Ainslie et al reported the PCL films would exhibit inflammatory response, 
although less than the lipopolysaccharide (LPS) 51. Others  reported  that the chemical 
modification of PCL, such as PLA-b-PCL-b-PEG, could decrease the PCL 
inflammation response to moderate level52 In this report, we show the PEA 
modification of PCL (PEA-b-PCL copolymer) also significantly reduced the 
inflammation of pure PCL.  It is important to know that the inflammatory data in 
Figure 6.13 also indicate that the PEA incorporated as a co-monomer unit into a 
copolymer has the capability to tame the inflammatory response induced by other 
relatively inflammatory biomaterials like PCL in this study. The very low 
inflammatory response to pure PEA-based biomaterials was also reported in other in 
vitro and in vivo studies44, 53-55.  Therefore, PEAs not only show very low level of 
inflammation by themselves but also could tame the inflammatory response induced 
by other biomaterials when PEAs are conjugated with other biomaterials. This unique 
biological property may have important impact on the developing low inflammatory 
biomaterials and medical devices.  
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Figure 6.11 Microscopic Image of attached BAEC on the polymer coatings on glass 
coverslips for 96h: (A) PCL; (B) PEA/PCL mixture (1:3; w/w) (PEA: 8-Phe-4, 
Mn=30,000); (C) PEA/PCL mixture (1:6; w/w) (PEA: 8-Phe-4, Mn=30,000); (D) PEA-
b-PCL copolymer (PEA/ε-CL=1:3; w/w) (PEA: 8-Phe-4, Mn=4,000); (E) PEA-b-PCL 
copolymer (PEA/ε-CL=1:6; w/w) (PEA: 8-Phe-4, Mn=4,000);(F) PEA (8-Phe-4, 
Mn=30,000) 
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Figure 6.12  MTT proliferation assay of BAEC on polymer coatings on glass 
coverslips (a) PCL; (b) PEA/PCL mixture (1:3; w/w ) (PEA: 8-Phe-4, Mn=30,000);(c) 
PEA/PCL mixture (1:6;w/w) (PEA: 8-Phe-4, Mn=30,000); (d) PEA-b-PCL copolymer 
(PEA/ε-CL=1:3; w/w) (PEA: 8-Phe-4, Mn=4,000); (e) PEA-b-PCL copolymer (PEA/ε-
CL=1:6; w/w) (PEA: 8-Phe-4, Mn=4,000); (f) PEA (8-Phe-4, Mn=30,000) 
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Figure 6.13 In vitro Measurement of Inflammatory Response of Polymers. J774 mouse 
macrophages were seeded on the polymer film to interact with the polymers. The 
mouse TNF-α production concentration was measured as an index of the inflammatory 
response. Blank control has no cells and negative control (NC) has the J774 mouse 
macrophages without any polymer treatment. LPS is the lipopolysaccharide.   
 
6.E Conclusion            
 
       A new biodegradable block copolymer family, PEA-b-PCL, has been successfully 
prepared and characterized. In a certain range, the molecular weight and polymer 
structure of PEA-b-PCLs could be well estimated and controlled. PEA-b-PCLs could 
be easily fabricated into different formulations, such as microspheres and electrospun 
fibers. Enzyme degradation tests showed that introducing PEA to PCL did not 
significantly change the degradation behavior of PCL. Cell attachment and 
proliferation tests showed that the PEA segment in the PEA-b-PCL could greatly 
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increase the cell attachment and proliferation performance of PCL, and could reach the 
same level as the PEA. The in vitro inflammation response test also proved that the 
PEA-b-PCL had low inflammation response. So the PEA-b-PCLs combined the 
favorable properties of PCL and PEA and expand the applications in the biomedical 
and pharmaceutical areas. The synthesis route of PEA-b-PCL could be easily applied 
to other polyester systems to obtain a variety of PEA-b-Polyesters.  
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7. A Abstract 
 
      In order to obtain a new type of positively charged and water insoluble polymer 
for biomedical applications, we reported the synthesis of a family of biodegradable L-
arginine and L-phenylalanine based hybrid poly (ester amide)s (Arg-Phe-PEAs) by 
solution polycondensation. These new cationic PEA polymers consist of 3 nontoxic 
building blocks: natural amino acids (L-arginine and L-phenylalanine), diols, and 
dicarboxylic acids.  All the prepared polymers were well characterized by standard 
physicochemical methods. Unlike the pure L-arginine based poly (ester amide)s (Arg-
PEAs), which have very good water solubility, these hybrid Arg-Phe-PEAs are water 
insoluble due to the presence of L-phenylalanine.  The static contact angle data 
showed that Arg-Phe-PEAs’ surface are much more hydrophilic compared with the 
pure L-phenylalanine based poly (ester amide)s (Phe-PEAs). In vitro biological tests 
of Arg-Phe-PEAs included enzymatic biodegradation, cell attachment and 
proliferation, and macrophage inflammation tests. The enzymatic biodegradation tests 
showed that the biodegradation rate of Arg-Phe-PEAs could be well controlled by 
changing the polymer composition.  The cell culture data indicated that the bovine 
aortic endothelial cells (BAEC) have very good cell attachment and proliferation on 
the Arg-Phe-PEA, almost same as the collagen coating. The in vitro inflammation 
tests showed that the new polymers have very low inflammation response. All these 
biological data suggest that these cationic and water insoluble Arg-Phe-PEAs could 
have great potential in the medical device coating, tissue engineering scaffolds and 
drug delivery. The synthesis route of Arg-Phe-PEAs could be easily applied to other 
amino acid based poly (ester amide) (PEA) systems to obtain a variety of water 
insoluble positively charged hybrid PEAs. 
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7.B Introduction 
 
      In recent years, due to the fast growing of biotechnology and pharmaceutical 
science, many new biodegradable and biocompatible polymers have been developed 1-
8. Among them, biodegradable amino acids based poly (ester amide)s (PEAs, Figure 
7.1) have been widely investigated due to their good biocompatibility, 
biodegradability and mechanical properties 7, 9-20. The amide and ester bonds on the 
PEA polymer backbone have provided merits of a combination of favorable properties 
of both polyesters and polyamides 7, 9-21.  Biodegradable PEAs were usually 
synthesized by polycondensation reaction of α-amino acids, aliphatic dicarboxylic 
acids and diols11. In the past few years, our group and other labs have established a 
general methodology for synthesis of PEAs through the solution polycondensation 
between di-p-toluenesulfonic acid salts of bis-(L-α-amino acid) α,ω-alkylene diesters 
(as bis-nucleophiles) and active di-p-nitrophenyl esters of dicarboxylic acids (as bis-
electrophiles) 7, 9-21. By using this well-established method, we have successfully 
obtained many different types of saturated and unsaturated PEAs and their functional 
derivatives. These PEAs have also been engineered into a variety of physical forms, 
such as fibers22 and electrospun fibrous membranes23 ,  3D microporous hydrogels17, 18  
and microspheres20. These PEAs appear to be good candidates for many biomedical 
applications ranging from surgical implants to drug/gene delivery and tissue 
engineering scaffolds 7, 9-25. The development of diverse applications for PEA has 
prompted us to design and prepare new functional PEAs. 
 
      Although PEAs consisting of different chemical structures have been synthesized 
and characterized by many research groups 7, 9-28, relatively little research efforts were 
focused on the synthesis of PEAs having pendant functional groups12, 24, 29. The 
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introduction of pendant functional groups along the polymer backbone could provide 
an efficient method of not only synthesizing more PEA derivatives but also tailoring 
the properties of PEAs including hydrophilicity, charge property, biodegradation rate 
and mechanical strength. In addition, the pendant functional groups would permit for 
chemically conjugating biologically active agents for controlled delivery. One newly 
developed synthesis method to achieve functional PEAs was based on the copolymer 
of PEA, which could introduce free amine, carboxylic acid or hydroxyl groups12, 24, 25, 
27-29. Another newly reported example is to use acidic or basic amino acids, such as the 
cationic L-arginine (Arg) to synthesize Arg-based poly (ester amide) (Arg-PEA)15, 27, 
28. However, the good water solubility of Arg-PEA restricted its applications as the 
biomaterials for biomedical devices or surgical implants.  
 
      In order to expand the applications of Arg-PEAs, we are reporting a new family of 
water insoluble and cationic hybrid Arg-Phe-PEAs. This method involves the 
polycondensation reaction of the mixture consisting of 3 different monomers: di-p-
toluenesulfonic acid diester salts of bis- (L-phenylalanine), α, ω-alkylene 
diesters/tetra-p-toluenesulfonic acid salts of bis- (L-arginine), and di-p-nitrophenyl 
ester of dicarboxylic acids. The percentage of L-arginine of the resulting PEAs could 
be controlled by the adjustment of the feed ratio of di-p-toluenesulfonic acid salts of 
bis- (L-phenylalanine) to tetra-p-toluenesulfonic acid salts of bis- (L-arginine). 
Compared with neutral pure Phe-PEAs, the new Arg-Phe-PEAs are positively 
charged. And compared with water soluble pure Arg-PEAs, the Arg-Phe-PEAs are 
water insoluble and can be processed in organic solvents. This approach could be a 
universal and simple synthetic route with a high potential utility for the preparation of 
hybrid PEAs having different pendant groups.  
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Figure 7.1 Chemical structure of poly (ester amide) 
 
7.C Experimental  
7.C.1 Materials 
 
      L-Arginine (L-Arg), L-phenylalanine (L-Phe), p-toluenesulfonic acid 
monohydrate, adipoyl chloride, sebacoyl chloride, 1, 4-butanediol, 1,6-hexaniol and p-
nitrophenol were all purchased from Alfa Aesar (Ward Hill, MA) and used without 
further purification. Poly (n-butyl methacrylate) (PBMA) was purchased from 
Polysciences (Warrington, PA) and used directly. Triethylamine from Fisher Scientific 
(Fairlawn, NJ) was dried by refluxing with calcium hydride, and then distilled before 
use. MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide), 
Phosphate-buffered saline (PBS, 0.1M, pH 7.4) were purchased from Sigma (St. 
Louis, MO).  Organic solvents like methanol, toluene, ethyl acetate, acetone, 2-
propanol and dimethyl sulfoxide (DMSO) were purchased from VWR Scientific 
(West Chester, PA) and were purified by standard methods before use. Other 
chemicals and reagents if not otherwise specified were purchased from Sigma (St. 
Louis, MO). α-Chymotrypsin (Type II, from bovine pancreas, 66 units/mg, solid) was 
purchased  from Sigma Chemical Co. (St. Louis, MO) and chosen as the model 
enzyme because it could hydrolyze ester linkages at C-terminal of hydrophobic α-
amino acids like L-phenylalanine.  
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7.C.2 Synthesis of Monomers and Polymers  
7.C.2.a Synthesis of Monomers  
 
      The general scheme of the synthesis of Arg-Phe-PEAs was divided into the 
following three major steps : the preparation of di-p-nitrophenyl ester of dicarboxylic 
acids (I) (Figure 7.2); the preparation of tetra-p-toluenesulfonic acid salts of bis (L-
arginine), α, ω-alkylene diesters,  and di-p-toluenesulfonic acid salts of bis- (L-
phenylalanine), α, ω-alkylene diesters (II) (Figure 7.3); and the synthesis of Arg-Phe-
PEAs (III) via solution polycondensation of (I) and (II) (Figure 7.4). All these three 
monomers have been synthesized in our prior studies 11.  Two types of monomer (I) 
were made: di-p-Nitrophenyl Adipate (NA), x=4; di-p-Nitrophenyl Sebacate (NS), 
x=8. x indicates the numbers of methylene group in the diacid. And four types of L-
phenylalanine or L-arginine based monomers (II) were made in this study: di-p-
toluenesulfonic acid salt of bis (L-phenylalanine) butane diesters, Phe-4, y=4; di-p-
toluenesulfonic acid salt of bis (L-phenylalanine) hexane diesters, Phe-6, y=6; tetra-p-
toluenesulfonic acid salt of bis (L-arginine) butane diesters, Arg-4-S, y=4; tetra-p-
toluenesulfonic acid salt of bis L-arginine) hexane diesters, Arg-6-S, y=6. S indicated 
that the L-arginine diester monomer was in the p-toluenesulfonic acid salt form. 
 
7.C.2.b Synthesis of Arg-Phe-PEA (III) by Solution Polycondensation of (I) and (II) 
Monomers     
     
      Arg-Phe-PEAs were prepared by the solution polycondensation of the above (I) 
and (II) monomers (Phe-4, Phe-6, Arg-4-S, Arg-6-S and NA, NS) at different 
combinations and are listed in Table 7.1. These Arg-Phe-PEAs are labeled as x-Arg-
y1-S-x-Phe-y2-z%, where x and y1/y2 are the numbers of methylene groups in diacid 
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and diol, respectively, and z% is the molar percent of L-arginine diester monomer in 
the mixture of L-arginine diester monomer and L-phenylalanine diester monomer.  For 
example, the 8-Arg-6-S-8-Phe-4-20% sample indicates that the x of this copolymer is 
8, and y1 (in Arg-block) is 6 and y2 (in Phe-block) is 4, and the molar % of L-Arg 
diester monomer II in the copolymer is 20%.  
 
      In order to simplify the PEA system for study, x was fixed in each copolymer in 
this study, suggesting only one type of monomer I, NA or NS, was used for each 
polymer. y1 is from arginine monomer II and y2 is from phenylalanine monomer II. 
One type of Phe-PEA (8-Phe-4) was also prepared here as the polymer control and its 
synthesis steps were reported previously11.   
 
      An example of the synthesis of 8-Arg-6-S-8-Phe-4-20% via a solution 
polycondensation is given here. Monomers NS (1.0 mmol), Arg-6-S (0.2 mmol) and 
Phe-4 (0.8 mmol) in 1.5 mL of dry DMSO were mixed well by vortexing. The mixture 
solution was heated up to 75 °C with stirring to obtain a uniformed mixture. 
Triethylamine (0.31 mL, 2.2 mmol) was added drop by drop to the mixture at 75 °C 
with vigorous stirring until a complete dissolution of the monomers. The solution 
color turned into yellow after several minutes. The reaction vial was then kept for 48 h 
at 75 °C in a thermostat oven without stirring. The polymer product was precipitated 
out from the solution by adding cold ethyl acetate, followed by decanted, dried and 
purified by Soxhlet extractor using ethyl acetate as solvent for 24 h. The final dried 
Arg-Phe-PEAs are yellow or pale yellow solid and dried in vacuo at room 
temperature.  
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7.C.3 Characterization 
 
       The physicochemical properties of the prepared monomers and polymers were 
characterized by various standard methods. For Fourier transform infrared (FTIR) 
characterization, the samples were ground into powders and mixed with KBr at a 
sample/KBr ratio of 1:10 (w/w). FTIR spectra were then obtained with a Perkin-Elmer 
(Madison, WI) Nicolet Magana 560 FTIR spectrometer with Omnic software for data 
acquisition and analysis. NMR spectra were recorded by a Varian Unity Inova 400-
MHz spectrometer (Palo Alto, CA). Deuterated dimethyl sulfoxide (DMSO-d6; 
Cambridge Isotope Laboratories) was used as the solvent. MestReNova software was 
used for the data analysis. The thermal properties were characterized with a DSC 2920 
(TA Instruments, New Castle, DE). The measurements were carried out from -10 to 
200 °C at a scanning rate of 10 °C/min and at a nitrogen gas flow rate of 25 mL/min. 
TA Universal Analysis software was used for thermal data analysis. The solubility of 
polymers in common organic solvents at room temperature was assessed by using 10.0 
mg/mL as solubility criteria. The static contact angle of polymers was measured by a 
Ramé-Hart Model 500 Advanced Goniometer/Tensiometer. The round micro cover 
glasses (diameter, 12 mm, no.2,VWR, West Chester, PA) were coated with a polymer 
DMF solutions (2 wt%) and vacuum drying before testing. The static contact angle 
was measured by dropping distilled water (4 μL) onto the polymer coated cover glass 
surface. An average of triplicates was used.  
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Figure 7.2 Synthesis of di-p-nitrophenyl ester of dicarboxylic acids monomer I. 
 
Table 7.1 Synthesized Arg-Phe-PEAs  
 
Monomer I Monomer II 
(L-arginine) 
Monomer II 
(L- Phenylalanine) 
Molar percent  
of L-Arg Monomer 
II 
NS Arg-4-S Phe-4 10 % 
NS Arg-4-S Phe-4 20 % 
NS Arg-4-S Phe-6 10 % 
NS Arg-4-S Phe-6 20 % 
NS Arg-6-S Phe-4 10 % 
NS Arg-6-S Phe-4 20 % 
NS Arg-6-S Phe-6 10 % 
NS Arg-6-S Phe-6 20 % 
NA Arg-4-S Phe-4 10 % 
NA Arg-4-S Phe-4 20 % 
NA Arg-4-S Phe-6 10 % 
NA Arg-4-S Phe-6 20 % 
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Figure 7.3 Synthesis of di-p-toluenesulfonic acid salt of bis (L-Phenylalanine) 
alkylene diesters and tetra-p-toluenesulfonic acid salt of bis(L-Arginine) alkylene 
diesters as monomers II. 
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Figure 7.4 Synthesis of Arg-Phe-PEAs by a solution polycondensation of monomers I 
and II at different feed ratios. 
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7.C.4 In vitro Enzymatic Biodegradation of Arg-Phe-PEA 
 
      The following polymers were selected for the in vitro enzymatic biodegradation 
tests. They were: 8-Arg-6-S-8-Phe-4-S-10%, 8-Arg-6-S-8-Phe-4-S-20% and 8-Phe-4. 
The polymer film samples (around 200 mg each, same size and thickness, round 
shape) was immersed in a small vial containing 10 mL of PBS buffer (pH= 7.4, 0.1 M) 
with or without α-chymotrypsin. The concentration of α-chymotrypsin was 0.2 
mg/mL.  The vials were then incubated at 37 °C with constant reciprocal shaking (ca. 
100 rpm). The immersion media were refreshed every time and every 2 days in order 
to maintain the enzymatic activity. After predetermined immersion duration, the 
polymer film samples were removed by filtration, washed with distilled water for 3 
times, and then dried in vacuum at 35 °C for 24 h to completely remove the residue 
water. The degree of biodegradation was estimated from the weight loss of the 
polymer film based on the following equation:  
Wt (%) = (Wo- Wt)/ Wo ×100 
Where Wo is the original weight of the dry polymer sample before immersion, and Wt 
is the dry polymer sample weight after incubation for t hours/days (with or without 
enzyme). The averaged weight loss of three specimens was measured for each sample 
(N=3) 
 
7.C.5 Cell Culture 
 
      The interaction of Arg-Phe-PEAs with cells was preliminarily studied to determine 
the level of cell attachment, proliferation and inflammation response. Bovine 
Endothelial Aorta Cells (BAECs) were used as the model cells for attachment and 
proliferation tests.  BAECs were purchase from VEC Technologies and maintained at 
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37 °C in 5 % CO2 in Medium 199 (Invitrogen, Carlsbad, CA) supplemented with 10 % 
Fetal Clone III (HyClone, Logan, UT), and 1 % each of penicillin–streptomycin, 
MEM amino acids (Invitrogen, Carlsbad, CA), and MEM vitamins (Mediatech, 
Manassas, VA). BAECs were used from passages 8–12. J774 mouse peritoneal 
macrophages were used as the model cells for in vitro inflammation response tests, 
which were obtained from ATCC and cultured at 37 ºC in 5 % CO2 in DMEM 
supplemented with 10 % FBS. J774s were used from passage 5-10.  For all the cells, 
the cell media was changed every 2 days. Cells were grown to 70 % confluence before 
splitting or harvesting. 
 
7.C.6 Cell Attachment and Proliferation Assay on Arg-Phe-PEA Coatings 
 
      The evaluation of the BAEC attachment and proliferation capability on the Arg-
Phe-PEA surface was performed by cell attachment assay followed by a MTT assay. 
The round micro cover glasses (diameter, 12 mm, no.2,VWR, West Chester, PA) were 
coated with polymer DMF solution (2 wt%) and vacuum drying. The following 
polymers were tested: PBMA, 8-Arg-6-S-8-Phe-4-20% and Phe-PEA (8-Phe-4). 
Commercially available PBMA was used as the positive control. The reason why 
PBMA was used is that PBMA has been widely used in the stent coating and other 
medical devices by some companies.30 Cell culture plate coated with collagen was 
used as negative control. After drying, the polymer coated glass coverslips were 
placed into cell culture plates and were sterilized for overnight under UV irradiation 
before use.  
 
      BAEC cells at an appropriate cell density concentration (20,000 cells/well) were 
seeded onto each test well in 24-well plates (BD FalconTM, polystyrene treated) and 
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then incubated in a 37 °C, 5 % CO2 incubator. Cell media was changed every day. 
After the predetermined periods (48 h and 96 h), the cell culture plates were removed 
from the incubator. Cell morphology was recorded under a microscope. The media 
from the wells were then aspirated, and 0.5 mL fresh media were added to each well. 
After that, 40 μL of MTT solution (5 mg/mL) was subsequently added to each well, 
followed by 4 h incubation at 37 °C, 5 % CO2. The cell culture medium was carefully 
removed and 400 μL of acidic isopropyl alcohol (with 0.1 M HCl) was added to 
dissolve the formed formazan crystal. The plate was slightly shaken for 30 mins and 
100 μL solution was transferred from each well to a 96 well cell culture plate. Optical 
density (OD) of each well was measured at 570 nm (subtract background reading at 
690 nm) by using a microplate reader. Triplicates were used in each experiment. 
 
7.C.7 In Vitro Measurement of Inflammatory Response of Arg-Phe-PEA30 
 
      J774 macrophages were seeded at 10,000 cells/well onto 12mm polymer-coated 
glass coverslips in 24-well tissue culture plates.  A plain glass coverslip was used as a 
negative control.  Positive controls were glass coverslips in media containing 
Lipopolysaccharide (LPS, from E. coli 0111:B4, Sigma-Aldrich, St. Louis, MO) at 
final concentrations of 1.25 µg/mL and 5 µg/mL.  A plain glass coverslip in media 
alone was used as a cell-free negative control. 8-Arg-6-S-8-Phe-4-20% was selected 
for this test. PBMA and PCL were used as polymer control. Macrophage activation 
after 48 h incubation was measured using an ELISA kit to measure mouse TNF-α 
release (Invitrogen, Carlsbad, CA) according to the exact manufacturer’s protocol. 
Sample TNF-α concentrations were calculated for a standard curve using a 4-
parameter standard curve-fitting algorithm (Gen5 software, BioTek Instruments, 
Winooski, VT).  N=3 for all samples.  All samples and standards were read in 
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duplicate on a 96-well plate reader at 450 nm and referenced against a chromogen 
blank. 
 
7.C.8 Statistics 
 
      Where appropriate, the data are presented as mean ± standard deviation calculated 
over at least three data points. Significant differences compared to control groups were 
evaluated by unpaired Student’s t-test or Dunnet test at p 0.05, and between more than 
two groups by Tukey’s test with or without one-way ANOVA analysis of variance. 
JMP software (version 8.0, from SAS Company) was used for data analysis. 
 
7.D Results and Discussion 
7.D.1 Synthesis and Characterization of PEAs  
 
      In this study, six types of monomers [two monomers I (NA, NS) and four 
monomers II (Phe-4, Phe-6, Arg-4-S and Arg-6-S)] were synthesized according to our 
previously published procedures11 for preparing Arg-Phe-PEAs. All these monomers 
were prepared with high yields and easily purified by re-crystallization. The chemical 
structure and purity of these 6 monomers had been confirmed by 1H-NMR, FTIR and 
melting temperature. All the monomer data were consistent with the published data11.  
 
      Arg-Phe-PEAs were prepared according to the reaction scheme in Figure 7.4. The 
reaction conditions were intensively studied and optimized in terms of reaction time, 
reaction temperature, monomer concentrations, reaction medium and catalyst. The 
final optimized reaction conditions are: reaction temperature: 75 °C; concentration of 
each monomer: 1.0-1.5 mmol/mL; the reaction medium: DMA; catalyst (acid 
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acceptor): NEt3.  All the Arg-Phe-PEAs were prepared with high yields (> 80%) under 
the optimized reaction conditions. For the chemical structure identification of the 
prepared Arg-Phe-PEAs, the polymer chemical structure was confirmed by 1H-NMR 
spectra. Figure 7.5 showed the 1H-NMR spectrum of a representative Arg-Phe-PEA 
(8-Arg-6-S-8-Phe-4-20%). All the 1H-NMR peaks of Arg-Phe-PEA were well 
identified, and the calculated Arg content is consistent with the theoretical value. The 
1H-NMR peaks marked with numbers from 1 to 20 are assigned to the corresponding 
protons as shown in Figure 7.5, which strongly supports the anticipated chemical 
structure of the Arg-Phe-PEA. 
 
7.D.2 Solubility 
 
      The solubility of Arg-Phe-PEAs can greatly affect their potential applications. All 
Arg-Phe-PEAs synthesized in this study were water insoluble (Table 7.2). The Arg-
Phe-PEAs copolymers with Arg contents ranging from 10 % to 20 % dissolved in 
DMSO and DMF, and showed some significant solubility difference from the pure 
Arg-PEA and Phe-PEA homopolymers. Compared with pure Arg-PEA, the Arg-Phe-
PEAs copolymers were water insoluble; while compared with pure Phe-PEA, they 
were insoluble in THF, chloroform.   
 
7.D.3 Static Contact Angle 
 
      The contact angle of Phe-PEA and Arg-Phe-PEA were measured and compared 
(Table 7.3). It was found that the Arg-Phe-PEAs showed significantly smaller contact 
angle values than the pure Phe-PEA homopolymer, i.e., 47 – 63% reduction due to the 
incorporation of Arg into Phe-PEAs. An increase in Arg content in the Arg-Phe-PEAs 
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(from 10% to 20%) reduced the contact angle further, i.e., more hydrophilic.  The 
contact angle is the angle formed by a liquid at the three phase boundary where the 
liquid, gas, and solid intersect. The small contact angle means that the adhesive forces 
are dominating, while the high contact angle means the cohesive forces are 
dominating. So the introducing of Arg into Phe-PEAs brought significant changes 
(from hydrophobic to hydrophilic) to the Arg-Phe-PEA polymer surface property 
(contact angle) compared with pure Phe-PEA and more L-arginine percent in the 
polymer composition made the polymer more hydrophilic. 
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Figure 7.5 1HNMR spectrum of 8-Arg-6-S-8-Phe-4-20% 
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Table 7.2 Solubility of Arg-Phe-PEA 
 
Arg-Phe-
PEAs 
Water Ethanol Acetone THF Chloroform DMF DMSO
4-Arg-4-S-
8-Phe-4-
10% 
- - - - - + + 
4-Arg-4-S-
8-Phe-4-
20% 
- - - - - + + 
8-Arg-6-S-
8-Phe-4-
10% 
- - - - - + + 
8-Arg-6-S-
8-Phe-4-
20% 
- - - - - + + 
8-Arg-6-S + - - - - + + 
4-Arg-4-S + - - - - + + 
8-Phe-4 - - - + + + + 
* The solubility of polymers was measured at 25 °C and 1.0 mg/mL was used as a 
standard to determine whether a polymer is soluble or insoluble: + means soluble, - 
means insoluble 
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7.D.4 Thermal Property of Arg-Phe-PEAs  
 
      Table 7.4 and Figure 7.6 show how the glass transition temperature (Tg) of Arg-
Phe-PEA copolymer is different from the pure Arg-PEA and Phe-PEA, and how the 
copolymer composition affected the Tg of copolymer. Figure 7.6 (plotted according to 
the Gordon-Taylor-Wood equation (k=0.21)31, 32) showed how the Tg of Arg-Phe-PEA 
copolymers depended on the Arg-PEA weight fraction in the copolymers. The 
following is the modified Gordon-Taylor-Wood equation: (Tg)Arg-Phe-PEA= [wArg-PEA. 
(Tg)Arg-PEA+ k.wPhe-PEA. (Tg)Phe-PEA]/ [wArg-PEA+ k.wPhe-PEA] 31, 32. The data in Table 7.4 
and Figure 7.6 demonstrate that the Tg value of Arg-Phe-PEA is affected by both of 
the Phe and Arg contents, and the Tg value of Arg-Phe-PEA is between the Tg values 
of pure Phe-PEA and pure Arg-PEA. Since pure Phe-PEA has a higher Tg value than 
that of a pure Arg-PEA, it’s expected that an increase in the percentage of Arg 
component in the Arg-Phe-PEA would result in a lower Tg of the hybrid Arg-Phe-PEA 
as demonstrated in Table 7.4 and Figure 7.6. Although the percentage of Arg content 
in the Arg-Phe-PEA copolymer is small (10 % or 20 %), the reduction in Tg is 
obvious. From Table 7.4, it was found that the introduction of 10% Arg content caused 
about 3 ° reduction of Tg. From Figure 7.6, we could find that the trend of Tg change 
almost has a linear relationship with the percentage of 8-Arg-6-S contents of the 
copolymer. The reason could be due to the significant change of the free volume of the 
copolymer structure as the pendant guanidine group from the Arg could increase the 
free volume of the copolymer chain and hence lower its Tg.  The PEA copolymer 
composition effect on Tg was also reported by Guo et al in their study of unsaturated 
and saturated Phe-based PEAs9. They observed the similar trend and relationship for 
the Tg dependence on the unsaturated to saturated blocks of Phe-PEA: the copolymer 
Tg value would be between the Tg value of a pure saturated and unsaturated Phe-based 
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PEAs. The main difference between Guo et al.’s system and our system is that Kai et 
al introduced an unsaturated component (C=C double bone) into the backbone of the 
Phe-based PEA9, while we used hydrophilic positively charged component (Arg 
block) to couple with the hydrophobic Phe block.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6 Tg of Arg-Phe-PEA copolymers as a function of the Arg-PEA weight 
fraction in the copolymers, plotted according to the Gordon-Taylor-Wood equation 
(k=0.21)31, 32. T=329.6 K for x=0 and T=304.7 K for x=100, x is the percentage of 8-
Arg-6-S. 
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7.D.5 In vitro Enzymatic Biodegradation of Arg-Phe-PEA 
 
Three types of polymer films were selected for the enzymatic (α-chymotrypsin, 
0.2 mg/mL) biodegradation tests. They are: 8-Phe-4, 8-Arg-4-S-8-Phe-4-10% and 8-
Arg-4-S-8-Phe-4-20%. Figure 7.7 shows the enzymatic biodegradation results of the 3 
polymers within 3 weeks period.  All 3 PEA samples show near linear weight loss 
profiles, suggestion that they were biodegraded under a surface erosion mechanism. 
From Figure 7.7, 8-Phe-4 film showed the fastest biodegradation rate as it was 
completely degraded within 12 days; the two Arg-Phe-PEA films showed the similar 
degradation profile as the 8-Phe-4, but with slightly slow rates, and the Arg-Phe-PEAs 
having a higher Arg contents  resulted in a slower biodegradation rate, e.g., 19 days 
for a complete weight loss of 8-Arg-4-S-8-Phe-4-20% vs. 15 days for 8-Arg-4-S-8-
Phe-4-10% .   
 
      According to the previous publications7, 9-11, 18-20, 33, 34, the Phe-PEA could be 
biodegraded by α-chymotrypsin within a few days to several weeks, and the 
degradation rate depends on the enzyme concentration and the type of PEAs and their 
formulation (powder, particle or solid film). Because α-chymotrypsin works for 
hydrophobic amino acid based polymers, the Arg-Phe-PEA copolymer having 
relatively more Phe contents (less Arg contents) would show a faster biodegradation 
rate. Thus, the degradation rate of this type of Arg-Phe-PEA copolymers could be 
controlled by adjusting the Arg-Phe-PEA copolymer composition. 
 
      The surface morphology changes of the Arg-Phe-PEA copolymer films upon 
biodegradation are shown in Figure 7.8. After 6 days of incubation, the 8-Arg-4-S-8-
Phe-4-20%. film showed a significant enzymatic catalyzed biodegradation as evident 
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by the appearance of visible eroded surface with many pores. After 10 days, the films 
were broken into small fragments. Kai et al also reported the investigation of 
biodegradation of ethylene glycol based Phe-PEA9, 19, the results showed that the 
enzyme degradation rate of PEAs is significantly affected by the PEA types. For 
example, within 24 hr, ethylene glycol based Phe-PEA had a weight loss for around 80 
wt %, while unsaturated PEA and saturated diol based PEA (such as 8-Phe-4) showed 
a weight loss of around 14 % and 6 %, respectively. The biodegradation data of the 
saturated diol based PEA (8-Phe-4) was consistent with our results. When comparing 
the SEM images of the enzyme biodegraded Arg-Phe-PEA films with the published 
SEM images of Phe-PEAs9, 19, similar surface morphology between these 2 polymer 
systems was observed.   
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   Table 7.3 Static contact angle of polymers 
 
Polymer Name PCL 8-Phe-4 Arg-Phe-PEA-1 
(10 % Arg) 
Arg-Phe-PEA-2 
(20 % Arg) 
Static Angle(o) 90.86±0.77 79.62±1.03 42.51±0.91 29.17±1.47 
 
 
 
 
    Table 7.4 Tg value of Phe-PEA, Arg-PEA and Arg-Phe-PEA 
 
PEA 8-Phe-4 8-Arg-6-S-8-Phe-4-
10% 
8-Arg-6-S-8-Phe-4-
20% 
8-Arg-6-
S 
Tg (°C) 48±2 45±2 42±2 32±2 
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Figure 7.7 Enzymatic biodegradation of Arg-Phe-PEA in α-chymotrypsin (0.2 
mg/mL) solution in terms of weight loss 
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Figure 7.8 SEM images of 8-Arg-4-S-8-Phe-4-20% polymer film incubated in 0.20 
mg/mL α-chymotrypsin solution at 37 °C: a, incubated for 0 days; b, incubated for 6 
days. 
 
7.D.6 Cell Attachment and Proliferation Assays 
 
      Four types of PEA-polymer coatings were tested for BAEC attachment and 
proliferation. They are: collagen, 8-Phe-4, PBMA, Arg-Phe-PEA (8-Arg-6-S-8-Phe-4-
20%). The cell culture plate coated with collagen was used here as a control and 
PBMA coated glass slide was used as a polymer control. The cell morphology data 
(Figure 7.9, 96 h) indicate that the cultured BAEC showed very good attachment and 
proliferation behavior on collagen, 8-Phe-4 and Arg-Phe-PEA coatings, while the 
PBMA could not support cell proliferation as well. When compared with collagen and 
8-Phe-4, the cell attachment performance on the Arg-Phe-PEA coating was almost at 
the same level.  
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      For the proliferation tests, an increase in cell number (cell proliferation) results in 
an increase in the amounts of MTT formazan produced and an increase in UV 
absorbance (optical density). Figure 7.10 showed that the PBMA could not support the 
BAEC proliferation well, while collagen, Arg-Phe-PEA and 8-Phe-4 could support the 
cell proliferation pretty well, and the Arg-Phe-PEA copolymer showed almost the 
same cell proliferation level as the 8-Phe-4 and collagen. The Dunnet statistical data 
analysis showed that there was no significant difference between the Arg-PEA 
treatment and the collagen control (or 8-Phe-4) at the p value of 0.05 level. So there is 
no evidence of cytotoxicity of Arg-PEAs. Therefore, based on the data from Figures 
7.9 and 7.10, the new positively charged water insoluble Arg-Phe-PEAs were nontoxic 
to the cells and could promote the cell attachment and proliferation, suggesting that 
the Arg-Phe-PEAs could be a good candidate for tissue engineering scaffold.  
 
      The excellent BAEC cell attachment and proliferation performance on Arg-Phe-
PEA surface is consistent with the reported the cationic Lys-Phe-PEA35. Horwitz et al 
reported how the surface charge property affected the BAEC cell attachment and 
proliferation35. They investigated three types of PEAs of different charge property 
(positive, neutral and negative), but with similar surface hydrophobicity (contact 
angle). Their results indicated that negatively charged PEAs could not support the 
BAEC attachment and proliferation well, while positively charged and neutral PEAs 
showed excellent BAEC attachment and proliferation35. When comparing the reported 
cationic Lys-Phe-PEA and the current cationic Arg-Phe-PEA, both have Phe-PEA 
component and positive charge, but with significant difference of the contact angle 
values (Lys-Phe-PEA is around 76° 35, while Arg-Phe-PEA is around 30-40°) 
indicating that the two types of polymers had very different hydrophobic/hydrophilic 
surface property. Thus, the similar cell attachment and proliferation performance 
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between the prior reported cationic Lys-Phe-PEA and the current cationic Arg-Phe-
PEA suggests that the surface charge property maybe the dominant factor for cell 
attachment. It is reasonable that a positively charged surface could facilitate the 
deposition of proteins necessary for cell attachment.       
 
7.D.7 In vitro Inflammatory Response of Arg-Phe-PEAs 
 
      In this study, the inflammatory responses to these new Arg-Phe-PEAs were 
assessed by examining the mouse macrophage activation after 48 hours incubation 
with polymer samples, and TNF-α released was measured by using an ELISA kit. 
PMBA was used as a polymer control because it’s a widely used FDA-approved 
biomaterial in medical devices like drug-eluting stents. PCL was also used as a 
polymer control because it is a FDA approved absorbable biomaterial.  The TNF-α 
release data in Figure 7.11 show that the positive control (LPS) showed a very high 
level inflammatory response as expected. PBMA and PCL showed medium level 
inflammation response, while Arg-Phe-PEA showed a significantly low level 
inflammation response, almost the same as the macrophage group (MΦ) without any 
treatment. The very low inflammation response will bring Arg-Phe-PEA potential 
applications for the medical device area.  
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Figure 7.9 Microscopic image of the attached BAEC on the polymer coated glass 
coverslips. 10x, and 96h: (A) PBMA coated ;(B) collagen coated; (C) 8-Phe-4 coated; 
(D) 8-Arg-6-S-8-Phe-4-20% coated; 
 
 
 
 
 
 
 
 
 
325 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10 Proliferation assay of BAEC on polymer coatings on glass coverslips (a) 
PBMA coated; (b) collagen coated;(c) 8-Phe-4 coated; (d) 8-Arg-6-S-8-Phe-4-20% 
coated 
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Figure 7.11 in vitro measurement of inflammatory response of polymers (Arg-Phe-
PEA: 8-Arg-6-S-8-Phe-4-20%) in terms of concentration of TNF-α released from J774 
macrophages 
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7.E Conclusion      
       
       A new family of water insoluble ionic and biodegradable hybrid poly (ester 
amide) copolymers (Arg-Phe-PEAs) has been successfully synthesized and 
characterized. The introduction of Arg moiety into Phe-PEAs could greatly alter the 
surface and bulk properties of Phe-PEAs, such as contact angle value and glass 
transition temperature. Enzyme biodegradation tests showed that the enzyme 
degradation rate of the Arg-Phe-PEAs was via surface-erosion mode and could be 
controlled by adjusting the Arg to Phe feed ratio during a solution polycondensation.  
In vitro cell attachment and proliferation tests showed that the new Arg-Phe-PEA 
copolymers could promote the BAEC cell attachment and proliferation as well as the 
pure Phe-PEA and collagen. The in vitro inflammatory response test indicated that the 
Arg-Phe-PEAs had very low inflammatory response when comparing with 2 
commercial FDA approved polymers. Therefore, this new Arg-Phe-PEA family could 
expand the applications of PEAs and may be good potential candidates for tissue 
engineering scaffolds and drug delivery. The synthesis route of Arg-Phe-PEA could be 
easily applied to other amino acid based PEAs.  
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APPENDICES 
 
Appendix 1: Chapter 3 Water Soluble Arginine Poly (ester amide) as Gene 
Delivery Vector and Investigation of Structure-Function Relationship  
A1.1 Transfection and cytotoxicity evaluation of SMC A10 and RSMC primary cell  
A1.1.1 MTT assay for cytotoxicity evaluation 
 
      SMC A10 and RSMC primary cells were obtained from American Tissue Culture 
Collection (ATCC). The cells were grown as recommended at 37 °C in 5 % CO2 in 
Dulbecco’s minimal essential medium (DMEM) supplemented with 10 % FBS 
(Germini, Woodland, CA) and 1 % penicillin–streptomycin solution. The evaluation 
of the cytotoxicity of Arg-PEA/DNA complexes was performed by MTT assay. 
Cultured cells were seeded at an appropriate cell density concentration (10,000 
cells/well) in 96-well plates and incubated overnight. Then the cells were treated with 
the freshly prepared aqueous Arg-PEA/DNA solutions. Cells without material treated 
were used as blank control. Cells treated with Superfect®/DNA, 
Lipofectamine2000®/DNA, PEI/DNA and PLL/DNA were used for comparison.    
After 48 h incubation, 20 μL of MTT solution (5 mg/mL) was added to each well, 
followed by 4 h incubation at 37 °C, 5 % CO2. The cell culture medium was then 
carefully removed and 200 μL of acidic isopropyl alcohol (with 0.1 M HCl) was added 
to dissolve the formed formazan crystal. The plate was slightly shaken for 20 mins to 
make sure the crystal dissolved completely.  Absorbance (OD) was measured 
immediately at 570 nm (subtract background reading at 690 nm) using a microplate 
reader (VersaMax Tunable Microplate reader Molecular Devices, USA). The cell 
viability (%) was calculated according to the following equation: 
Viability (%) = (OD570(sample)-OD620(sample))/ (OD570(control)-OD620(control)) × 100% 
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Where the OD570(control) represents the measurement from the wells treated with 
medium only and the OD570(sample) from the wells treated with various polymer/plasmid 
DNA complexes.  (Error bars represent mean + SEM, * P<0.05, number means the 
polymer/DNA weight ratio) As shown in Figure 1, the Arg-PEA treated groups 
showed comparable cell viabilities to the blank control group, while the Superfect®, 
Lipofectamine2000®, PEI and PLL treated groups showed significant reduction of cell 
viabilities. The Lipofectamine2000® and Superfect® were used as the recommendation 
of manufacture protocol. The DNA (μg): Lipofectamine2000® (μL) ratio was fixed at 
1:2.5. 
  
 
 
 
 
 
 
 
 
 
 
Figure 1 Cytotoxicity evaluation of Arg-PEA/DNA complexes by MTT assay. Control 
(blank) is the cells only without any material treatment. Various WRs of Arg-PEA to 
DNA were tested for 3 types of Arg-PEAs, from 2-Arg-3-S to 8-Arg-3-S. The 
numbers after the Arg-PEA, PEI, PLL and SF (Superfect®) name indicated the 
corresponding WR. Lipofectamine2000® and Superfect® were used as the 
recommendation of manufacture protocol.  
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A1.1.2 Firefly luciferase assay for transfection efficiency evaluation  
  
      Plasmid DNA was prepared and purified following the manufacturer’s protocol. 
Arg-PEA 1X PBS buffer solution was freshly prepared in 1.5 mL microfuge tube right 
before the transfection test (start the transfection tests within 4 hours after making the 
Arg-PEA solution). For 2-Arg-3-S, the suggested solution concentration is 50 mg/mL. 
For 8-Arg-3-S, the suggested solution concentration is 10 mg/mL. If needed, slightly 
heat the solution in 60 degree isotherm heat bath to make sure all the polymers were 
completely dissolved.  After that, vortex the solution for 5 seconds and let the polymer 
solution cool down to room temperature before making the Arg-PEA/DNA complex. 
 
      The Arg-PEA/ DNA complexes were prepared by adding the plasmid DNA 
solution with calculated volume to the freshly prepared Arg-PEA solutions to obtain 
systems with given DNA amount (1 µg/well for 24-well plate and 0.25 µg/well for 96-
well plate) and weight ratios of Arg-PEA/DNA (for 2-Arg-3-S, the optimized ratio is 
1000-3000). 2-3 weight ratios are suggested for each polymer. The following are some 
details for the complex preparation:  add the calculated  amount of DNA solution to 
polymer solution, then perform immediate pipe up and down for 3-5 seconds after 
mixing the solutions (do not vortex or centrifuge), and then equilibrate  solution in the 
cell culture hood for 20-30 minutes at room temperature (UV irradiation is suggested).  
 
      The cells were seeded at 30 x 103 /well in a 24-well plate or 5 x 103 /well in a 96-
well plate 24-48 hours before transfection (70 % confluent at transfection). For 24-
well plate, 1 μg COL (-772)/LUC or GFP DNA was formulated with the different 
Arg-PEA solutions at various weight ratios. For Superfect® control, 1 μg of plasmid 
DNA in 60 μL serum-free DMEM were supplemented with 5 μL (3 μg/ μL) of the 
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Superfect® (SF) solution according to manufacturer’s recommendation. For 
Lipofectamine2000® control, 1 μg of plasmid DNA in 50 μL serum-free DMEM were 
supplemented with 2.5 μL of the Lipofectamine2000® solution in 50 μL serum-free 
DMEM according to manufacturer’s recommendation. Immediately before 
transfection, cells were washed twice with 1X PBS, and then the 1 mL serum-free 
DMEM were added to each well. Arg-PEA/DNA complex solution and control 
solutions were then added into each well immediately, pipe up and down for 2-3 
seconds. Cells were transfected for 3-4 h (cell line) or 12-16 h (primary cells) at 37 °C 
(5 % CO2), and then the media was removed. After that, 0.5 mL of complete media for 
cell (follow the ATCC protocol) were added to each well and kept incubation. Cells 
were harvested for luciferase reading or GFP reading after 48 hours.  Luciferase assay 
was performed according to Promega’s recommendation. Briefly, cells from each well 
of a 24-well plate were lysed in 100 μL lysis buffer, transferred to a micro-tube,  and 
then centrifuged at 10 000 g for 2 min. Supernatants were collected and analyzed for 
luciferase activity. In a typical experiment 20 μL of supernatant was added to 
luminometric tubes containing 100 μL of luciferase substrate (Promega). Light 
emission was measured with a Dual-luciferase detection system for a period of 5 sec. 
the relative light units/s was determined. Triplicates were used in each experiment. 
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Figure 2 SMC A10 transfection efficiency of Arg-PEA/DNA complexes was 
expressed by firefly luciferase activity. Plasmid DNA used here was COL (-772)/Luc. 
Lipofectamine2000® was used as the recommendations of Invitrogen® protocol. 
Various WRs of Arg-PEA to DNA were tested and the number after the Arg-PEA was 
the corresponding WR. 
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A1.1.3 GFP assay 
 
 
 
 
 
 
 
 
 
Figure 3 GFP transfection efficiency of SMC A10 was recorded under fluorescence 
microscope (10X). SMC A10 cells were transfected by (A) Lipofectamine2000® and 
(B) Arg-PEA (2-Arg-3-S, WR=2,000) (4h treatment and GFP images were taken after 
48h). Lipofectamine2000® was used as the recommendations of Invitrogen® protocol 
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A1.1.4 Cell morphology (48 h, 10X) for RSMC primary cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 RSMC primary cell morphology was recorded under microscope (10X, 12 h 
treatment, pictures taken after 48h): (A) negative control, no material added;        (B) 
cells treated with 2,000 μg 2-Arg-3-S/1 μg DNA per well (24 well); (C) cells treated 
with 3.0 μL Lipofectamine2000®/1 μg DNA per well (24 well). 
 
A1.2 DNA delivery by UArg-PEA  
A1.2.1 Firefly luciferase assay for transfection efficiency evaluation of UArg-PEA  
  
      Plasmid DNA was prepared and purified following the manufacturer’s protocol. 
UArg-PEA 1X PBS buffer solution was freshly prepared in 1.5 mL microfuge tube 
right before the transfection test (start the transfection tests within 4 hours after 
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making the UArg-PEA solution). For 2-UArg-2-S, the suggested solution 
concentration is 10 mg/mL. For 2-UArg-4-S, the suggested solution concentration is 2 
mg/mL.  If needed, slightly heat the solution in 60 degree isotherm heat bath to make 
sure all the polymers were completely dissolved.  After that, vortex the solution for 5 
seconds and let the polymer solution cool down to room temperature before making 
the UArg-PEA/DNA complex. The UArg-PEA/ DNA complexes were prepared by 
adding the plasmid DNA solution with calculated volume to the freshly prepared 
UArg-PEA solutions to obtain systems with given DNA amount (1 µg/well for 24-
well plate and 0.25 µg/well for 96-well plate) and weight ratios of UArg-PEA/DNA 
(for 2-uArg-2-S, the optimized ratio is 500-2000; for 2-UArg-4-S, the ratio is 200-
500). 2-5 weight ratios are suggested for each polymer. The following are some details 
for the complex preparation:  add the calculated  amount of DNA solution to polymer 
solution, then perform immediate pipe up and down for 3-5 seconds after mixing the 
solutions (do not vortex or centrifuge), and then equilibrate  solution in the cell culture 
hood for 20-30 minutes at room temperature (UV irradiation is suggested).  
 
      The cells were seeded at 30 x 103 /well in a 24-well plate or 5 x 103 /well in a 96-
well plate 24-48 hours before transfection (70 % confluent at transfection). For 24-
well plate, 1 μg COL (-772)/LUC or GFP DNA was formulated with the different 
Arg-PEA solutions at various weight ratios. For Superfect® control, 1 μg of plasmid 
DNA in 60 μL serum-free DMEM were supplemented with 5 μL (3 μg/ μL) of the 
Superfect® (SF) solution according to manufacturer’s recommendation. For 
Lipofectamine2000® control, 1 μg of plasmid DNA in 50 μL serum-free DMEM were 
supplemented with 2.5 μL of the Lipofectamine2000® solution in 50 μL serum-free 
DMEM according to manufacturer’s recommendation. Immediately before 
transfection, cells were washed twice with 1X PBS, and then the 1 mL serum-free 
341 
 
DMEM were added to each well. UArg-PEA/DNA complex solution and control 
solutions were then added into each well immediately, pipe up and down for 2-3 
seconds. Cells were transfected for 3-4 h cell line at 37 °C (5 % CO2), and then the 
media was removed. After that, 0.5 mL of complete media for cell (follow the ATCC 
protocol) were added to each well and kept incubation. Cells were harvested for 
luciferase reading after 48 hours.  Luciferase assay was performed according to 
Promega’s recommendation. Briefly, cells from each well of a 24-well plate were 
lysed in 100 μL lysis buffer, transferred to a micro-tube,  and then centrifuged at 10 
000 g for 2 min. Supernatants were collected and analyzed for luciferase activity. In a 
typical experiment 20 μL of supernatant was added to luminometric tubes containing 
100 μL of luciferase substrate (Promega). Light emission was measured with a Dual-
luciferase detection system for a period of 5 sec. the relative light units/s was 
determined. Triplicates were used in each experiment. 
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Figure 5 SMC A10 transfection efficiency of UArg-PEA/DNA complexes was 
expressed by firefly luciferase activity. Plasmid DNA used here was COL (-772)/Luc. 
Superfect® and Lipofectamine2000® were used as the recommendations of 
manufacturer protocol. Various WRs of Arg-PEA to DNA were tested and the number 
after the UArg-PEA was the corresponding WR. 
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Appendix 2: Chapter 4 Advanced Generation of Amino Acid-based Poly (ester 
amide)s as Non-viral Gene Delivery Vector for Primary and Stem Cells and 
Structure-Function Study 
A2.1 Firefly luciferase assay for transfection efficiency evaluation of A10 SMC cell 
lines  
 
      Plasmid DNA was prepared and purified following the manufacturer’s protocol. 
Arg-PEA 1X PBS buffer solution was freshly prepared in 1.5 mL microfuge tube right 
before the transfection test (start the transfection tests within 4 hours after making the 
Arg-PEA solution). For 8-Arg-3-S, the suggested solution concentration is 10 mg/mL.  
And for 2-Arg-6E-Cl (in the viscous state), the suggested concentration is 10 mg/mL. 
If needed, slightly heat the solution in 60 degree isotherm heat bath to make sure all 
the polymers were completely dissolved.  After that, vortex the solution for 5 seconds 
and let the polymer solution cool down to room temperature before making the Arg-
PEA/DNA complex. 
 
      The Arg-PEA/ DNA complexes were prepared by adding the plasmid DNA 
solution with calculated volume to the freshly prepared Arg-PEA solutions to obtain 
systems with given DNA amount (1 µg/well for 24-well plate and 0.25 µg/well for 96-
well plate) and weight ratios of Arg-PEA/DNA (for 2-Arg-6E-CL, the ratio is 500-
1000). 2-3 weight ratios are suggested for each polymer. The following are some 
details for the complex preparation:  add the calculated  amount of DNA solution to 
polymer solution, then perform immediate pipe up and down for 3-5 seconds after 
mixing the solutions (do not vortex or centrifuge), and then equilibrate  solution in the 
cell culture hood for 20-30 minutes at room temperature (UV irradiation is suggested).  
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      The cells were seeded at 30 x 103 /well in a 24-well plate or 5 x 103 /well in a 96-
well plate 24-48 hours before transfection (70 % confluent at transfection). For 24-
well plate, 1 μg COL (-772)/LUC or GFP DNA was formulated with the different 
Arg-PEA solutions at various weight ratios. For Superfect® control, 1 μg of plasmid 
DNA in 60 μL serum-free DMEM were supplemented with 5 μL (3 μg/ μL) of the 
Superfect® (SF) solution according to manufacturer’s recommendation. For 
Lipofectamine2000® control, 1 μg of plasmid DNA in 50 μL serum-free DMEM were 
supplemented with 2.5 μL of the Lipofectamine2000® solution in 50 μL serum-free 
DMEM according to manufacturer’s recommendation. Immediately before 
transfection, cells were washed twice with 1X PBS, and then the 1 mL serum-free 
DMEM were added to each well. Arg-PEA/DNA complex solution and control 
solutions were then added into each well immediately, pipe up and down for 2-3 
seconds. Cells were transfected for 3-4 h (cells) at 37 °C (5 % CO2), and then the 
media was removed. After that, 0.5 mL of complete media for cell (follow the ATCC 
protocol) were added to each well and kept incubation. Cells were harvested for 
luciferase reading or GFP reading after 48 hours.  Luciferase assay was performed 
according to Promega’s recommendation. Briefly, cells from each well of a 24-well 
plate were lysed in 100 μL lysis buffer, transferred to a micro-tube,  and then 
centrifuged at 10 000 g for 2 min. Supernatants were collected and analyzed for 
luciferase activity. In a typical experiment 20 μL of supernatant was added to 
luminometric tubes containing 100 μL of luciferase substrate (Promega). Light 
emission was measured with a Dual-luciferase detection system for a period of 5 sec. 
the relative light units/s was determined. Triplicates were used in each experiment. 
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Figure 6 SMC A10 transfection efficiency of Arg-PEA/DNA complexes was 
expressed by firefly luciferase activity. Plasmid DNA used was COL (-772)/Luc. 
Lipofectamine2000® was used as the recommendations of Invitrogen® protocol. 
Various WRs of Arg-PEA to DNA were tested and the number after the Arg-PEAs 
was the corresponding WR. 
 
A2.2 Transfection and cytotoxicity evaluation of SVEC4-10 endothelial cell  
A2.2.1 Firefly luciferase assay for transfection efficiency evaluation  
 
      Plasmid DNA was prepared and purified following the manufacturer’s protocol. 
Arg-PEA 1X PBS buffer solution was freshly prepared in 1.5 mL microfuge tube right 
before the transfection test (start the transfection tests within 4 hours after making the 
Arg-PEA solution). For 2-Arg-3-S, the suggested solution concentration is 50 mg/mL. 
For 8-Arg-3-S, the suggested solution concentration is 10 mg/mL.  And for 2-Arg-6E-
Cl (in the viscous state), the suggested concentration is 10 mg/mL. If needed, slightly 
heat the solution in 60 degree isotherm heat bath to make sure all the polymers were 
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completely dissolved.  After that, vortex the solution for 5 seconds and let the polymer 
solution cool down to room temperature before making the Arg-PEA/DNA complex. 
 
       The Arg-PEA/ DNA complexes were prepared by adding the plasmid DNA 
solution with calculated volume to the freshly prepared Arg-PEA solutions to obtain 
systems with given DNA amount (1 µg/well for 24-well plate and 0.25 µg/well for 96-
well plate) and weight ratios of Arg-PEA/DNA (for 2-Arg-3-S, the optimized ratio is 
1000-3000; for 2-Arg-6E-CL, the ratio is 500-1000). 2-3 weight ratios are suggested 
for each polymer. The following are some details for the complex preparation:  add the 
calculated  amount of DNA solution to polymer solution, then perform immediate pipe 
up and down for 3-5 seconds after mixing the solutions (do not vortex or centrifuge), 
and then equilibrate  solution in the cell culture hood for 20-30 minutes at room 
temperature (UV irradiation is suggested).  
 
      The cells were seeded at 30 x 103 /well in a 24-well plate or 5 x 103 /well in a 96-
well plate 24-48 hours before transfection (70 % confluent at transfection). For 24-
well plate, 1 μg COL (-772)/LUC or GFP DNA was formulated with the different 
Arg-PEA solutions at various weight ratios. For Superfect® control, 1 μg of plasmid 
DNA in 60 μL serum-free DMEM were supplemented with 5 μL (3 μg/ μL) of the 
Superfect® (SF) solution according to manufacturer’s recommendation. For 
Lipofectamine2000® control, 1 μg of plasmid DNA in 50 μL serum-free DMEM were 
supplemented with 2.5 μL of the Lipofectamine2000® solution in 50 μL serum-free 
DMEM according to manufacturer’s recommendation. Immediately before 
transfection, cells were washed twice with 1X PBS, and then the 1 mL serum-free 
DMEM were added to each well. Arg-PEA/DNA complex solution and control 
solutions were then added into each well immediately, pipe up and down for 2-3 
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seconds. Cells were transfected for 3-4 h at 37 °C (5 % CO2), and then the media was 
removed. After that, 0.5 mL of complete media for cell (follow the ATCC protocol) 
were added to each well and kept incubation. Cells were harvested for luciferase 
reading or GFP reading after 48 hours.  Luciferase assay was performed according to 
Promega’s recommendation. Briefly, cells from each well of a 24-well plate were 
lysed in 100 μL lysis buffer, transferred to a micro-tube,  and then centrifuged at 10 
000 g for 2 min. Supernatants were collected and analyzed for luciferase activity. In a 
typical experiment 20 μL of supernatant was added to luminometric tubes containing 
100 μL of luciferase substrate (Promega). Light emission was measured with a Dual-
luciferase detection system for a period of 5 sec. the relative light units/s was 
determined. Triplicates were used in each experiment. 
 
 
 
 
 
 
 
 
 
 
Figure 7 SVEC4-10 endothelial cells transfection efficiency of Arg-PEA/DNA 
complexes was expressed by firefly luciferase activity. Plasmid DNA used was COL 
(-772)/Luc. Lipofectamine2000® and Superfect® (SF) was used as the 
recommendations of manufacture protocol. Various WRs of Arg-PEA to DNA were 
tested and the number after the Arg-PEAs was the corresponding WR. 
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A2.2.2 GFP assay 
 
 
 
 
 
 
 
Figure 8 GFP transfection efficiency of SVEC4-10 endothelial cells was recorded 
under fluorescence microscope (10X). SVEC4-10 endothelial cells were transfected by 
(A) Lipofectamine2000®, (B) Superfect®, (C) 2-Arg-6E-Cl-1000(4h treatment and 
GFP images were taken after 48h). Lipofectamine2000® and Superfect® were used as 
the recommendations of manufacture protocol. 
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A2.2.3 MTT assay 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 Cytotoxicity evaluation of Arg-PEEA/DNA complexes by MTT assay for 
SVEC4-10 endothelial cells. Control (blank) is the cells only without any material 
treatment. Lipofectamine2000® and Superfect® were used as the recommendation of 
manufacture protocol.  
 
A2.3 Transfection and cytotoxicity evaluation of RAW 264.7 macrophages 
A2.3.1 Firefly luciferase assay for transfection efficiency evaluation 
 
      Plasmid DNA was prepared and purified following the manufacturer’s protocol. 
Arg-PEA 1X PBS buffer solution was freshly prepared in 1.5 mL microfuge tube right 
before the transfection test (start the transfection tests within 4 hours after making the 
Arg-PEA solution). For 2-Arg-3-S, the suggested solution concentration is 50 mg/mL. 
For 8-Arg-3-S, the suggested solution concentration is 10 mg/mL.  And for 2-Arg-6E-
Cl (in the viscous state), the suggested concentration is 10 mg/mL. If needed, slightly 
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heat the solution in 60 degree isotherm heat bath to make sure all the polymers were 
completely dissolved.  After that, vortex the solution for 5 seconds and let the polymer 
solution cool down to room temperature before making the Arg-PEA/DNA complex. 
 
      The Arg-PEA/ DNA complexes were prepared by adding the plasmid DNA 
solution with calculated volume to the freshly prepared Arg-PEA solutions to obtain 
systems with given DNA amount (1 µg/well for 24-well plate and 0.25 µg/well for 96-
well plate) and weight ratios of Arg-PEA/DNA (for 2-Arg-3-S, the optimized ratio is 
1000-3000; for 2-Arg-6E-CL, the ratio is 500-1000). 2-3 weight ratios are suggested 
for each polymer. The following are some details for the complex preparation:  add the 
calculated  amount of DNA solution to polymer solution, then perform immediate pipe 
up and down for 3-5 seconds after mixing the solutions (do not vortex or centrifuge), 
and then equilibrate  solution in the cell culture hood for 20-30 minutes at room 
temperature (UV irradiation is suggested).  
 
      The RAW 264.7 macrophages cell lines were seeded at 30 x 103 /well in a 24-well 
plate or 5 x 103 /well in a 96-well plate 24-48 hours before transfection (70 % 
confluent at transfection). For 24-well plate, 1 μg COL (-772)/LUC or GFP DNA was 
formulated with the different Arg-PEA solutions at various weight ratios. For 
Superfect® control, 1 μg of plasmid DNA in 60 μL serum-free DMEM were 
supplemented with 5 μL (3 μg/ μL) of the Superfect® (SF) solution according to 
manufacturer’s recommendation. For Lipofectamine2000® control, 1 μg of plasmid 
DNA in 50 μL serum-free DMEM were supplemented with 2.5 μL of the 
Lipofectamine2000® solution in 50 μL serum-free DMEM according to 
manufacturer’s recommendation. Immediately before transfection, cells were washed 
twice with 1X PBS, and then the 1 mL serum-free DMEM were added to each well. 
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Arg-PEA/DNA complex solution and control solutions were then added into each well 
immediately, pipe up and down for 2-3 seconds. Cells were transfected for 3-4 h at 37 
°C (5 % CO2), and then the media was removed. After that, 0.5 mL of complete media 
for cell (follow the ATCC protocol) were added to each well and kept incubation. 
Cells were harvested for luciferase reading or GFP reading after 48 hours.  Luciferase 
assay was performed according to Promega’s recommendation. Briefly, cells from 
each well of a 24-well plate were lysed in 100 μL lysis buffer, transferred to a micro-
tube,  and then centrifuged at 10 000 g for 2 min. Supernatants were collected and 
analyzed for luciferase activity. In a typical experiment 20 μL of supernatant was 
added to luminometric tubes containing 100 μL of luciferase substrate (Promega). 
Light emission was measured with a Dual-luciferase detection system for a period of 5 
sec. the relative light units/s was determined. Triplicates were used in each 
experiment. 
 
 
 
 
 
 
 
 
Figure 10 RAW 264.7 macrophages transfection efficiency evaluation of Arg-
PEA/DNA complexes by firefly luciferase assay. Plasmid DNA used was COL (-
772)/Luc. Lipofectamine2000® was used as the recommendations of Invitrogen® 
protocol. Various WRs of Arg-PEA to DNA were tested and the number after the Arg-
PEAs was the corresponding WR. 
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A2.3.2 GFP assay  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 GFP transfection efficiency evaluation of RAW 264.7 macrophages under 
fluorescence microscope (10X). RAW 264.7 macrophages were transfected by (a) 
Superfect®; (b) Lipofectamine2000®; (c), 2-Arg-6E-Cl (WR=1,000); (d), 2-Arg-6E-Cl 
(WR=500). (4h treatment and GFP images were taken after 48h) 
 
A2.3.3 MTT assay 
 
       The evaluation of the cytotoxicity of Arg-PEA/DNA complexes was performed 
by MTT assay. Cultured RAW 264.7 macrophages cell lines were seeded at an 
appropriate cell density concentration (10,000 cells/well) in 96-well plates and 
incubated overnight. Then the cells were treated with the freshly prepared aqueous 
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Arg-PEA/DNA solutions. Cells without material treated were used as blank control. 
Cells treated with Superfect®/DNA, Lipofectamine2000®/DNA, PEI/DNA and 
PLL/DNA were used for comparison.    After 48 h incubation, 20 μL of MTT solution 
(5 mg/mL) was added to each well, followed by 4 h incubation at 37 °C, 5 % CO2. 
The cell culture medium was then carefully removed and 200 μL of acidic isopropyl 
alcohol (with 0.1 M HCl) was added to dissolve the formed formazan crystal. The 
plate was slightly shaken for 20 mins to make sure the crystal dissolved completely.  
Absorbance (OD) was measured immediately at 570 nm (subtract background reading 
at 690 nm) using a microplate reader (VersaMax Tunable Microplate reader Molecular 
Devices, USA). The cell viability (%) was calculated according to the following 
equation: 
Viability (%) = (OD570(sample)-OD620(sample))/ (OD570(control)-OD620(control)) × 100% 
Where the OD570(control) represents the measurement from the wells treated with 
medium only and the OD570(sample) from the wells treated with various polymer/plasmid 
DNA complexes.  (Error bars represent mean + SEM, * P<0.05, number means the 
polymer/DNA weight ratio) 
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Figure 12 Cytotoxicity evaluation of Arg-PEA/DNA complexes by MTT assay. 
Control (blank) was cells only without any material treatment. Various WRs of Arg-
PEA to DNA were tested. RAW 264.7 macrophages were treated by Arg-PEA/DNA 
complex for 4h. The number after the Arg-PEAs was the corresponding WR. 
Lipofectamine2000® and Superfect® were used as the recommendation of 
manufacturer protocol.   
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A2.3.4 Cell morphology (48 h, 10X) for RAW 264.7 macrophages cells 
 
 
 
 
 
 
 
Figure 13 RAW 264.7 macrophages cell morphology under microscope (10X, 12 h 
treatment, picture taken after 48h). Cells were treated by 2-Arg-6E-Cl/DNA complex 
(WR=2000/1) at a concentration of 2 mg/mL for 4h  
 
A2.4 Transfection and cytotoxicity evaluation of rat aortic fibroblast primary cell 
 
      Plasmid DNA was prepared and purified following the manufacturer’s protocol. 
Arg-PEA 1X PBS buffer solution was freshly prepared in 1.5 mL microfuge tube right 
before the transfection test (start the transfection tests within 4 hours after making the 
Arg-PEA solution). And for 2-Arg-6E-Cl (in the viscous state), the suggested 
concentration is 10 mg/mL. If needed, slightly heat the solution in 60 degree isotherm 
heat bath to make sure all the polymers were completely dissolved.  After that, vortex 
the solution for 5 seconds and let the polymer solution cool down to room temperature 
before making the Arg-PEA/DNA complex. 
 
      The Arg-PEA/ DNA complexes were prepared by adding the plasmid DNA 
solution with calculated volume to the freshly prepared Arg-PEA solutions to obtain 
systems with given DNA amount (1 µg/well for 24-well plate and 0.25 µg/well for 96-
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well plate) and weight ratios of Arg-PEA/DNA (for 2-Arg-6E-CL, the ratio is 500-
1000). 2-3 weight ratios are suggested for each polymer. The following are some 
details for the complex preparation:  add the calculated  amount of DNA solution to 
polymer solution, then perform immediate pipe up and down for 3-5 seconds after 
mixing the solutions (do not vortex or centrifuge), and then equilibrate  solution in the 
cell culture hood for 20-30 minutes at room temperature (UV irradiation is suggested).  
 
      The rat aortic fibroblast primary cells were seeded at 30 x 103 /well in a 24-well 
plate or 5 x 103 /well in a 96-well plate 24-48 hours before transfection (70 % 
confluent at transfection). For 24-well plate, 1 μg COL (-772)/LUC or GFP DNA was 
formulated with the different Arg-PEA solutions at various weight ratios. For 
Superfect® control, 1 μg of plasmid DNA in 60 μL serum-free DMEM were 
supplemented with 5 μL (3 μg/ μL) of the Superfect® (SF) solution according to 
manufacturer’s recommendation. Immediately before transfection, cells were washed 
twice with 1X PBS, and then the 1 mL serum-free DMEM were added to each well. 
Arg-PEA/DNA complex solution and control solutions were then added into each well 
immediately, pipe up and down for 2-3 seconds. Cells were transfected for 3-4 h at 37 
°C (5 % CO2), and then the media was removed. After that, 0.5 mL of complete media 
for cell (follow the ATCC protocol) were added to each well and kept incubation. 
Cells were harvested for GFP reading after 48 hours.   
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A2.4.1 GFP assay 
 
 
 
 
 
 
 
 
 
Figure 14 GFP transfection efficiency evaluation of rat aortic fibroblast primary cell 
under fluorescence microscope (10X). Rat aortic fibroblast primary cells were 
transfected by Superfect® and 2-Arg-6E-Cl (WR=1,000). (4h treatment and GFP 
images were taken after 48h) 
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A2.4.2 Cell morphology (48 h, 10X) for rat aortic fibroblast primary cell 
 
 
 
 
 
 
 
 
 
Figure 15 Rat aortic fibroblast primary cell morphology under microscope (10X, 12 h 
treatment, picture taken after 48h). Cells were treated by 2-Arg-6E-Cl/DNA complex 
(WR=1000/1) at a concentration of 2 mg/mL for 4h. 
 
A2.5 Inflammation assay for Arg-PEA/DNA complex  
 
      The details of inflammation assay protocol exactly followed the manufacturer’s 
protocol (TNF-α Mouse ELISA Kit of Invitrogen®). Figure 16 showed the evaluation 
of in vitro inflammation response of Arg-PEA/DNA complexes. The amount of nitrite 
(NO) produced from RAW macrophages was measured as the index of inflammation 
responses. Higher NO amount means the more severe inflammation response, while 
lower NO amount means the less inflammation response. The RAW macrophages 
were treated for 28 h. CpG DNA and Non CpG DNA were used as the controls.  From 
Figure 16, it was found that compared with CpG DNA, the pure Arg-PEA polymers, 
including 2-Arg-3-S and 2-Arg-6E-Cl, caused much less inflammation response. And 
the NO production of Arg-PEA groups showed no significant difference from the non 
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CpG DNA group. Further investigation showed that compared with CpG DNA group, 
the Arg-PEA/ CpG DNA complex group caused less inflammation response, which 
indicated that when Arg-PEA formed complex with CpG DNA, the inflammation 
response of CpG DNA would be significantly reduced. Between the two Arg-PEA 
groups, 2-Arg-6E-Cl group showed much better inflammation response reduction 
performance than 2-Arg-3-S group. For the Arg-PEA/ Non CpG DNA complexes, 
they showed decreased inflammation response compared with Non CpG DNA, but the 
difference is not as significant as the CpG group. 
 
 
 
 
 
 
 
 
Figure 16 Nitrite production from RAW macrophages after 28 hrs’ treatment. Ctrl: 
Control, no Arg-PEA or DNA added; CpG; the plasmid DNA causing severe 
inflammation response; Non CpG: the plasmid DNA causing no severe inflammation 
response; The DNA amount was fixed at 1 µg/well for 24 well cell culture plate. The 
number after the Arg-PEA/DNA complex is the weight ratio of Arg-PEA to DNA 
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Appendix 3: Chapter 5 Arginine-based Poly (ester amide)s and Pluronic 
Diacrylate Cationic Hybrid Hydrogel for Tissue Engineering and Drug Delivery 
Applications 
A3.1 BAEC and fibroblast cell attachment on hydrogel surface 
 
      Bovine endothelial aorta cells (BAECs) were purchased from VEC Technologies, 
kindly offered by Professor Cynthia Reinhart-King at Department of Biomedical 
Engineering of Cornell University. BAECs were cultured at 37 °C in 5 % CO2 in 
Medium 199 (Invitrogen, Carlsbad, CA) supplemented with 10 % Fetal Clone III 
(HyClone, Logan, UT), and 1 % each of penicillin–streptomycin, MEM amino acids 
(Invitrogen, Carlsbad, CA), and MEM vitamins (Mediatech, Manassas, VA). BAECs 
were used from passages 8–12. Media was changed every 2 days. BAEC were grown 
to 70 % confluence before splitting or harvesting. Cell culture plates were coated with 
2 wt% gelatin aqueous solution before using. 
 
      The cell attachment and proliferation on the Arg-UPEA/PluronicDA/PEGDA 
hybrid hydrogel surfaces was evaluated by cell morphology. Pure PluronicDA or 
PluronicDA/PEGDA hybrid hydrogel was selected as the hydrogel control and the cell 
culture plate without any treatment was used as the negative control.  The cells used 
for this study were BAEC cells. The purified hydrogels were cut into round shape with 
the diameter that just filled the well of 24-well cell culture plates.  Before being put 
into the 24-well cell culture plates, the hydrogels were sterilized under UV light (from 
the cell culture hood) for 1 h. After that, the hydrogels were washed twice by PBS 
buffer and cell culture media. Then, the hydrogels were placed into the wells of the 
cell culture plate and fixed by sterilized rubber ring which has the same diameter as 
the well of cell culture plate. BAEC cells were seeded at an appropriate cell density 
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(10,000 cells/well) and incubated overnight. After 48 h incubation, the cell attachment 
and proliferation on the hydrogel surface was record by an optical microscope.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Representative micrographs of BAEC cells after 48 hrs’ culture on the 
hydrogel surface.10x. (A) F68-PEG700 (3/1, w/w); (B) F127-PEG700 (3/1, w/w); (C) 
F127-PEG700-2-UArg-2-S(3/1/1, w/w/w); (D) F127-PEG700-2-UArg-2-S(4.5/1.5/4, 
w/w/w).  
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Figure 18 Representative micrographs of BAEC cells after 48 hrs’ culture on the 
collagen treated hydrogel surface. Hydrogel was treated with collagen by soaking in 
2% collagen water solution for 5 mins.  10x. (A) F68-PEG700 (3/1, w/w) ;(B) F127-
PEG700 (3/1, w/w); (C) F127-PEG700-2-UArg-2-S(3/1/1, w/w/w); (D) F127-
PEG700-2-UArg-2-S(4.5/1.5/4, w/w/w).  
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Figure 19 Representative micrographs of Human Detroit 539 fibroblast cells after 48 
hrs’ culture on the hydrogel (F68-PEG700 (3:1/w: w)) surface. 10x.   
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
364 
 
Appendix 4:  Chapter 6-Poly (ester amide)-b-Poly (ε-caprolactone): Synthesis, 
Characterization, Formulation, and In Vitro Cellular Response  
A4.1 Materials  
 
      L-Phenylalanine (L-Phe), p-toluenesulfonic acid monohydrate (TosOH.H2O), 
adipoyl chloride, sebacoyl chloride, 1, 4-butanediol, 1,6-hexanediol and p-nitrophenol 
were all purchased from Alfa Aesar (Ward Hill, MA) and used without further 
purification. Triethylamine from Fisher Scientific (Fairlawn, NJ) was dried by 
refluxing with calcium hydride, and then distilled before use. Solvents like toluene, 
ethyl acetate, acetone, 2-propanol; N, N-dimethylacetamide (DMA) and dimethyl 
sulfoxide (DMSO) were purchased from VWR Scientific (West Chester, PA) and 
were purified by standard methods before use. Other chemicals and reagents if not 
otherwise specified were purchased from Sigma (St. Louis, MO). 
 
A4.2 Synthesis of PEAs 
 
      The preparation of PEAs involved the following three basic steps: (1) the synthesis 
of monomer I: di-p-nitrophenyl esters of dicarboxylic acids; (2) the synthesis of 
monomer II: di-p-toluenesulfonic acid salts of bis-L-phenylalanine esters; (3) the 
synthesis of PEAs via the solution polycondensation of monomers I and II. For PEA 
monomers, the synthesis steps were exactly followed the reported methods. About the 
synthesis of PEAs, different polymerization conditions were evaluated. In the report, 
we mainly focused on the effects of molar ratios of monomers (r=I/II) and 
polymerization time. Other conditions and steps were exactly followed the reported 
references.   
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A4.3 Material characterization 
 
      The chemical structures of the synthesized monomers and polymers were 
characterized with standard chemical methods. For Fourier transform infrared (FTIR) 
characterization, the samples were ground into powders and mixed with KBr at a 
sample/KBr ratio of 1:10 (w/w). FTIR spectra were then obtained with a PerkinElmer 
(Madison, WI) Nicolet Magana 560 FTIR spectrometer with Omnic software for data 
acquisition and analysis. NMR spectra were recorded with a Varian (Palo Alto, CA) 
Unity Inova 400-MHz spectrometer operating at 400 and 100 MHz for 1H and 13C 
NMR, respectively. Deuterated chloroform (CDCl3-d1; Cambridge Isotope 
Laboratories, Andover, MA; for NA and NS) with tetramethylsilane as an internal 
standard or deuterated dimethyl sulfoxide (DMSO-d6; Cambridge Isotope 
Laboratories; for NA, NS, PB and All polymers) was used as the solvent.  The 
number-average molecular weight (Mn), weight-average molecular weight (Mw), and 
molecular weight distribution (MWD) of the synthesized  polymers  were determined 
with a model 510 gel permeation chromatograph (Waters Associates, Inc., Milford, 
United States) equipped with a high-pressure liquid chromatography pump, a Waters 
486 UV detector, and a Waters 2410 differential refractive index detector. 
Tetrahydrofuran (THF) was used as the eluent (1.0 mL/min). The columns were 
calibrated with polystyrene standards with a narrow MWD.  
 
A4.4 Results and discussion 
 
      The following two PEAs were selected for this study: 4-Phe-4 and 8-Phe-4. First, 
the two polymers were investigated for the relationship between Mn and 
polymerization time (h) at the monomer molar ratio of I /II (r=NS/PB) of 1.0. Figure 
366 
 
20 showed the Mn-Time curve of polymerization of 4-Phe-4 and Figure 21 showed the 
Mn-Time curve of polymerization of 8-Phe-4. Both figures indicated that at the 
beginning several hours, the Mn of PEA significantly increased with a very fast speed. 
After that, the Mn of PEA would slowly increase for a few more hours. The whole Mn 
increasing time would be around 10-15 h. Then the Mn of PEA would be at a constant 
value, which is around 20-30 Kg/mol, depending on the PEA type. For 4-Phe-4, it’s 
around 22 Kg/mol, while for 8-Phe-4, it’s around 25 Kg/mol.      
 
 
 
 
 
 
 
 
 
 
 
Figure 20 Mn-Time curve of polymerization of 4-Phe-4 with r=1.00 
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Figure 21 Mn-Time curve of polymerization of 8-Phe-4 with r=1.00  
       
      Then we continued to investigate the 8-Phe-4 for the relationship between Mn and 
polymerization time (h) at the monomer molar ratios of I /II (r=NS/PB) other than 1.0. 
Two molar ratios, 0.9 and 0.8 were selected.  Figure 22 and 23 showed the Mn-Time 
curve of polymerization of 8-Phe-4 with molar ratios of 0.9 and 0.8, respectively. The 
figures showed that within the beginning 1 hour, the Mn of PEA almost immediately 
reached a constant value, depending on the molar ratio. For r=0.90, it’s around 7 
Kg/mol, while for r=0.80, it’s around 4 Kg/mol. After that, the PEA Mn would not 
change. The Mn increasing trend and final Mn value of PEAs were reproducible.       
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Figure 22 Mn-Time curve of polymerization of 8-Phe-4 with r=0.90  
 
 
 
 
 
 
 
 
 
 
 
Figure 23 Mn-Time curve of polymerization of 8-Phe-4 with r=0.80  
 
      Figure 24 showed the Mn-Time curve of polymerization of 8-Phe-4-b-PCL with a 
weight ratio of 1 to 6 for 8-Phe-4 to ε-CL and the Mn of 8-Phe-4 is around 4,000 
369 
 
Kg/mol. And Figure 25 showed the Mn-Time curve of polymerization of 8-Phe-4-b-
PCL with a weight ratio of 1 to 6 for 8-Phe-4 to ε-CL and the Mn of 8-Phe-4 is around 
7,000 Kg/mol. Both figures showed that at the beginning several hours, the Mn of 
PEA-b-PCL significantly increased with a very fast speed. After that, the Mn of PEA-
b-PCL would slowly increase for a few more hours. The whole Mn increasing time 
would be around 15-25 h. Then the Mn of PEA would be at a constant value, which 
depends on the Mn of PEA. Higher Mn of PEA would cause higher Mn of PEA-b-PCL. 
 
 
 
 
 
 
 
 
 
 
 
Figure 24 Mn-Time curve of polymerization of 8-Phe-4-b-PCL (8-Phe-4 with Mn of 
4k, 8-Phe-4/ε-CL=1/6, w/w) 
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Figure 25 Mn-Time curve of polymerization of 8-Phe-4-b-PCL (8-Phe-4 with Mn of 
7k, 8-Phe-4/ε-CL=1/6, w/w) 
